ÿþ<html xmlns:v="urn:schemas-microsoft-com:vml" xmlns:o="urn:schemas-microsoft-com:office:office" xmlns:w="urn:schemas-microsoft-com:office:word" xmlns:x="urn:schemas-microsoft-com:office:excel" xmlns:p="urn:schemas-microsoft-com:office:powerpoint" xmlns:a="urn:schemas-microsoft-com:office:access" xmlns:dt="uuid:C2F41010-65B3-11d1-A29F-00AA00C14882" xmlns:s="uuid:BDC6E3F0-6DA3-11d1-A2A3-00AA00C14882" xmlns:rs="urn:schemas-microsoft-com:rowset" xmlns:z="#RowsetSchema" xmlns:b="urn:schemas-microsoft-com:office:publisher" xmlns:ss="urn:schemas-microsoft-com:office:spreadsheet" xmlns:c="urn:schemas-microsoft-com:office:component:spreadsheet" xmlns:odc="urn:schemas-microsoft-com:office:odc" xmlns:oa="urn:schemas-microsoft-com:office:activation" xmlns:html="http://www.w3.org/TR/REC-html40" xmlns:q="http://schemas.xmlsoap.org/soap/envelope/" xmlns:rtc="http://microsoft.com/officenet/conferencing" xmlns:D="DAV:" xmlns:Repl="http://schemas.microsoft.com/repl/" xmlns:mt="http://schemas.microsoft.com/sharepoint/soap/meetings/" xmlns:x2="http://schemas.microsoft.com/office/excel/2003/xml" xmlns:ppda="http://www.passport.com/NameSpace.xsd" xmlns:ois="http://schemas.microsoft.com/sharepoint/soap/ois/" xmlns:dir="http://schemas.microsoft.com/sharepoint/soap/directory/" xmlns:ds="http://www.w3.org/2000/09/xmldsig#" xmlns:dsp="http://schemas.microsoft.com/sharepoint/dsp" xmlns:udc="http://schemas.microsoft.com/data/udc" xmlns:xsd="http://www.w3.org/2001/XMLSchema" xmlns:sub="http://schemas.microsoft.com/sharepoint/soap/2002/1/alerts/" xmlns:ec="http://www.w3.org/2001/04/xmlenc#" xmlns:sp="http://schemas.microsoft.com/sharepoint/" xmlns:sps="http://schemas.microsoft.com/sharepoint/soap/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:udcs="http://schemas.microsoft.com/data/udc/soap" xmlns:udcxf="http://schemas.microsoft.com/data/udc/xmlfile" xmlns:udcp2p="http://schemas.microsoft.com/data/udc/parttopart" xmlns:m="http://schemas.microsoft.com/office/2004/12/omml" xmlns:st="&#1;" xmlns:st1="urn:schemas-microsoft-com:office:smarttags" xmlns:st2="urn:schemas:contacts" xmlns="http://www.w3.org/TR/REC-html40"> <head> <meta http-equiv=Content-Type content="text/html; charset=unicode"> <meta name=ProgId content=Word.Document> <meta name=Generator content="Microsoft Word 12"> <meta name=Originator content="Microsoft Word 12"> <link rel=File-List href="cvita_files/filelist.xml"> <link rel=Edit-Time-Data href="cvita_files/editdata.mso"> <!--[if !mso]> <style> v\:* {behavior:url(#default#VML);} o\:* {behavior:url(#default#VML);} w\:* {behavior:url(#default#VML);} .shape {behavior:url(#default#VML);} </style> <![endif]--> <title>Curriculum Vitae</title> <o:SmartTagType namespaceuri="urn:schemas-microsoft-com:office:smarttags" name="country-region"/> <o:SmartTagType namespaceuri="urn:schemas:contacts" name="Sn"/> <o:SmartTagType namespaceuri="urn:schemas:contacts" name="GivenName"/> <o:SmartTagType namespaceuri="urn:schemas:contacts" name="title"/> <o:SmartTagType namespaceuri="urn:schemas-microsoft-com:office:smarttags" name="Street"/> <o:SmartTagType namespaceuri="urn:schemas-microsoft-com:office:smarttags" name="PersonName"/> <o:SmartTagType namespaceuri="urn:schemas-microsoft-com:office:smarttags" name="address"/> <o:SmartTagType namespaceuri="urn:schemas-microsoft-com:office:smarttags" name="State"/> <o:SmartTagType namespaceuri="urn:schemas-microsoft-com:office:smarttags" name="City"/> <o:SmartTagType namespaceuri="urn:schemas-microsoft-com:office:smarttags" name="place"/> <o:SmartTagType namespaceuri="urn:schemas-microsoft-com:office:smarttags" name="PlaceType"/> <o:SmartTagType namespaceuri="urn:schemas-microsoft-com:office:smarttags" name="PlaceName"/> <link rel=themeData href="cvita_files/themedata.thmx"> <link rel=colorSchemeMapping href="cvita_files/colorschememapping.xml"> <!--[if gte mso 9]><xml> <w:WordDocument> <w:Zoom>90</w:Zoom> <w:SpellingState>Clean</w:SpellingState> <w:GrammarState>Clean</w:GrammarState> <w:TrackMoves/> <w:TrackFormatting/> <w:ValidateAgainstSchemas/> <w:SaveIfXMLInvalid>false</w:SaveIfXMLInvalid> <w:IgnoreMixedContent>false</w:IgnoreMixedContent> <w:AlwaysShowPlaceholderText>false</w:AlwaysShowPlaceholderText> <w:DoNotPromoteQF/> <w:LidThemeOther>EN-US</w:LidThemeOther> <w:LidThemeAsian>X-NONE</w:LidThemeAsian> <w:LidThemeComplexScript>X-NONE</w:LidThemeComplexScript> <w:Compatibility> <w:BreakWrappedTables/> <w:SnapToGridInCell/> <w:WrapTextWithPunct/> <w:UseAsianBreakRules/> <w:DontGrowAutofit/> <w:SplitPgBreakAndParaMark/> <w:DontVertAlignCellWithSp/> <w:DontBreakConstrainedForcedTables/> <w:DontVertAlignInTxbx/> <w:Word11KerningPairs/> <w:CachedColBalance/> </w:Compatibility> <w:BrowserLevel>MicrosoftInternetExplorer4</w:BrowserLevel> <m:mathPr> <m:mathFont m:val="Cambria Math"/> <m:brkBin m:val="before"/> <m:brkBinSub m:val="&#45;-"/> <m:smallFrac m:val="off"/> <m:dispDef/> <m:lMargin m:val="0"/> <m:rMargin m:val="0"/> <m:defJc m:val="centerGroup"/> <m:wrapIndent m:val="1440"/> <m:intLim m:val="subSup"/> <m:naryLim m:val="undOvr"/> </m:mathPr></w:WordDocument> </xml><![endif]--><!--[if gte mso 9]><xml> <w:LatentStyles DefLockedState="false" DefUnhideWhenUsed="false" DefSemiHidden="false" DefQFormat="false" LatentStyleCount="267"> <w:LsdException Locked="false" QFormat="true" Name="Normal"/> <w:LsdException Locked="false" QFormat="true" Name="heading 1"/> <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true" QFormat="true" Name="heading 2"/> <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true" QFormat="true" Name="heading 3"/> <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true" QFormat="true" Name="heading 4"/> <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true" QFormat="true" Name="heading 5"/> <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true" QFormat="true" Name="heading 6"/> <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true" QFormat="true" Name="heading 7"/> <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true" QFormat="true" Name="heading 8"/> <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true" QFormat="true" Name="heading 9"/> <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true" QFormat="true" Name="caption"/> <w:LsdException Locked="false" QFormat="true" Name="Title"/> <w:LsdException Locked="false" Priority="1" Name="Default Paragraph Font"/> <w:LsdException Locked="false" QFormat="true" Name="Subtitle"/> <w:LsdException Locked="false" QFormat="true" Name="Strong"/> <w:LsdException Locked="false" QFormat="true" Name="Emphasis"/> <w:LsdException Locked="false" Priority="99" Name="No List"/> <w:LsdException Locked="false" Priority="99" SemiHidden="true" Name="Placeholder Text"/> <w:LsdException Locked="false" Priority="1" QFormat="true" Name="No Spacing"/> <w:LsdException Locked="false" Priority="60" Name="Light Shading"/> <w:LsdException Locked="false" Priority="61" Name="Light List"/> <w:LsdException Locked="false" Priority="62" Name="Light Grid"/> <w:LsdException Locked="false" Priority="63" Name="Medium Shading 1"/> <w:LsdException Locked="false" Priority="64" Name="Medium Shading 2"/> <w:LsdException Locked="false" Priority="65" Name="Medium List 1"/> <w:LsdException Locked="false" Priority="66" Name="Medium List 2"/> <w:LsdException Locked="false" Priority="67" Name="Medium Grid 1"/> <w:LsdException Locked="false" Priority="68" Name="Medium Grid 2"/> <w:LsdException Locked="false" Priority="69" Name="Medium Grid 3"/> <w:LsdException Locked="false" Priority="70" Name="Dark List"/> <w:LsdException Locked="false" Priority="71" Name="Colorful Shading"/> <w:LsdException Locked="false" Priority="72" Name="Colorful List"/> <w:LsdException Locked="false" Priority="73" Name="Colorful Grid"/> <w:LsdException Locked="false" Priority="60" Name="Light Shading Accent 1"/> <w:LsdException Locked="false" Priority="61" Name="Light List Accent 1"/> <w:LsdException Locked="false" Priority="62" Name="Light Grid Accent 1"/> <w:LsdException Locked="false" Priority="63" Name="Medium Shading 1 Accent 1"/> <w:LsdException Locked="false" Priority="64" Name="Medium Shading 2 Accent 1"/> <w:LsdException Locked="false" Priority="65" Name="Medium List 1 Accent 1"/> <w:LsdException Locked="false" Priority="99" SemiHidden="true" Name="Revision"/> <w:LsdException Locked="false" Priority="34" QFormat="true" Name="List Paragraph"/> <w:LsdException Locked="false" Priority="29" QFormat="true" Name="Quote"/> <w:LsdException Locked="false" Priority="30" QFormat="true" Name="Intense Quote"/> <w:LsdException Locked="false" Priority="66" Name="Medium List 2 Accent 1"/> <w:LsdException Locked="false" Priority="67" Name="Medium Grid 1 Accent 1"/> <w:LsdException Locked="false" Priority="68" Name="Medium Grid 2 Accent 1"/> <w:LsdException Locked="false" Priority="69" Name="Medium Grid 3 Accent 1"/> <w:LsdException Locked="false" Priority="70" Name="Dark List Accent 1"/> <w:LsdException Locked="false" Priority="71" Name="Colorful Shading Accent 1"/> <w:LsdException Locked="false" Priority="72" Name="Colorful List Accent 1"/> <w:LsdException Locked="false" Priority="73" Name="Colorful Grid Accent 1"/> <w:LsdException Locked="false" Priority="60" Name="Light Shading Accent 2"/> <w:LsdException Locked="false" Priority="61" Name="Light List Accent 2"/> <w:LsdException Locked="false" Priority="62" Name="Light Grid Accent 2"/> <w:LsdException Locked="false" Priority="63" Name="Medium Shading 1 Accent 2"/> <w:LsdException Locked="false" Priority="64" Name="Medium Shading 2 Accent 2"/> <w:LsdException Locked="false" Priority="65" Name="Medium List 1 Accent 2"/> <w:LsdException Locked="false" Priority="66" Name="Medium List 2 Accent 2"/> <w:LsdException Locked="false" Priority="67" Name="Medium Grid 1 Accent 2"/> <w:LsdException Locked="false" Priority="68" Name="Medium Grid 2 Accent 2"/> <w:LsdException Locked="false" Priority="69" Name="Medium Grid 3 Accent 2"/> <w:LsdException Locked="false" Priority="70" Name="Dark List Accent 2"/> <w:LsdException Locked="false" Priority="71" Name="Colorful Shading Accent 2"/> <w:LsdException Locked="false" Priority="72" Name="Colorful List Accent 2"/> <w:LsdException Locked="false" Priority="73" Name="Colorful Grid Accent 2"/> <w:LsdException Locked="false" Priority="60" Name="Light Shading Accent 3"/> <w:LsdException Locked="false" Priority="61" Name="Light List Accent 3"/> <w:LsdException Locked="false" Priority="62" Name="Light Grid Accent 3"/> <w:LsdException Locked="false" Priority="63" Name="Medium Shading 1 Accent 3"/> <w:LsdException Locked="false" Priority="64" Name="Medium Shading 2 Accent 3"/> <w:LsdException Locked="false" Priority="65" Name="Medium List 1 Accent 3"/> <w:LsdException Locked="false" Priority="66" Name="Medium List 2 Accent 3"/> <w:LsdException Locked="false" Priority="67" Name="Medium Grid 1 Accent 3"/> <w:LsdException Locked="false" Priority="68" Name="Medium Grid 2 Accent 3"/> <w:LsdException Locked="false" Priority="69" Name="Medium Grid 3 Accent 3"/> <w:LsdException Locked="false" Priority="70" Name="Dark List Accent 3"/> <w:LsdException Locked="false" Priority="71" Name="Colorful Shading Accent 3"/> <w:LsdException Locked="false" Priority="72" Name="Colorful List Accent 3"/> <w:LsdException Locked="false" Priority="73" Name="Colorful Grid Accent 3"/> <w:LsdException Locked="false" Priority="60" Name="Light Shading Accent 4"/> <w:LsdException Locked="false" Priority="61" Name="Light List Accent 4"/> <w:LsdException Locked="false" Priority="62" Name="Light Grid Accent 4"/> <w:LsdException Locked="false" Priority="63" Name="Medium Shading 1 Accent 4"/> <w:LsdException Locked="false" Priority="64" Name="Medium Shading 2 Accent 4"/> <w:LsdException Locked="false" Priority="65" Name="Medium List 1 Accent 4"/> <w:LsdException Locked="false" Priority="66" Name="Medium List 2 Accent 4"/> <w:LsdException Locked="false" Priority="67" Name="Medium Grid 1 Accent 4"/> <w:LsdException Locked="false" Priority="68" Name="Medium Grid 2 Accent 4"/> <w:LsdException Locked="false" Priority="69" Name="Medium Grid 3 Accent 4"/> <w:LsdException Locked="false" Priority="70" Name="Dark List Accent 4"/> <w:LsdException Locked="false" Priority="71" Name="Colorful Shading Accent 4"/> <w:LsdException Locked="false" Priority="72" Name="Colorful List Accent 4"/> <w:LsdException Locked="false" Priority="73" Name="Colorful Grid Accent 4"/> <w:LsdException Locked="false" Priority="60" Name="Light Shading Accent 5"/> <w:LsdException Locked="false" Priority="61" Name="Light List Accent 5"/> <w:LsdException Locked="false" Priority="62" Name="Light Grid Accent 5"/> <w:LsdException Locked="false" Priority="63" Name="Medium Shading 1 Accent 5"/> <w:LsdException Locked="false" Priority="64" Name="Medium Shading 2 Accent 5"/> <w:LsdException Locked="false" Priority="65" Name="Medium List 1 Accent 5"/> <w:LsdException Locked="false" Priority="66" Name="Medium List 2 Accent 5"/> <w:LsdException Locked="false" Priority="67" Name="Medium Grid 1 Accent 5"/> <w:LsdException Locked="false" Priority="68" Name="Medium Grid 2 Accent 5"/> <w:LsdException Locked="false" Priority="69" Name="Medium Grid 3 Accent 5"/> <w:LsdException Locked="false" Priority="70" Name="Dark List Accent 5"/> <w:LsdException Locked="false" Priority="71" Name="Colorful Shading Accent 5"/> <w:LsdException Locked="false" Priority="72" Name="Colorful List Accent 5"/> <w:LsdException Locked="false" Priority="73" Name="Colorful Grid Accent 5"/> <w:LsdException Locked="false" Priority="60" Name="Light Shading Accent 6"/> <w:LsdException Locked="false" Priority="61" Name="Light List Accent 6"/> <w:LsdException Locked="false" Priority="62" Name="Light Grid Accent 6"/> <w:LsdException Locked="false" Priority="63" Name="Medium Shading 1 Accent 6"/> <w:LsdException Locked="false" Priority="64" Name="Medium Shading 2 Accent 6"/> <w:LsdException Locked="false" Priority="65" Name="Medium List 1 Accent 6"/> <w:LsdException Locked="false" Priority="66" Name="Medium List 2 Accent 6"/> <w:LsdException Locked="false" Priority="67" Name="Medium Grid 1 Accent 6"/> <w:LsdException Locked="false" Priority="68" Name="Medium Grid 2 Accent 6"/> <w:LsdException Locked="false" Priority="69" Name="Medium Grid 3 Accent 6"/> <w:LsdException Locked="false" Priority="70" Name="Dark List Accent 6"/> <w:LsdException Locked="false" Priority="71" Name="Colorful Shading Accent 6"/> <w:LsdException Locked="false" Priority="72" Name="Colorful List Accent 6"/> <w:LsdException Locked="false" Priority="73" Name="Colorful Grid Accent 6"/> <w:LsdException Locked="false" Priority="19" QFormat="true" Name="Subtle Emphasis"/> <w:LsdException Locked="false" Priority="21" QFormat="true" Name="Intense Emphasis"/> <w:LsdException Locked="false" Priority="31" QFormat="true" Name="Subtle Reference"/> <w:LsdException Locked="false" Priority="32" QFormat="true" Name="Intense Reference"/> <w:LsdException Locked="false" Priority="33" QFormat="true" Name="Book Title"/> <w:LsdException Locked="false" Priority="37" SemiHidden="true" UnhideWhenUsed="true" Name="Bibliography"/> <w:LsdException Locked="false" Priority="39" SemiHidden="true" UnhideWhenUsed="true" QFormat="true" Name="TOC Heading"/> </w:LatentStyles> </xml><![endif]--><!--[if !mso]><object classid="clsid:38481807-CA0E-42D2-BF39-B33AF135CC4D" id=ieooui></object> <style> st1\:*{behavior:url(#ieooui) }st2\:*{behavior:url(#ieooui) } </style> <![endif]--> <style> <!-- /* Font Definitions */ @font-face {font-family:Batang; panose-1:2 3 6 0 0 1 1 1 1 1; mso-font-alt:¼ÕÐ; mso-font-charset:129; mso-generic-font-family:roman; mso-font-pitch:variable; mso-font-signature:-1342176593 1775729915 48 0 524447 0;} @font-face {font-family:SimSun; panose-1:2 1 6 0 3 1 1 1 1 1; mso-font-alt:‹[SO; mso-font-charset:134; mso-generic-font-family:auto; mso-font-pitch:variable; mso-font-signature:3 680460288 22 0 262145 0;} @font-face {font-family:"Cambria Math"; panose-1:2 4 5 3 5 4 6 3 2 4; mso-font-charset:0; mso-generic-font-family:roman; mso-font-pitch:variable; mso-font-signature:-1610611985 1107304683 0 0 159 0;} @font-face {font-family:"\@Batang"; panose-1:2 3 6 0 0 1 1 1 1 1; mso-font-charset:129; mso-generic-font-family:roman; mso-font-pitch:variable; mso-font-signature:-1342176593 1775729915 48 0 524447 0;} @font-face {font-family:"\@SimSun"; panose-1:2 1 6 0 3 1 1 1 1 1; mso-font-charset:134; mso-generic-font-family:auto; mso-font-pitch:variable; mso-font-signature:3 680460288 22 0 262145 0;} /* Style Definitions */ p.MsoNormal, li.MsoNormal, div.MsoNormal {mso-style-unhide:no; mso-style-qformat:yes; mso-style-parent:""; margin:0in; margin-bottom:.0001pt; mso-pagination:widow-orphan; font-size:12.0pt; font-family:"Times New Roman","serif"; mso-fareast-font-family:SimSun; color:black;} a:link, span.MsoHyperlink {mso-style-unhide:no; color:blue; text-decoration:underline; text-underline:single;} a:visited, span.MsoHyperlinkFollowed {mso-style-unhide:no; color:purple; text-decoration:underline; text-underline:single;} p {mso-style-unhide:no; mso-margin-top-alt:auto; margin-right:0in; mso-margin-bottom-alt:auto; margin-left:0in; mso-pagination:widow-orphan; font-size:12.0pt; font-family:"Times New Roman","serif"; mso-fareast-font-family:SimSun; color:black;} span.SpellE {mso-style-name:""; mso-spl-e:yes;} span.GramE {mso-style-name:""; mso-gram-e:yes;} .MsoChpDefault {mso-style-type:export-only; mso-default-props:yes; font-size:10.0pt; mso-ansi-font-size:10.0pt; mso-bidi-font-size:10.0pt;} @page WordSection1 {size:8.5in 11.0in; margin:1.0in 1.25in 1.0in 1.25in; mso-header-margin:.5in; mso-footer-margin:.5in; mso-paper-source:0;} div.WordSection1 {page:WordSection1;} --> </style> <!--[if gte mso 10]> <style> /* Style Definitions */ table.MsoNormalTable {mso-style-name:"Table Normal"; mso-tstyle-rowband-size:0; mso-tstyle-colband-size:0; mso-style-noshow:yes; mso-style-priority:99; mso-style-qformat:yes; mso-style-parent:""; mso-padding-alt:0in 5.4pt 0in 5.4pt; mso-para-margin:0in; mso-para-margin-bottom:.0001pt; mso-pagination:widow-orphan; font-size:10.0pt; font-family:"Times New Roman","serif";} </style> <![endif]--> <meta content=8.0.4308 name=Version> <meta content="7/8/97" name=Date> <meta content="C:\Program Files\Microsoft Office\Office\html.dot" name=Template> <!--[if gte mso 9]><xml> <o:shapedefaults v:ext="edit" spidmax="1026"/> </xml><![endif]--><!--[if gte mso 9]><xml> <o:shapelayout v:ext="edit"> <o:idmap v:ext="edit" data="1"/> </o:shapelayout></xml><![endif]--> </head> <body bgcolor=white lang=EN-US link=blue vlink=purple style='tab-interval:.5in'> <div class=WordSection1> <p align=center style='text-align:center'><b><i><span style='font-family:"Arial","sans-serif"; mso-bidi-font-family:"Times New Roman"'>Curriculum vita<br> </span></i></b><i><span style='font-size:10.0pt;font-family:"Arial","sans-serif"; mso-bidi-font-family:"Times New Roman";color:windowtext;mso-bidi-font-weight: bold'>(updated 1/23/2012)<o:p></o:p></span></i></p> <p><st1:PersonName st="on" w:st="on"><b><span style='font-size:10.0pt; font-family:"Arial","sans-serif";mso-bidi-font-family:"Times New Roman"'>Michael Blaber</span></b></st1:PersonName><b><span style='font-size:10.0pt;font-family: "Arial","sans-serif";mso-bidi-font-family:"Times New Roman"'>, Ph.D.<br> </span></b><span style='font-size:10.0pt;font-family:"Arial","sans-serif"; mso-bidi-font-family:"Times New Roman";mso-bidi-font-weight:bold'>Department of <st1:PlaceName w:st="on">Biomedical</st1:PlaceName> <st1:PlaceName w:st="on">Sciences</st1:PlaceName><br> <st1:PlaceType w:st="on">College</st1:PlaceType> of <st1:PlaceName w:st="on">Medicine</st1:PlaceName><br> <st1:PlaceName w:st="on">Florida</st1:PlaceName> <st1:PlaceType w:st="on">State</st1:PlaceType> <st1:PlaceType w:st="on">University</st1:PlaceType><br> <st1:place w:st="on"><st1:City w:st="on">Tallahassee</st1:City></st1:place>, FL 32306-4300<br> TEL: (850) 644-3361 FAX: (850) 644-5781<i> </i></span><span style='font-family: "Arial","sans-serif";mso-bidi-font-family:"Times New Roman"'><br> <a href="mailto:michael.blaber@med.fsu.edu"><span style='font-size:10.0pt'>michael.blaber@med.fsu.edu</span></a><o:p></o:p></span></p> <p><span style='font-family:"Arial","sans-serif";mso-bidi-font-family:"Times New Roman"'><a href="http://www.mikeblaber.org/cvita.html#teaching"><i><span style='font-size: 10.0pt'>Jump to teaching...</span></i></a><br> <a href="http://www.mikeblaber.org/cvita.html#funding"><i><span style='font-size:10.0pt'>Jump to funding...</span></i></a></span><i><span style='font-size:10.0pt;font-family:"Arial","sans-serif";mso-bidi-font-family: "Times New Roman"'><br> </span></i><span style='font-family:"Arial","sans-serif";mso-bidi-font-family: "Times New Roman"'><a href="http://www.mikeblaber.org/cvita.html#publications"><i><span style='font-size:10.0pt'>Jump to publications...</span></i></a><o:p></o:p></span></p> <div class=MsoNormal align=center style='text-align:center'><span style='font-family:"Arial","sans-serif";mso-bidi-font-family:"Times New Roman"'> <hr size=1 width="100%" align=center> </span></div> <p align=center style='text-align:center'><b><span style='font-family:"Arial","sans-serif"; mso-bidi-font-family:"Times New Roman"'>Education<o:p></o:p></span></b></p> <p><b><span style='font-size:10.0pt;font-family:"Arial","sans-serif"; mso-bidi-font-family:"Times New Roman"'>Ph.D.</span></b><span style='font-size: 10.0pt;font-family:"Arial","sans-serif";mso-bidi-font-family:"Times New Roman"'>, <b>Biological Chemistry</b>, University of California, Irvine CA <i>Thesis Director: Dr. Ralph A. Bradshaw </i>(9/85-2/90)<br> <b>B.A.</b>, <b>Biochemistry/Molecular Biology</b>, <st1:PlaceType st="on" w:st="on">University</st1:PlaceType> of <st1:PlaceName st="on" w:st="on">California</st1:PlaceName>, <st1:place st="on" w:st="on"><st1:City st="on" w:st="on">Santa Barbara</st1:City> <st1:State st="on" w:st="on">CA</st1:State></st1:place> (9/76-6/80)<o:p></o:p></span></p> <p align=center style='text-align:center'><b><span style='font-family:"Arial","sans-serif"; mso-bidi-font-family:"Times New Roman"'>Professional Experience<o:p></o:p></span></b></p> <p><b><span style='font-size:10.0pt;font-family:"Arial","sans-serif"; mso-bidi-font-family:"Times New Roman"'>Faculty, Program in Neuroscience</span></b><span style='font-size:10.0pt;font-family:"Arial","sans-serif";mso-bidi-font-family: "Times New Roman";mso-bidi-font-weight:bold'>, Florida State University</span><span style='font-size:10.0pt;font-family:"Arial","sans-serif";mso-bidi-font-family: "Times New Roman"'>, Tallahassee FL (4/10-present)<br> <b>Invited Research Fellow, </b><span style='mso-bidi-font-weight:bold'>Quantum Beam Science Directorate, Japan Atomic Energy Agency (JAEA) (09-10)<b><br> Professor of Biomedical Sciences</b></span>, College of Medicine, Florida State University, Tallahassee FL (8/07-present)<b> <br> Associate Professor of Biomedical Sciences</b>, College of Medicine, Florida State University, Tallahassee FL (8/05-7/07)<br> <b>Associate Professor of Chemistry</b>, College of Arts &amp; Sciences, Florida State University, Tallahassee FL (8/00-7/05)<br> <b>Faculty, Program in Molecular Biophysics</b><span style='mso-bidi-font-weight: bold'>, Florida State University</span>, Tallahassee FL (8/94-present)<b><br> Assistant Professor of Chemistry</b>, College of Arts &amp; Sciences, Florida State University, Tallahassee FL (8/94-7/00)<br> <b>Postdoctoral Fellow</b>, Institute of Molecular Biology, University of Oregon, Eugene OR <i>Postdoctoral Director: Dr. Brian W. Matthews</i> (3/90-7/94) <br> <b>Research Associate</b>, Department of Protein Chemistry, Genentech, Inc., South San Francisco, CA (9/80-8/85)<b><o:p></o:p></b></span></p> <p align=center style='text-align:center'><b><span style='font-family:"Arial","sans-serif"; mso-bidi-font-family:"Times New Roman"'>Awards<o:p></o:p></span></b></p> <p><b style='mso-bidi-font-weight:normal'><span style='font-size:10.0pt; font-family:"Arial","sans-serif";mso-bidi-font-family:"Times New Roman"; mso-bidi-font-style:italic'>U.S. Patent 13/044,723, </span></b><i><span style='font-size:10.0pt;font-family:"Arial","sans-serif";mso-bidi-font-family: "Times New Roman"'>Method For Development Of A Peptide Building Block Useful For De Novo Protein Design</span></i><span style='font-size:10.0pt;font-family: "Arial","sans-serif";mso-bidi-font-family:"Times New Roman";mso-bidi-font-style: italic'>, Blaber, M. and Lee, J. (3/11, pending)<i><br> </i><b style='mso-bidi-font-weight:normal'>U.S. Patent 61/179,751</b><i>, Fibroblast Growth Factor Mutants Having Improved Functional Half-Life And Methods Of Their Use</i>, Blaber, M. and Lee, J. (5/10, pending)<i> </i><b style='mso-bidi-font-weight:normal'><br> U.S. Patent 12/833,773, </b><i>Methods and Materials for Treating Inflammatory Conditions</i>, Scarisbrick, I.A., Blaber, S.I., Blaber, M. and Rodriguez, M. (9/10, pending)<br> <b style='mso-bidi-font-weight:normal'>U.S. Patent 7,790,682</b>, <i>Engineered Human Acidic Fibroblast Growth Factors and Associated Methods</i>, Blaber, M. and Brych, S. (9/10)<b style='mso-bidi-font-weight:normal'><br> U.S. Patent 7,776,825</b></span><span style='font-size:10.0pt;font-family:"Arial","sans-serif"; mso-bidi-font-family:"Times New Roman"'>,<i> Mutant Polypeptides of Fibroblast Growth Factor 1, </i>Blaber, M. and Dubey, V.K. (8/10)<br> <b style='mso-bidi-font-weight:normal'><span style='mso-bidi-font-style:italic'>U.S. Patent 7,754,216 B2</span></b><span style='mso-bidi-font-style:italic'>, <i>Method of Treating Multiple Sclerosis with Anti-K6 Antibody</i>, Scarisbrick, I.A., Blaber, S.I., Blaber, M. and Rodriguez, M. (7/10)<br> <b style='mso-bidi-font-weight:normal'>U.S. Patent 7,696,171</b></span>,<i> Mutant Polypeptides of Fibroblast Growth Factor 1, </i>Blaber, M. and Dubey, V.K. (4/10)<br> <b style='mso-bidi-font-weight:normal'><span style='mso-bidi-font-style:italic'>U.S. Patent 7,659,379</span></b><span style='mso-bidi-font-style:italic'>, <i>Mutants of Human Fibroblast Growth Factor Having Increased Stability and/or Mitogenic Potency, </i></span>Blaber, M. and Dubey, V.K. (2/10)<b style='mso-bidi-font-weight: normal'><span style='mso-bidi-font-style:italic'><span style='mso-spacerun:yes'>  </span><br> U.S. Patent 7,595,296</span></b>,<i> Mutant Polypeptides of Fibroblast Growth Factor 1, </i>Blaber, M. and Dubey, V.K. (9/09)<br> <b>E.K. Frey-E. <span class=SpellE>Werle</span> Commemorative Gold Medal</b><span style='mso-bidi-font-weight:bold'> (09)<b><br> Faculty Ranking #1, </b></span>Department of Biomedical Sciences<b>, </b>Florida State University<b> </b>(09)<br> <b>European Patent 1,513,553 B1</b><span style='mso-bidi-font-weight:bold'>, <i style='mso-bidi-font-style:normal'>Methods and Materials for Treating and Diagnosing Kallikrein-6 Related Inflammatory Conditions</i>, Scarisbrick, I.A., Blaber, S.I. and Blaber, M. (11/08)<b><br> Outstanding Senior Faculty Researcher Award, </b></span>Department of Biomedical Sciences, College of Medicine<b>, </b>Florida State University<b> </b>(07)<br> <b style='mso-bidi-font-weight:normal'>FSU Innovator Award</b>, Florida State University (04, 06, 07, 10)<br> <b style='mso-bidi-font-weight:normal'>U.S. Patent 0,127,391 A1</b>, <i style='mso-bidi-font-style:normal'>Methods and Materials for Treating Inflammatory Conditions</i>, Scarisbrick, I.A., Blaber, S.I., Blaber, M. and Moses, R. (5/03; pending)<b><br> Faculty Ranking #1, </b>Department of Chemistry &amp; Biochemistry<b>, </b>Florida State University<b> </b>(02)<br> <b style='mso-bidi-font-weight:normal'>U.S. Patent 0,146,731 A1</b>, <i style='mso-bidi-font-style:normal'>Synthetic Nucleic Acid Sequences for 2,5-Diketo-D-Gluconic Acid <span class=SpellE>Reductases</span> and Associated Methods</i>, Sanli, G., Blaber, S.I. and Blaber, M. (1/02; pending)<b><br> Tenured, </b>Florida State University<b> </b>(9/00)<b><br> University Teaching Award</b>, Florida State University, Tallahassee FL (4/99)<br> <b>First Year Assistant Professor Award</b>, FSU, Tallahassee FL (5/95)<br> <b>N.I.H. Postdoctoral Fellowship GM13709-01, </b>Institute of Molecular Biology, University of Oregon, Eugene OR (3/90-2/93)<br> <b>N.I.H. <span class=SpellE>Predoctoral</span> Fellowship GM07134-11, </b>University of California, Irvine CA (9/86-8/89)<br> <b>Earl C. Anthony Dissertation Fellowship</b>, University of California, Irvine CA (9/89-12/89)<br> <b style='mso-bidi-font-weight:normal'><span style='mso-bidi-font-style:italic'>U.S. Patent 5,219,569</span></b>,<i> Protease Resistant Urokinase, </i>Blaber, M., <span class=SpellE>Heyneker</span>, H.L. and <span class=SpellE>Vehar</span>, G.A. (6/93)<span style='mso-bidi-font-style:italic'><o:p></o:p></span></span></p> <p><span style='font-size:10.0pt;font-family:"Arial","sans-serif";mso-bidi-font-family: "Times New Roman"'><o:p>&nbsp;</o:p></span></p> <p align=center style='text-align:center'><a name=teaching></a><b><span style='font-family:"Arial","sans-serif";mso-bidi-font-family:"Times New Roman"'>Teaching - Courses Developed<o:p></o:p></span></b></p> <p><b><span style='font-size:10.0pt;font-family:"Arial","sans-serif"; mso-bidi-font-family:"Times New Roman"'>BCH4053L Biochemistry Lab</span></b><span style='font-size:10.0pt;font-family:"Arial","sans-serif";mso-bidi-font-family: "Times New Roman"'> (Undergraduate, HTML format. </span><span style='font-size: 10.0pt;mso-bidi-font-size:12.0pt;font-family:"Arial","sans-serif";mso-bidi-font-family: "Times New Roman"'><a href="http://mikeblaber.org/oldwine/BCH4053l/bch4053l.htm">http://mikeblaber.org/oldwine/BCH4053l/bch4053l.htm</a></span><span style='font-size:10.0pt;font-family:"Arial","sans-serif";mso-bidi-font-family: "Times New Roman"'>) FSU (1/04)<br> <b>BCH4053 Biochemistry I</b> (Undergraduate, HTML format. </span><span style='font-size:10.0pt;mso-bidi-font-size:12.0pt;font-family:"Arial","sans-serif"; mso-bidi-font-family:"Times New Roman"'><a href="http://mikeblaber.org/oldwine/BCH4053/bch4053.htm">http://mikeblaber.org/oldwine/BCH4053/bch4053.htm</a></span><span style='font-size:10.0pt;font-family:"Arial","sans-serif";mso-bidi-font-family: "Times New Roman"'>) FSU (9/01)<br> <b>CHM 1046 General Chemistry II</b> (Undergraduate, HTML format. </span><span style='font-size:10.0pt;mso-bidi-font-size:12.0pt;font-family:"Arial","sans-serif"; mso-bidi-font-family:"Times New Roman"'><a href="http://mikeblaber.org/oldwine/chm1046/chm1046.htm">http://mikeblaber.org/oldwine/chm1046/chm1046.htm</a></span><span style='font-size:10.0pt;font-family:"Arial","sans-serif";mso-bidi-font-family: "Times New Roman"'>) FSU (1/00)<br> <b>CHM 1045 General Chemistry I</b> (Undergraduate, HTML format, </span><span style='font-size:10.0pt;mso-bidi-font-size:12.0pt;font-family:"Arial","sans-serif"; mso-bidi-font-family:"Times New Roman"'><a href="http://mikeblaber.org/oldwine/chm1045/chm1045.htm">http://mikeblaber.org/oldwine/chm1045/chm1045.htm</a></span><span style='font-size:10.0pt;font-family:"Arial","sans-serif";mso-bidi-font-family: "Times New Roman"'>) FSU (4/99)<br> <b>BCH 5425 Molecular Biology and Biotechnology</b> (Graduate, HTML format, </span><span style='font-size:10.0pt;mso-bidi-font-size:12.0pt;font-family:"Arial","sans-serif"; mso-bidi-font-family:"Times New Roman"'><a href="http://mikeblaber.org/oldwine/bch5425/bch5425.htm">http://mikeblaber.org/oldwine/bch5425/bch5425.htm</a></span><span style='font-size:10.0pt;font-family:"Arial","sans-serif";mso-bidi-font-family: "Times New Roman"'>) FSU (1/96)<br> <b>BCH 5887 Protein Structure and Stability</b> FSU (9/95)<o:p></o:p></span></p> <p align=center style='text-align:center'><b><span style='font-family:"Arial","sans-serif"; mso-bidi-font-family:"Times New Roman"'>Teaching - Courses Taught<o:p></o:p></span></b></p> <p><b><span style='font-size:10.0pt;font-family:"Arial","sans-serif"; mso-bidi-font-family:"Times New Roman"'>BMS 6401 Medical Pharmacology</span></b><span style='font-size:10.0pt;font-family:"Arial","sans-serif";mso-bidi-font-family: "Times New Roman";mso-bidi-font-weight:bold'> (small group facilitation) FSU (Sp 09, Sp 10, F 11)<br> <b>BMS 6301 General Medical Microbiology</b> (small group facilitation) FSU (F 09)<b><br> BMS 5525 <span class=SpellE>Bioregulation</span> </b>(2 lectures on <span class=SpellE>Molec</span>. Visualization, Protein/Nucleic Acid Interactions) FSU (Sp 08, Sp 09, Sp 10)<br> <b>BMS 6204 Medical Biochemistry </b>(28 lectures) FSU (Sp 07)<br> <b>BMS 6110C Clinical Microanatomy</b> (small group facilitation) FSU (F 05, F 06)<b><br> BMS 6204 Medical Biochemistry </b>(small group facilitation) FSU (Sp 06, Sp 07)<br> <b>BMS 6520 Systemic Physiology </b>(small group facilitation) FSU (Sp 06-Sp 09)<br> <b>BMS 6001 <span class=SpellE>Epigenetics</span></b> (team lectures) FSU (Sp 06)<b><br> BMS 6601 General Pathology &amp; Immunology </b>(small group facilitation) FSU (F 05-F 11, Sp 10)<b><br> BCH 4053L Biochemistry Lab </b></span><span style='font-size:10.0pt;font-family: "Arial","sans-serif";mso-bidi-font-family:"Times New Roman"'>(Undergraduate) FSU (Sp 04)<br> <b>BMS 6204 Medical Biochemistry, Protein Structure and Folding</b> FSU (Sp 02, Sp 03)<br> <b>BCH 4053 Biochemistry I </b>(Undergraduate) FSU (F 01-F 03)<br> <b>CHM 1046 General Chemistry II</b> (Undergraduate) FSU (Sp 00-Sp 03)<br> <b>CHM 1045 General Chemistry I</b> (Undergraduate <b>distance learning</b>) FSU (Su 99)<br> <b>BCH 5425 Molecular Biology and Biotechnology</b><i> </i>(Graduate) FSU (Sp 96-Sp 99)<br> <b>CHM 1045 General Chemistry I</b> (Undergraduate) FSU (F 96, F 98-F 00)<br> <b>BCH 5887 Protein Structure and Stability</b> (Graduate) FSU (F 95)<b><o:p></o:p></b></span></p> <p align=center style='text-align:center'><b><span style='font-family:"Arial","sans-serif"; mso-bidi-font-family:"Times New Roman"'>Postdoctoral Fellows Trained<o:p></o:p></span></b></p> <p><span style='font-size:10.0pt;font-family:"Arial","sans-serif";mso-bidi-font-family: "Times New Roman";mso-bidi-font-weight:bold'><br> <b>Dr. Hyesook Yoon </b>(2009-2010)<b> </b>Ph.D. 2008 Department of Chemistry &amp; Biochemistry, Florida State University, Tallahassee FL<br> <b>Dr. Jihun Lee</b></span><span style='font-size:10.0pt;font-family:"Arial","sans-serif"; mso-bidi-font-family:"Times New Roman"'> (2007-2010) Ph.D. 2007 Department of Chemistry &amp; Biochemistry, Florida State University, Tallahassee FL; <i style='mso-bidi-font-style:normal'>Outstanding achievement as a postdoctoral scholar award</i>, Department of Biomedical Sciences, FSU, 2010<br> <b>Dr. Akshaya Kumar Meher</b> (2007-2008) Ph.D. 2007 Central Drug Research Institute, <span class=SpellE>Lucknow</span> India<br> <b>Dr. <st1:PersonName w:st="on">Vikash Kumar Dubey</st1:PersonName></b> (2004-2006) Ph.D. 2003 <st1:place w:st="on"><st1:PlaceName w:st="on">Banaras</st1:PlaceName> <st1:PlaceName w:st="on">Hindu</st1:PlaceName> <st1:PlaceType w:st="on">University</st1:PlaceType></st1:place>. Current position: Assistant Professor, India Institute of Technology, <span class=SpellE>Guwahati</span> India<br> <b>Dr. <span class=SpellE>Jhimli</span> <span class=SpellE>Dasgupta</span></b><span style='mso-bidi-font-weight:bold'> (2004-2005) Ph.D. 2004 <span class=SpellE>Saha</span> Institute of Nuclear Physics<b> <br> Dr. Steven Whitten</b></span> (1999-2000, Co-P.I. with Dr. Timothy Logan). Ph.D. 1999 <st1:place st="on" w:st="on"><st1:PlaceName st="on" w:st="on">Johns</st1:PlaceName> <st1:PlaceName st="on" w:st="on">Hopkins</st1:PlaceName> <st1:PlaceType st="on" w:st="on">University</st1:PlaceType></st1:place>. Current position: Research Scientist, Red Storm Scientific, LLC, <st1:address w:st="on"><st1:Street w:st="on">2200 Market Street, Suite 703</st1:Street>, <st1:City w:st="on">Galveston</st1:City> <st1:State w:st="on">TX</st1:State></st1:address> <br> <b>Dr. <span class=SpellE>Sumit</span> <span class=SpellE>Khurana</span></b> (1997-1999). Ph.D. 1996 India Institute of Technology. Current position: Sr. Research Scientist, <span class=SpellE>Immunomics</span> Operations, Beckman Coulter Inc., 7330 Carroll Road, San Diego CA <br> <b>Dr. <span class=SpellE>Ramesh</span> <span class=SpellE>Badisa</span></b> (1998). Ph.D. 1996 All India Institute of Medical Sciences. Current position: Research Scientist, Walker Cancer Research Institute, <st1:Street w:st="on">1634 Metropolitan Boulevard</st1:Street>, <st1:City w:st="on">Tallahassee</st1:City> <st1:State w:st="on">FL</st1:State> <span style='mso-bidi-font-weight:bold'><o:p></o:p></span></span></p> <p align=center style='text-align:center'><b><span style='font-family:"Arial","sans-serif"; mso-bidi-font-family:"Times New Roman"'>Graduate Students - Major Professor<o:p></o:p></span></b></p> <p><b><span style='font-size:10.0pt;font-family:"Arial","sans-serif"; mso-bidi-font-family:"Times New Roman"'>Helen Phipps,</span></b><span style='font-size:10.0pt;font-family:"Arial","sans-serif";mso-bidi-font-family: "Times New Roman";mso-bidi-font-weight:bold'> Biomedical Sciences, FSU (11-present; Co-PI with Dr. Jake Vanlandingham)<b><br> Xue Xia,</b> Biomedical Sciences, FSU (11-present)<br> <b>Sara Jackson, M.S. </b>Biomedical Sciences, FSU (10-11)<b><br> Liam Longo,</b> Molecular Biophysics, FSU (10-present)<b><br> Cristina Russo, Ph.D., </b></span><span style='font-size:10.0pt;font-family: "Arial","sans-serif";mso-bidi-font-family:"Times New Roman"'>Molecular Biophysics, (Co-advisor with Dr. Marcia <span class=SpellE>Fenley</span>) FSU (05-10), <i style='mso-bidi-font-style:normal'>Salt-dependence of protein-DNA binding: insights into protein electrostatics and redesign</i> <br> <b>Hyesook Yoon, Ph.D.</b><span style='mso-bidi-font-weight:bold'>, Chemistry and Biochemistry, FSU (05-08), <i style='mso-bidi-font-style:normal'>Activation profiles and regulatory cascades of the Human Kallikrein-related peptidases</i><br> <b>Nikki Held, M.S. </b></span>Chemistry and Biochemistry, FSU (05-06)<br> <b>Jihun Lee, Ph.D. </b>Chemistry and Biochemistry, FSU (03-07), <i style='mso-bidi-font-style:normal'><span style='mso-bidi-font-weight:bold'>Characterization of the Effects of </span></i></span><i style='mso-bidi-font-style:normal'><span style='font-size:10.0pt;font-family:Symbol;mso-bidi-font-family:Arial; mso-bidi-font-weight:bold'>b</span></i><i style='mso-bidi-font-style:normal'><span style='font-size:10.0pt;font-family:"Arial","sans-serif";mso-bidi-font-weight: bold'>-Turn Sequence </span></i><i style='mso-bidi-font-style:normal'><span style='font-size:10.0pt;font-family:"Arial","sans-serif";mso-bidi-font-family: "Times New Roman";mso-bidi-font-weight:bold'>on Protein Stability, Folding Kinetics, Functionality and Turn Structure</span></i><span style='font-size: 10.0pt;font-family:"Arial","sans-serif";mso-bidi-font-family:"Times New Roman"; mso-bidi-font-weight:bold'>, Current position: Postdoctoral Researcher, Department of Biomedical Sciences, Florida State University, FL</span><span style='font-size:10.0pt;font-family:"Arial","sans-serif";mso-bidi-font-family: "Times New Roman"'><br> <b>Gurunathan Laxmikanthan, Ph.D. </b>Chemistry and Biochemistry, FSU (02-06), <span style='mso-bidi-font-style:italic'>AHA <span class=SpellE>Predoctoral</span> Fellowship, <i>An Insight into the Structure, Function and Activation Cascades of the Classical Human Kallikreins</i> Current position: Postdoctoral Researcher, Brown University,</span></span><span style='font-family:"Arial","sans-serif"; mso-bidi-font-family:"Times New Roman"'> </span><span style='font-size:10.0pt; font-family:"Arial","sans-serif";mso-bidi-font-family:"Times New Roman"; mso-bidi-font-style:italic'>Providence, RI</span><span style='font-size:10.0pt; font-family:"Arial","sans-serif";mso-bidi-font-family:"Times New Roman"'><br> <b>Jocelyn Dudley, M.S. </b>Chemistry and Biochemistry, FSU (02-05), <span style='mso-bidi-font-style:italic'>NSF GK-12 Fellowship</span><b><br> Matthew <span class=SpellE>Bernett</span>, Ph.D. </b>Chemistry, FSU (01-04), <i style='mso-bidi-font-style:normal'>High-Resolution Structures of the Proteins Human Kallikrein 6 and Human Fibroblast Growth Factor-1: Structure and Function Relationships</i>. Current position: Research Scientist, <span class=SpellE>Xencor</span> Inc., Monrovia CA<br> <b>Stephen Brych, Ph.D. </b>Chemistry, FSU (99-04), <span style='mso-bidi-font-style: italic'>NSF Fellowship, <i>A Redesigned Hydrophobic Core of a Symmetric Protein <span class=SpellE>Superfold</span> with Increased Primary Structure Symmetry</i>. Current position: Research Scientist, Pharmaceutics, Amgen, <st1:place w:st="on"><st1:City st="on" w:st="on">Thousand Oaks</st1:City> <st1:State st="on" w:st="on">CA</st1:State></st1:place></span><br> <b>Jae-won Kim, Ph.D. </b>Chemistry, FSU (99-03), <i style='mso-bidi-font-style: normal'>Structure and Biophysical Characterization of </i></span><i style='mso-bidi-font-style:normal'><span style='font-size:10.0pt;font-family: Symbol'>b</span></i><i style='mso-bidi-font-style:normal'><span style='font-size:10.0pt;font-family:"Arial","sans-serif";mso-bidi-font-family: "Times New Roman"'>-turn of Human Acidic Fibroblast Growth Factor</span></i><span style='font-size:10.0pt;font-family:"Arial","sans-serif";mso-bidi-font-family: "Times New Roman"'>. Current position: Research Scientist, Amgen, Seattle WA<br> <b>Gulsah Sanli, Ph.D. </b>Chemistry, FSU (98-02), <i style='mso-bidi-font-style: normal'>Expression and Structural Characterization of 2,5-Diketo-D-Gluconic Acid <span class=SpellE>Reductase</span> : A Commercially Important Enzyme for Biosynthesis of Vitamin C</i>. Current position: Assistant Professor, Department of Chemistry, Izmir Institute of Technology, Turkey<br> <b>Heidi Wenger, M.S.</b>, Chemistry, FSU (98-99,02)<br> <b>Frank J. <span class=SpellE>Culajay</span>, M.S. </b>Biology, FSU (96-00), <i style='mso-bidi-font-style:normal'>Thermodynamic Characterization of Mutations of Human Acidic Fibroblast Growth Factor</i>. Current <span class=SpellE>position:Sr</span>. Research Scientist, MD Anderson Cancer Center, Houston TX<br> <b>Daniel <span class=SpellE>Adamek</span>, Ph.D</b>. Molecular Biophysics, FSU (95-02) <i>Co-P.I. with Dr. D.L.D. Caspar, Characterization of the Hydrophobic Cavity of Interleukin 1-Beta</i><span style='mso-bidi-font-style:italic'>, Current position: Research Scientist, Marshall Space Flight Center, NASA</span><br> <span class=SpellE><b>Elodie</b></span><b> Lang</b>, <b>M.S.,</b> Chemistry, FSU (94-96), Current position: Marketing Manager, <span class=SpellE>Laboratoires</span> <span class=SpellE>Prodene</span> <span class=SpellE>Klint</span>, Paris France<br> <b>Aleksandar Popovic</b>, <b>M.S.,</b> Chemistry, FSU (94-96), Current position: Minister of Science and Environmental Protection, Government of Serbia<b><o:p></o:p></b></span></p> <p align=center style='text-align:center'><b><span style='font-family:"Arial","sans-serif"; mso-bidi-font-family:"Times New Roman"'>Graduate Students - Graduate Committee<o:p></o:p></span></b></p> <p><b><span style='font-size:10.0pt;font-family:"Arial","sans-serif"; mso-bidi-font-family:"Times New Roman"'>Ann <span class=SpellE>Koslova</span></span></b><span style='font-size:10.0pt;font-family:"Arial","sans-serif";mso-bidi-font-family: "Times New Roman";mso-bidi-font-weight:bold'>, Molecular Biophysics, FSU (11-present)<br> <b>Miles Bradshaw</b>, NHMFL, FSU (11-present) <br> <b>Xue Wang</b>, Chemistry &amp; Biochemistry, FSU (10-present)<br> <b>Yuan Mao</b>, Chemistry &amp; Biochemistry, FSU (10-present)<br> <b>Qian Zhang</b>, Chemistry &amp; Biochemistry, FSU (10-present)<b><br> Santosh Valeja</b>, Chemistry &amp; Biochemistry, FSU (10-present)<br> <b>Joey Bowler</b>, Chemistry &amp; Biochemistry, FSU (10-present)<br> <b>Ian Walton</b>, Chemistry &amp; Biochemistry, FSU (10-11)<br> <b>Anna Lomasney</b>, Chemistry &amp; Biochemistry, FSU (09-present)<br> <b>Van <span class=SpellE>Quach</span></b>, Chemistry &amp; Biochemistry, FSU (09)<br> <b>Robert Demont</b>, Chemistry &amp; Biochemistry, FSU (09-10)<br> <b>Robert Harris</b>, Molecular Biophysics, FSU (09-11)<br> <b>Xu Wang</b>, Chemistry &amp; Biochemistry, FSU (08-10)<b><br> Casey O'Brien</b>, Chemistry &amp; Biochemistry, FSU (08-10)<br> <b>Larry Walker</b>, Chemistry &amp; Biochemistry, FSU (08-11)<br> <span class=SpellE><b>Bodhand</b></span><b> <span class=SpellE>Dhole</span></b>, Biology, FSU (07-11)<b><br> <span class=SpellE>Deepa</span> Salagala</b>, Molecular Biophysics, FSU (07-11)<b><br> <span class=SpellE>Qiyu</span> Zhu</b>, Chemistry &amp; Biochemistry, FSU (07-11)<br> <b>Richard Chi</b>, Biology, FSU (06-07)<br> <b>Jyotica Batra</b>, Physics, FSU (06-09)<b><br> Alex Chew</b>, Molecular Biophysics, FSU (06-09)<br> <b>Lee Miller</b>, Chemistry &amp; Biochemistry, FSU (06-07) <br> <b>Boris <span class=SpellE>Breiner</span></b>, Chemistry &amp; Biochemistry, FSU (06-07)<br> <b>Karen Alvarez-<span class=SpellE>Delfin</span></b>, Biology, FSU (05-11)<br> <span class=SpellE><b>Pallavi</b></span><b> <span class=SpellE>Tawdi</span></b>, Biology, FSU (05-08)<b> <br> <span class=SpellE>Shenping</span> Wu</b>, Molecular Biophysics, FSU (05-08)<br> <b>Heather <span class=SpellE>Ongley</span></b>, Chemistry and Biochemistry, FSU (05-07)<b> <br> <span class=SpellE>Ramzi</span> <span class=SpellE>Alsallaq</span></b>, Molecular Biophysics, FSU (05-07)<b><br> Zhang, <span class=SpellE>Xiaojun</span></b></span><span style='font-size:10.0pt; font-family:"Arial","sans-serif";mso-bidi-font-family:"Times New Roman"'>, Biology, FSU (04-08)<b> <br> <span class=SpellE>Mioara</span> <span class=SpellE>Larion</span></b>, Chemistry and Biochemistry, FSU (04-06)<b><br> <span class=SpellE>Sumiko</span> Takahashi</b>, Chemistry and Biochemistry, FSU (04-06)<br> <b style='mso-bidi-font-weight:normal'>Sri <span class=SpellE>Oruganti</span></b>, Chemistry and Biochemistry, FSU (03-07)<b><br> Maria <span class=SpellE>Semavina</span></b>, Molecular Biophysics, FSU (03-06)<br> <span class=SpellE><b>Ilker</b></span><b> <span class=SpellE>Sen</span></b>, Molecular Biophysics, FSU (03-07)<br> <span class=SpellE><b>Sunjin</b></span><b> Jo</b>, Chemistry and Biochemistry, FSU (03-07)<b><br> Geoffrey C. Klein</b>, Chemistry and Biochemistry, FSU (03-05)<b><br> <span class=SpellE>Yun</span> Kang</b>, Biology, FSU (02-07)<b><br> <span class=SpellE>Weishu</span> Bu</b>, Molecular Biophysics, FSU (01-07)<b><br> Mohammad <span class=SpellE>Yousef</span></b>, Molecular Biophysics, FSU (00-03)<b><br> Laura Mertz, </b>Chemistry, FSU (99-00)<br> <b>Anne Stone, </b>Molecular Biophysics, FSU (98-99)<br> <b>Pamela <span class=SpellE>Twigg</span>, </b>Molecular Biophysics, FSU (98-02)<b> <br> James <span class=SpellE>Gattis</span>, </b>Chemistry, FSU (98-04)<br> <b>Maria Elena Vasquez, </b>Mathematics, FSU (98-00)<br> <b>Jeffery Haber, </b>Molecular Biophysics, FSU (98-99)<br> <span class=SpellE><b>Alla</b></span><b> <span class=SpellE>Korpanova</span>, </b>Molecular Biophysics, FSU (97-01)<br> <b>Ken Mann, M.S., </b>Biology, FSU (96-98)<br> <b>Li Zhang, M.S., </b>Chemistry, FSU (96-97)<br> <b>Ana <span class=SpellE>deCarvalho</span>, </b>Biology, FSU (96-01)<br> <b>Scott <span class=SpellE>Olenych</span>, </b>Biology, FSU (96-present)<br> <b>Virginia A. Gottschalk, </b>Biology, FSU (96-01)<br> <b>Eric <span class=SpellE>Fontano</span>, </b>Molecular Biophysics, FSU (96-01)<br> <b>John H. Evans IV, </b>Biology, FSU (96-97)<br> <b>Brian Patterson, </b>Chemistry, FSU (96-99)<br> <b>Paul Schmidt, M.S., </b>Chemistry, FSU (96-97)<br> <b>Delbert D. <span class=SpellE>Bauzon</span>, M.S.,</b> Chemistry, FSU (95-97)<br> <span class=SpellE><b>Zivana</b></span><b> <span class=SpellE>Tezak</span>, Ph.D., </b>Biology, FSU (94-97)<span style='mso-bidi-font-weight:bold'><o:p></o:p></span></span></p> <p align=center style='text-align:center'><b><span style='font-family:"Arial","sans-serif"; mso-bidi-font-family:"Times New Roman"'>Undergraduate Students<o:p></o:p></span></b></p> <p><b><span style='font-size:10.0pt;font-family:"Arial","sans-serif"; mso-bidi-font-family:"Times New Roman"'>Joseph Babcock</span></b><span style='font-size:10.0pt;font-family:"Arial","sans-serif";mso-bidi-font-family: "Times New Roman";mso-bidi-font-weight:bold'>, Directed Independent Studies (Sp 11-F 11)<b><br> Jonathan Truong</b>, Directed Independent Studies (F 10-Sp 11)<br> <b>Michael Binner</b>, Directed Independent Studies (Sp 10-F 10)<br> <b>Elise Gunzburger</b>, Research Assistant (Su 09)<br> <b>Miles Bradshaw</b>, Honors Thesis Committee (F 07-F 09)<br> <span class=SpellE><b>Annalise</b></span><b> Smith</b>, Independent Research Experience (co-mentored by Dr. Marcia <span class=SpellE>Fenley</span>) (Su 08-F 08)<br> <b>Winston Lee,</b> Research Assistant (Su 08-Sp10)<b><br> Eric Aspinwall,</b> Independent Research Experience (Sp 08-Sp 09)<br> <span class=SpellE><b>Farhan</b></span><b> Abdul Rashid</b>, Work study (F 07), Directed Independent Studies (Sp 08-F 08)<br> <span class=SpellE><b>Marni</b></span><b> Becker</b>, Directed Independent Studies (F 07-Sp 08)<br> <b>Collin Tully</b>, Volunteer Research Assistant (F 07)<b><br> Chris Carr</b>, Directed Independent Studies (Su 06)<br> <b>Benjamin Katz</b>, Honors Thesis Committee (F 05-F 07)<br> <span class=SpellE><b>Sharmeel</b></span><b> <span class=SpellE>Maraj</span></b>, Directed Independent Studies (Sp 06)<br> <span class=SpellE><b>Jazmin</b></span><b> Overton</b>, Directed Independent Studies (Sp 06)<br> <b>Liam Longo</b>, Directed Independent Studies (F 05-Sp 09); </span><i><span style='font-size:10.0pt;font-family:"Arial","sans-serif";mso-bidi-font-family: "Times New Roman"'>Recipient of American Cancer Society Fisher Undergraduate Fellowship </span></i><span style='font-size:10.0pt;font-family:"Arial","sans-serif"; mso-bidi-font-family:"Times New Roman";mso-bidi-font-style:italic'>(Su 08),<i> Florida State University Undergraduate Research and Creative Endeavors (URACE) Award </i>(Su 08)</span><span style='font-size:10.0pt;font-family:"Arial","sans-serif"; mso-bidi-font-family:"Times New Roman";mso-bidi-font-weight:bold'><br> <b>Mei-Ling <span class=SpellE>Shotts</span></b>, Directed Independent Studies (Sp 05-Sp 06)<br> <b>Lauren <span class=SpellE>Seabrooks</span></b>, Directed Independent Studies (Sp 05); Hughes Fellow (Su 05 - Sp 06)<br> <b>Laura Griffith</b>, Directed Independent Studies (Sp 05)<br> <b>Aaron Rodriquez, </b>Directed Independent Studies (F 04-Sp 06)<br> <span class=SpellE><b>Shadee</b></span><b> Thomas Lake</b>, Directed Independent Studies (F 04)<br> <b>John Jacob, </b></span><span style='font-size:10.0pt;font-family:"Arial","sans-serif"; mso-bidi-font-family:"Times New Roman"'>Hughes Fellow (Su 04-Sp 05)<br> <b>Michael Miller, </b>Directed Independent Studies, FSU (F 03-Sp 04), <i style='mso-bidi-font-style:normal'>Hughes Fellow</i> (Su 04 - Sp 05)<br> <b>Jamie Woodcock, </b>Directed Independent Studies, FSU (Su 03-Sp 04)<br> <b>Stephen <span class=SpellE>Viel</span>, </b>Directed Independent Studies, FSU (Su 03-Sp 04)<br> <b>Joanna Balsamo, </b>Directed Independent Studies, FSU (F 02-Sp 03)<b><br> Nicholas Frost, </b>Directed Independent Studies, FSU (F 01-Sp 03)<i> Recipient of American Cancer Society Fisher Undergraduate Fellowship </i><span style='mso-bidi-font-style:italic'>(Su 02)</span><br> <b>Scott <span class=SpellE>Agbuya</span>, </b>Directed Independent Studies, FSU (Su 01-Su 02)<b><br> Ginger <span class=SpellE>Spielmann</span>, </b>Directed Independent Studies, FSU (Su 01-Su 02)<br> <span class=SpellE><b>Jenni</b></span><b> <span class=SpellE>Chikar</span></b>, Independent Research Experience (Su 01-F 02)<br> <b>Kim Pause</b>, Independent Research Experience (Su 01-F 02)<b><br> Stephen <span class=SpellE>Klusza</span></b>, Honors Thesis Committee, FSU (F 00)<br> <b>Colleen <span class=SpellE>Mulvey</span></b>, Honors Thesis Committee, FSU (F 00)<br> <b>Michele Blanco,</b> Directed Independent Studies, FSU (F 00)<br> <b>William <span class=SpellE>Paneral</span>,</b> Directed Independent Studies, FSU (Su 00)<b><br> Amy Peterson</b>, Honors Thesis Committee, FSU (Sp 00)<b><br> <span class=SpellE>Binitie</span> <span class=SpellE>Odian</span></b>, Honors Thesis Committee, FSU (Sp 00)<b><br> <span class=SpellE>Cherra</span> <span class=SpellE>Pumphrey</span>, </b>Directed Independent Studies, FSU (F 99)<b><br> John Davis, </b>Directed Independent Studies, FSU (F 99, Sp 00)<b><br> Sarah Brockway, </b>Honors Thesis Committee, FSU (Sp 00)<br> <b>Nathan Noble, </b>Directed Independent Studies, FSU (Sp 99)<br> <b>David Kennedy, </b>Directed Independent Studies, FSU (F 98-Sp 99)<br> <span class=SpellE><b>Kesha</b></span><b> Williams, </b>Directed Independent Studies, FSU (Sp 98-Sp 99) <i>Recipient of NSF Undergraduate Research Fellowship (F98)<br> </i><b>Jaime Schiller, </b>Directed Independent Studies, FSU (Sp 97)<br> <b>Emily Earp, </b>Directed Independent Studies, FSU (Sp 97)<br> <b>Sasha Grek, </b>Directed Independent Studies, FSU (Sp 97-Su 00) <i>Recipient of American Cancer Society Fisher Undergraduate Fellowship </i><span style='mso-bidi-font-style:italic'>(Su 97),<i> Florida Space Grant Consortium Fellowship</i></span> <i>(Su 98), American Cancer Society Fisher Undergraduate Fellowship (Su 99), <span class=SpellE>Caffrey</span> Fellowship </i><span style='mso-bidi-font-style:italic'>(Sp 99)<i><br> </i></span><b>Jorge Hernandez, </b>Directed Independent Studies, FSU (F 96)<br> <b>Stephanie Dillon, </b>Directed Independent Studies, FSU (Su 96)<br> <b>William Greenleaf, </b>Chemistry 1051L (Honors), FSU (Sp 96)<br> <span class=SpellE><b>Cinthia</b></span><b> <span class=SpellE>Hahm</span>,</b> Directed Independent Studies, FSU (F 95-Sp 96)<br> <b>Daniel <span class=SpellE>Adamek</span>,</b> Directed Independent Studies, FSU (Su 95-F 95)<b> <br> Amanda Childers,</b> Chemistry 1051L (Honors), FSU (Sp 95)<b> <br> Nicole <span class=SpellE>Alavi</span>,</b> Chemistry 1051L (Honors), FSU (Sp 95) <b><o:p></o:p></b></span></p> <p align=center style='text-align:center'><b><span style='font-family:"Arial","sans-serif"; mso-bidi-font-family:"Times New Roman"'>Service<o:p></o:p></span></b></p> <p><b><span style='font-size:10.0pt;font-family:"Arial","sans-serif"; mso-bidi-font-family:"Times New Roman"'>Editorial and Advisory Boards: <br> </span></b><span style='font-size:10.0pt;font-family:"Arial","sans-serif"; mso-bidi-font-family:"Times New Roman";mso-bidi-font-weight:bold'>Editorial Board, <i style='mso-bidi-font-style:normal'>Archives of Biochemistry and Biophysics</i> (8/10-7/13)<br> Editorial Board, <i style='mso-bidi-font-style:normal'>Research and Reports in Biology</i> (7/10-present)<br> Editor, <i style='mso-bidi-font-style:normal'>Journal of Proteins and Proteomics</i> (8/08-present)<br> Scientific Advisory Board, <span class=SpellE><i style='mso-bidi-font-style: normal'>Zign</i></span><i style='mso-bidi-font-style:normal'> Therapeutics Inc.</i> (08-09)<br> Scientific Advisory Board, <span class=SpellE><i style='mso-bidi-font-style: normal'>CardioVascular</i></span><i style='mso-bidi-font-style:normal'> <span class=SpellE>BioTherapeutics</span> Inc</i>. (08)<br> Editorial Advisory Board<b>, </b></span><i><span style='font-size:10.0pt; font-family:"Arial","sans-serif";mso-bidi-font-family:"Times New Roman"'>Protein Science</span></i><span style='font-size:10.0pt;font-family:"Arial","sans-serif"; mso-bidi-font-family:"Times New Roman"'> (1/03-12/05; 1/06-12/08)<br> <span style='mso-bidi-font-weight:bold'>Editorial Board<b>, </b></span><i>Molecular and Cellular Proteomics</i> (6/01-8/06)<span style='mso-bidi-font-weight:bold'><o:p></o:p></span></span></p> <p><b><span style='font-size:10.0pt;font-family:"Arial","sans-serif"; mso-bidi-font-family:"Times New Roman"'>Peer Review:<br> </span></b><span style='font-size:10.0pt;font-family:"Arial","sans-serif"; mso-bidi-font-family:"Times New Roman";mso-bidi-font-weight:bold'>N.I.H. Macromolecular Structure and Function (MSFC) Study Section (<i style='mso-bidi-font-style:normal'>ad hoc</i>) (2/08) <br> National Science Foundation, Integrative <span class=SpellE>Organismal</span> Biology Panel <i style='mso-bidi-font-style:normal'>Ad hoc</i> (8/05)<b><br> </b>National Science Foundation, Molecular Biochemistry Panel (10/04 - 4/08) <br> </span><span style='font-size:10.0pt;font-family:"Arial","sans-serif"; mso-bidi-font-family:"Times New Roman"'>American Heart Association, Cell Function &amp; Metabolism (10/04 - 10/06)<br> <span style='mso-bidi-font-weight:bold'>National Science Foundation, Molecular Biochemistry <i style='mso-bidi-font-style:normal'>Ad hoc</i>. (9/04)<br> National Science Foundation, Molecular Biophysics <i style='mso-bidi-font-style: normal'>Ad hoc</i>. (8/04)<br> </span>N.I.H. High End Shared Instrumentation ZRG1 BPC-D 30 1 (6/04)<br> American Heart Association, Southern and Ohio Valley Research Consortium, Committee 3A (3/04)<br> NASA (NRA 00-HEDS-03 Cellular and Macromolecular Biotechnology), Structural Biology Panel (01)<b><br> </b>American Cancer Society, Florida Division (96-03)<br> Petroleum Research Foundation <i style='mso-bidi-font-style:normal'>Ad hoc</i> (96,00,05)<o:p></o:p></span></p> <p><b style='mso-bidi-font-weight:normal'><span style='font-size:10.0pt; font-family:"Arial","sans-serif";mso-bidi-font-family:"Times New Roman"'>Organizer/Officer:<br> </span></b><span style='font-size:10.0pt;font-family:"Arial","sans-serif"; mso-bidi-font-family:"Times New Roman"'>Chair, International Scientific Advisory Board, 4<sup>th</sup> International Symposium on Kallikreins and Kallikrein-related Peptidases (2011)<br> Chair, Organizing Committee, Life Sciences Symposium, Florida State University (2011, 2012)<br> International<b style='mso-bidi-font-weight:normal'> </b>Scientific Advisory Board, 3<sup>nd</sup> International Symposium on Kallikreins and Kallikrein-related Peptidases (2009)<br> Scientific Organization Committee, 2<sup>nd</sup> International Symposium on Kallikreins and Kallikrein-related Peptidases (2007)<br> Immediate past Chair (1/04-12/04),<b style='mso-bidi-font-weight:normal'> </b><span style='mso-bidi-font-weight:bold'>Chair<b>, </b></span>(1/04-12/04), Chair-elect (1/03-12/03), Chair-elect-designate (1/02-12/02) American Chemical Society, Florida Section <br> <span style='mso-bidi-font-weight:bold'>James R. Fisher Fellowship Committee<b>,</b></span> American Cancer Society, Florida Section (2003 - present)<b><br> </b><span style='mso-bidi-font-weight:bold'>Program Chair, Florida Annual Meeting and Exposition of the <st1:PersonName w:st="on">American Chemical Society</st1:PersonName> (FAME),<b> </b></span>(2003)<br> <span style='mso-bidi-font-weight:bold'>Co-Chair, Protein Engineering Session,<b> </b></span><st1:PersonName w:st="on">American Chemical Society</st1:PersonName>, Southeast Region (SERMACS) (01)<br> <span style='mso-bidi-font-weight:bold'>Chair, Scientific Session</span>, American Cancer Society, Florida Division (97)<span style='mso-bidi-font-weight: bold'><o:p></o:p></span></span></p> <p><b><span style='font-size:10.0pt;font-family:"Arial","sans-serif"; mso-bidi-font-family:"Times New Roman"'>Outreach:<br> </span></b><span class=SpellE><span style='font-size:10.0pt;font-family:"Arial","sans-serif"; mso-bidi-font-family:"Times New Roman"'>ChemWiki</span></span><span style='font-size:10.0pt;font-family:"Arial","sans-serif";mso-bidi-font-family: "Times New Roman"'> Consortium (<i style='mso-bidi-font-style:normal'><a href="http://chemwiki.ucdavis.edu/Wikitexts/Misc/Development_Details">http://chemwiki.ucdavis.edu/Wikitexts/Misc/Development_Details</a></i>) (10-present)<br> <span class=SpellE>Godby</span> High School Science Fair Judge (04,06,08,09) <br> <span style='mso-bidi-font-weight:bold'>Chair, Alumni Newsletter Committee</span>, Department of Chemistry, FSU (02-03)<br> Chiles High School Science Fair Judge (00, 04)<br> Capital Regional Science Fair Judge, Leon County (98,99,02,05,07,10,11) <br> Lincoln High School Science Fair Judge (97)<b><o:p></o:p></b></span></p> <p><b><span style='font-size:10.0pt;font-family:"Arial","sans-serif"; mso-bidi-font-family:"Times New Roman"'>Departmental/University:<br> </span></b><span style='font-size:10.0pt;font-family:"Arial","sans-serif"; mso-bidi-font-family:"Times New Roman";mso-bidi-font-weight:bold'>Program Publicity Committee, Program in Neuroscience, FSU (F 10)<br> Mission Statement Committee, Department of Biomedical Sciences, FSU (Su 10)<br> Chair, Translational Science Laboratory Search Committee, College of Medicine, FSU (Sp 10)<br> Department of Biomedical Sciences Faculty Evaluation Committee (Sp 10)<br> Web Site Development Committee, College of Medicine, FSU (09-10)<br> Faculty Development Committee, Department of Biomedical Sciences (F09-present)<br> Member, Neuroscience Graduate Program Committee, FSU (09-10)<b><br> </b>Director, Invited Seminar Speaker Series, College of Medicine (09-10) <br> Dean Search Committee, College of Medicine (F 07-S 08)<br> Chair, Bylaws and Policy Committee, Department of Biomedical Sciences (F 06-present)<br> Core Lab Faculty Users Committee, Department of Biomedical Sciences (F 06)<b><br> </b>Faculty Development Committee, Department of Biomedical Sciences (F 06)<b><br> </b>Chair, Graduate Recruiting and Admissions Committee, Department of Biomedical Sciences (F 06)<br> Human Subjects Institutional Review Board, Florida State University (Sp 06)<br> Graduate Recruiting and Admissions Committee, Department of Biomedical Sciences (F 05-07)<br> Chemistry Screening Committee, CSIT Faculty Search, </span><span style='font-size:10.0pt;font-family:"Arial","sans-serif";mso-bidi-font-family: "Times New Roman"'>FSU (Su 01)<span style='mso-bidi-font-weight:bold'><br> Director, Graduate Recruiting and Admissions Committee</span>, Department of Chemistry, FSU (Su 00-Su 02)<br> <span style='mso-bidi-font-weight:bold'>Computational Structural Biology 2001 Symposium Committee</span>,<span style='mso-bidi-font-weight:bold'> </span>FSU (Sp 00)<br> <span style='mso-bidi-font-weight:bold'>Executive Committee</span>, Department of Chemistry, FSU (Sp 00-Su 03)<br> <span style='mso-bidi-font-weight:bold'>General Chemistry Committee</span>, Department of Chemistry, FSU (Sp 00-present)<br> <span style='mso-bidi-font-weight:bold'>Molecular Recognition Initiative Building Committee, </span>Department of Chemistry, FSU (Sp 00)<span style='mso-bidi-font-weight:bold'><br> Merit Committee</span>, Department of Chemistry, FSU (F 99)<br> <span style='mso-bidi-font-weight:bold'>Research Training Grant Computational Committee</span>, FSU (Sp 99)<br> <span style='mso-bidi-font-weight:bold'>Structural Biology Scientific Advisory Committee</span>, FSU (Sp 98-present)<br> <span style='mso-bidi-font-weight:bold'>Graduate Advising Policy Committee</span>, Department of Chemistry, FSU (Sp 98)<br> <span style='mso-bidi-font-weight:bold'>Nominating Committee for Director</span>, Institute of Molecular Biophysics, FSU (F 97)<br> <span style='mso-bidi-font-weight:bold'>Building Committee</span>, Institute of Molecular Biophysics, FSU (F 97)<br> <span style='mso-bidi-font-weight:bold'>Executive Committee</span>, Institute of Molecular Biophysics, FSU (F 96, Sp01-Su03) <br> <span style='mso-bidi-font-weight:bold'>Cell Culture Oversight Committee</span>, Institute of Molecular Biophysics, FSU (F 96-present)<br> <span style='mso-bidi-font-weight:bold'>Graduate Student Selection Committee</span>, Molecular Biophysics, FSU (Sp 95-Sp 98, Sp03-present)<br> <span style='mso-bidi-font-weight:bold'>Michael Kasha Award Committee</span>, FSU (Sp 95)<br> <span style='mso-bidi-font-weight:bold'>Graduate Recruiting and Advising Committee</span>, Department of Chemistry, FSU (F 95-present)<br> <span style='mso-bidi-font-weight:bold'>Biochemistry Faculty Search Committee</span>, Department of Chemistry, FSU (F 95)<br> <span style='mso-bidi-font-weight:bold'>Bylaws Committee</span>, Department of Chemistry, FSU (F 95) <br> <span style='mso-bidi-font-weight:bold'>Biochemistry Faculty Search Committee</span>, Department of Chemistry, FSU (F 94)<br> <span style='mso-bidi-font-weight:bold'>Organic Faculty Search Committee</span>, Department of Chemistry, FSU (F 94)<span style='mso-bidi-font-weight:bold'><o:p></o:p></span></span></p> <p align=center style='text-align:center'><a name=funding></a><b><span style='font-family:"Arial","sans-serif";mso-bidi-font-family:"Times New Roman"'>Funding - External<o:p></o:p></span></b></p> <p><span style='font-size:10.0pt;font-family:"Arial","sans-serif";mso-bidi-font-family: "Times New Roman"'>37. Florida Department of Health Technology Transfer Feasibility Grant (1KF03),</span> <span style='font-size:10.0pt;font-family: "Arial","sans-serif";mso-bidi-font-family:"Times New Roman"'>Blaber, M. (P.I.), <i style='mso-bidi-font-style:normal'>Development of &quot;second-generation&quot; fibroblast growth factor-1 for pro-<span class=SpellE>angiogenic</span> therapy</i>, $99,350 ($86,391 direct) (2/1/11-1/31/12)<br> 36. NINDS Administrative Supplements for Summer Research Experiences, (1R15NS057771-01), Blaber, M. (P.I.) $18,392 (6/1/09-8/31/10)<br> 35. Enterprise Florida SBIR/STTR Phase 0 Pilot Program, Michael Blaber (P.I.), <i style='mso-bidi-font-style:normal'>Development of Second-generation Forms of Fibroblast Growth Factor-1 for Pro-angiogenic Therapy</i>. $3,000 (11/13/08)<br> 34. Dept. of Health and Human Services, Public Health Service (1R01NS052741-01A2), Scarisbrick, I.A. (P.I.), <i style='mso-bidi-font-style: normal'>Regulation and Function of Kallikreins in Spinal Cord Injury and Repair</i>. Sub-contract award to Blaber, M. $252,636 ($171,862 direct) (4/1/08-3/31/13)<br> 33. Dept. of Health and Human Services, Public Health Service (1R15NS057771-01), Blaber, M. (P.I.), <i style='mso-bidi-font-style:normal'>Interactions between CNS-specific Human Kallikreins and the PA System in Inflammation</i>. $220,500 ($150,000 direct) (1/1/07-12/31/09)<br> 32. <span style='mso-bidi-font-weight:bold'>American Heart Association (0655133B)</span>, Blaber, M. (P.I.), <i>Characterization of Fibroblast Growth Factor-1 Mutants with Enhanced Properties for Angiogenic Therapy</i>. <span style='mso-bidi-font-weight:bold'>$264,000 ($240,000 direct)</span> (7/06 - 6/09)<br> 31. <span style='mso-bidi-font-weight:bold'>National Multiple Sclerosis Society - Pilot Award (PP1113)</span>, Blaber, M. (P.I.), <i>Identification of Activation Cascades Involving Human Kallikrein 6</i>. <span style='mso-bidi-font-weight: bold'>$44,000 ($40,000 direct)</span> (3/05 - 2/06)<br> 30. <span style='mso-bidi-font-weight:bold'>National Science Foundation (MCB 0314740)</span>, Blaber, M. (P.I.), <i>Probing the Role of Primary Sequence Asymmetry in a Symmetric <span class=SpellE>Superfold</span></i>. <span style='mso-bidi-font-weight:bold'>$391,660 ($280,357 direct)</span> (8/03 - 7/06)<br> 29. <span class=SpellE><span style='mso-bidi-font-weight:bold'>Berlex</span></span><span style='mso-bidi-font-weight:bold'> Biosciences</span>, Blaber, M. (P.I.), <i>Production of Recombinant Active Rat Kallikrein 6 Protein</i>. <span style='mso-bidi-font-weight: bold'>$23,597 ($16,162 direct)</span> (4/03 - 7/03)<br> 28. <span style='mso-bidi-font-weight:bold'>National Multiple Sclerosis Society (RG 3406-A-2)</span>, Blaber, M. (P.I.), <i>Regulation and Structural Study of a Novel Protease Implicated in Demyelination</i>. <span style='mso-bidi-font-weight: bold'>$342,021 ($313,201 direct)</span> (4/03 - 3/06)<br> 27. <span style='mso-bidi-font-weight:bold'>National Multiple Sclerosis Society - Pilot Award (PP0757)</span>, Blaber, M. (P.I.), <i>Enzymatic Characterization of a Novel CNS-specific Serine Protease</i>. <span style='mso-bidi-font-weight: bold'>$27,500 ($25,000 direct)</span> (9/00 - 8/01)<br> 26. <span style='mso-bidi-font-weight:bold'>Future Graph, Inc</span>., Blaber, M. (P.I.), <i>Licensing of Web-based Undergraduate Chemistry Instructional Material</i>. <span style='mso-bidi-font-weight:bold'>$3,000</span> (12/99)<br> 25. <span style='mso-bidi-font-weight:bold'>American Heart Association, Established Investigator Grant (0040235N)</span> Blaber, M. (P.I.),<i>Structure, Stability and Functional Studies of 2,5-Diketo-D-Gluconate <span class=SpellE>Reductases</span></i>. <span style='mso-bidi-font-weight:bold'>$299,453 ($272,230 direct)</span> (1/00 - 12/03)<br> 24.<span style='mso-bidi-font-weight:bold'> <st1:place w:st="on"><st1:State w:st="on">Florida</st1:State></st1:place> Space Grant Consortium,<i> </i></span>Blaber, M. (P.I.),<span class=SpellE><i>Deconvolution</i></span><i> of Calorimetric Data for Protein Stability Studies.</i> <span style='mso-bidi-font-weight:bold'>$14,000 (direct)</span> (5/98-4/99)<br> 23.<span style='mso-bidi-font-weight:bold'> Dept. of Health and Human Services, Public Health Service (GM54429-01)</span>,<span style='mso-bidi-font-weight: bold'> </span>Blaber, M. (P.I.), <i>Structure, Stability and Regulation of Human Acidic FGF. </i><span style='mso-bidi-font-weight:bold'>$500,000 ($350,000 direct)</span> (5/96-5/01)<br> 22.<span style='mso-bidi-font-weight:bold'> American Heart Association, </span>Blaber, M. (P.I.),<span style='mso-bidi-font-weight:bold'> </span><i>Design of a Thermostable Human Acidic Fibroblast Growth Factor</i>. <span style='mso-bidi-font-weight: bold'>$270,000 ($255,000 direct) </span>(4/96-5/99)<i> (Note: declined due to overlapping N.I.H. grant award</i>) <br> 21.<span style='mso-bidi-font-weight:bold'> MicroCal, Inc. Travel Award</span><i>, </i>Blaber, M., <i>1st International Conference on the Applications of <span class=SpellE>Biocalorimetry</span>.</i> <span style='mso-bidi-font-weight:bold'>$500 </span>(6/96)<br> 20.<span style='mso-bidi-font-weight:bold'> Finn <span class=SpellE>Wold</span> Travel Award</span>, Blaber, M., <i>Protein Society Meeting.</i> <span style='mso-bidi-font-weight:bold'>$400 </span>(4/96)<br> 19.<i> </i><span style='mso-bidi-font-weight:bold'>American Cancer Society, <st1:place w:st="on"><st1:State w:st="on">Florida</st1:State></st1:place> Division - Starter Grant (F95FU-1)</span>, Blaber, M. (P.I.), <i>The Role of Protein Stability in the Regulation of Human Acidic Fibroblast Growth Factor.</i> <span style='mso-bidi-font-weight:bold'>$22,000 (direct) </span>(6/95-5/96)<o:p></o:p></span></p> <p align=center style='text-align:center'><b><span style='font-family:"Arial","sans-serif"; mso-bidi-font-family:"Times New Roman"'>Funding - Internal<o:p></o:p></span></b></p> <p><span style='font-size:10.0pt;font-family:"Arial","sans-serif";mso-bidi-font-family: "Times New Roman"'>19. <st1:place w:st="on"><st1:PlaceName w:st="on">Florida</st1:PlaceName> State University</st1:place> Research Foundation, Application Proof of Concept (GAP) Grant, Blaber, M. (P.I.), Schlenoff, J. (Co-P.I.), <i style='mso-bidi-font-style: normal'>Novel Biocompatible Polymer Material Using Engineered Human Fibroblast Growth Factor-1 for Accelerated Wound healing</i>. $50,000 (1/12-12/12)<br> 18. Florida State University Research Foundation, Equipment and Infrastructure Enhancement Grant, Blaber, M. (Co-P.I.), <i style='mso-bidi-font-style:normal'>Acquisition of a <span class=SpellE>Rigaku</span> Automated Detector and X-Ray Generator System</i>, $44,000 (12/10)<br> 17. Florida State University, Department of Biomedical Sciences Collaborative Project Exploration Grant, Blaber, M. (P.I.), <i style='mso-bidi-font-style: normal'>High Temperature  Crystals of FGF-1 Mutants,</i> $18,000 (11/10)<br> 16.<span style='mso-bidi-font-weight:bold'> Florida State University, College of Medicine Bridge Grant, Blaber, M. (P.I.), <i style='mso-bidi-font-style: normal'>Symmetric Deconstruction of Fibroblast Growth Factor-1,</i> $40,000 (12/09)<br> 15. Florida State University, Council on Research and Creativity Planning Grant,</span> Blaber, M. (P.I.),<span style='mso-bidi-font-weight:bold'> </span><i>Combinatorial Protein Redesign for Enhanced Thermostability,</i> <span style='mso-bidi-font-weight: bold'>$24,000 </span>(11/07)<br> 14. <st1:place w:st="on"><st1:PlaceName w:st="on">Florida</st1:PlaceName> State University</st1:place> Research Foundation, IRB Research &amp; Creative Activity Award, Blaber, M. (P.I.), $5,000 (7/07)<br> 13. Florida State University Research Foundation, Equipment and Infrastructure Enhancement Grant, Blaber, M. (Co-P.I.) <i style='mso-bidi-font-style:normal'>Critical Enhancements to Macromolecular X-ray Facility</i>, $49,500 (7/07)<br> 12. <st1:place w:st="on"><st1:PlaceName w:st="on">Florida</st1:PlaceName> State University</st1:place> Research Foundation, Application Proof of Concept (GAP) Grant, Blaber, M. (P.I.), <i style='mso-bidi-font-style:normal'>Heparin Binding Properties of Mutant FGF-1</i>. $40,000 (8/05)<br> 11. <span style='mso-bidi-font-weight:bold'>Florida State University Research Foundation, Cornerstone Program Enhancement Grant</span>, Blaber, M. (P.I.), <i>The Role of a Newly-identified Enzyme in Multiple Sclerosis and Spinal Cord Damag</i>e. <span style='mso-bidi-font-weight:bold'>$99,652 </span>(4/02)<br> 10.<span style='mso-bidi-font-weight:bold'> <st1:place w:st="on"><st1:PlaceName w:st="on">Florida</st1:PlaceName> <st1:PlaceType w:st="on">State</st1:PlaceType> <st1:PlaceType w:st="on">University</st1:PlaceType></st1:place>, Council on Research and Creativity Planning Grant,</span> Blaber, M. (P.I.),<span style='mso-bidi-font-weight:bold'> </span><i>Structure and Function Studies of <span class=SpellE>Myelencephalon</span>-specific Protease, an Enzyme Implicated in Nerve Damage and Multiple Sclerosis.</i> <span style='mso-bidi-font-weight: bold'>$20,000 </span>(11/01)<br> 9. <st1:place w:st="on"><st1:PlaceName w:st="on"><span style='mso-bidi-font-weight: bold'>Florida</span></st1:PlaceName><span style='mso-bidi-font-weight:bold'> State University</span></st1:place><span style='mso-bidi-font-weight:bold'> Research Foundation, Cornerstone Program Enhancement Grant, </span>Blaber, M. (Co-P.I.),<i>Program in Real-Time Electron Paramagnetic Resonance for the Life and Chemical Sciences, </i><span style='mso-bidi-font-weight:bold'>$100,000</span> (3/01)<br> 8. <span style='mso-bidi-font-weight:bold'>Graduate Recruiting Supplement, College of Arts and Sciences</span>, <span style='mso-bidi-font-weight:bold'>$7,000</span> Blaber, M. (P.I.), (12/00)<br> 7. <st1:place w:st="on"><st1:PlaceName w:st="on"><span style='mso-bidi-font-weight: bold'>Florida</span></st1:PlaceName><span style='mso-bidi-font-weight:bold'> <st1:PlaceType w:st="on">State</st1:PlaceType> <st1:PlaceType w:st="on">University</st1:PlaceType></span></st1:place><span style='mso-bidi-font-weight:bold'> Research Foundation, Cornerstone Program Enhancement Grant</span>, Blaber, M. (Co-P.I.),<i>Drug Development for Cystic Fibrosis</i>. Teem, J., Blaber, M., and Logan, T. <span style='mso-bidi-font-weight: bold'>$100,000</span> (3/99) (Co-PI)<br> 6.<span style='mso-bidi-font-weight:bold'> <st1:place w:st="on"><st1:PlaceName w:st="on">Florida</st1:PlaceName> State University</st1:place>, Distance Learning Course Development Grant<i>,</i></span> Blaber, M. (P.I.),<i><span style='mso-bidi-font-weight:bold'> </span>BCH5425 Molecular Biology and Biotechnology.</i> <span style='mso-bidi-font-weight:bold'>$8,000</span> (5/99)<br> 5.<span style='mso-bidi-font-weight:bold'> <st1:place w:st="on"><st1:PlaceName w:st="on">Florida</st1:PlaceName> State University</st1:place>, Council on Research and Creativity Planning Grant,</span> Blaber, M. (P.I.),<span style='mso-bidi-font-weight:bold'> </span><i>Protein Engineering of 2,5-diketo-D-Gluconate <span class=SpellE>Reductase</span> - An Enzyme for Vitamin C Biosynthesis.</i> <span style='mso-bidi-font-weight:bold'>$12,000 </span>(5/99)<br> 4.<span style='mso-bidi-font-weight:bold'> <st1:PlaceName w:st="on">Florida</st1:PlaceName> State University, Distance Learning Course Development Grant</span><i>,</i> Blaber, M. (P.I.),<i> CHM1045 General Chemistry I. </i><span style='mso-bidi-font-weight: bold'>$8,000 </span>(11/98)<br> 3.<span style='mso-bidi-font-weight:bold'> <st1:PlaceName w:st="on">Florida</st1:PlaceName> <st1:PlaceType w:st="on">State</st1:PlaceType> <st1:PlaceType w:st="on">University</st1:PlaceType>, Web Based Coursework Development Summer Grant,</span> Blaber, M. (P.I.),<i> CHM1045 <st1:place w:st="on"><st2:title w:st="on">General</st2:title> <st2:GivenName w:st="on">Chemistry</st2:GivenName> <st2:Sn w:st="on">I.</st2:Sn></st1:place> </i><span style='mso-bidi-font-weight:bold'>$5,200 </span>(5/98)<br> 2.<span style='mso-bidi-font-weight:bold'> <st1:place w:st="on"><st1:PlaceName w:st="on">Florida</st1:PlaceName> State University</st1:place>, Council on Research and Creativity Planning Grant</span>, Blaber, M. (P.I.),<i> Protease Structure and Specificity Relationships. </i><span style='mso-bidi-font-weight: bold'>$12,000 </span>(11/96)<br> 1.<span style='mso-bidi-font-weight:bold'> Florida State University, Council on Research and Creativity First Year Assistant Professor Award, </span>Blaber, M. (P.I.), <i>A Study of Protein Structure and Stability Relationships.</i> <span style='mso-bidi-font-weight:bold'>$8,900 </span>(5/95)<o:p></o:p></span></p> <p align=center style='text-align:center'><b><span style='font-family:"Arial","sans-serif"; mso-bidi-font-family:"Times New Roman"'>Book Reviews/Journals Refereed <o:p></o:p></span></b></p> <p><span style='font-size:10.0pt;font-family:"Arial","sans-serif";mso-bidi-font-family: "Times New Roman";mso-bidi-font-style:italic'>5. <i>Protein Structure and Function, </i>prospectus review, Pearson Prentice Hall (2005)<i><br> </i>4. <i>Recombinant DNA - The Basics Series, </i><span class=SpellE>Metzenberg</span>, S., (review) Garland Science/BIOS Scientific Publishers (2004) <br> 3. <i>Molecular Biology of the Gene</i></span><span style='font-size:10.0pt; font-family:"Arial","sans-serif";mso-bidi-font-family:"Times New Roman"'> (5<sup>th</sup> Edition) Watson (review, Chapter 8 - <i>DNA Replication; </i>Chapter 12<i> - Mechanisms of Transcription</i>), Benjamin Cummings (2003)<br> 2. <i>Biochemistry, The Chemical Reactions of Living Cells</i> (2<sup>nd</sup> Edition) Metzler (review, Chapter 6 - <i>Thermodynamics and Biochemical <span class=SpellE>Equilibria</span></i>), Harcourt Academic Press (2000)<br> 1. <i>Cases in Industry Practice for Biotechnology (review)</i>, Pearson Publishing, <st1:place w:st="on"><st1:City w:st="on">Livonia</st1:City>, <st1:State w:st="on">MI</st1:State></st1:place> (2000)<o:p></o:p></span></p> <p><i><span style='font-size:10.0pt;font-family:"Arial","sans-serif"; mso-bidi-font-family:"Times New Roman"'>Protein Science, Proteins: Structure, Function and Genetics, Journal of Biological Chemistry, <span class=SpellE>Biochemica</span> et <span class=SpellE>Biophysica</span> <span class=SpellE>Acta</span>, Proceedings of the National Academy of Sciences, Journal of Molecular Biology, International Journal of Biological Macromolecules, Biochemistry, Journal of Physical Chemistry, Journal of Molecular Structure, Biochemical Journal, Crystal Growth &amp; Design, International Journal of Biological Macromolecules, Cell Research, <span class=SpellE>Acta</span> <span class=SpellE>Crystallographica</span> Section F, European Biophysics Journal, Biological Chemistry, <span class=SpellE>BioEssays</span>, Cancer Biomarkers<o:p></o:p></span></i></p> <p align=center style='text-align:center'><b><span style='font-family:"Arial","sans-serif"; mso-bidi-font-family:"Times New Roman"'>Memberships in Professional Societies<o:p></o:p></span></b></p> <p><st1:PersonName w:st="on"><i><span style='font-size:10.0pt;font-family:"Arial","sans-serif"; mso-bidi-font-family:"Times New Roman"'>American Chemical Society</span></i></st1:PersonName><i><span style='font-size:10.0pt;font-family:"Arial","sans-serif";mso-bidi-font-family: "Times New Roman"'>, Biophysical Society, Protein Society, American Association for the Advancement of Science (AAAS), Federation of American Societies for Experimental Biology (FASEB), International Union of Crystallographers (<span class=SpellE>IUCr</span>), American Society for Biochemistry &amp; Molecular Biology (ASBMB), Clinical Chemistry<o:p></o:p></span></i></p> <p align=center style='text-align:center'><b><span style='font-family:"Arial","sans-serif"; mso-bidi-font-family:"Times New Roman"'>Oral Research Presentations - Invited<o:p></o:p></span></b></p> <p><span style='font-size:10.0pt;font-family:"Arial","sans-serif";mso-bidi-font-family: "Times New Roman";mso-bidi-font-style:italic'>42. <i>Functional intersection of matrix <span class=SpellE>metalloproteases</span> with kallikrein-related peptidases</i>, 4<sup>th</sup> International Symposium on Kallikreins, Rhodes Island, Greece (11)<br> 41. <i>Protein engineering for human therapeutics</i>, 1<sup>st</sup> Annual FSU Life Sciences Symposium, <i>From Molecules to Medicine</i>, Tallahassee, FL (11)<br> 40. <i>Experimental support for the  gene duplication &amp; fusion hypothesis of protein evolution via a  constant architecture model</i>, Department of Chemistry &amp; Biochemistry, U. Arizona (10)<br> 39. <i>Deconstruction of a Symmetric Protein <span class=SpellE>Superfold</span></i>, Department of Pharmaceutical Chemistry, University of Kansas (10)<br> 38.</span> <i><span style='font-size:10.0pt;font-family:"Arial","sans-serif"; mso-bidi-font-family:"Times New Roman"'>Human Kallikrein-related Peptidases (KLK s): Activation Cascades and Inflammatory Demyelination</span></i><span style='font-size:10.0pt;font-family:"Arial","sans-serif";mso-bidi-font-family: "Times New Roman";mso-bidi-font-style:italic'>, Neuroscience Symposium, Department of Psychology, FSU (10)<br> 37. <i>Structural Biology and Enzymology of the Human Kallikrein-related Peptidases</i> (<i>E.K. Frey-E. <span class=SpellE>Werle</span> Gold Medal Award</i>), 3<sup>rd</sup> International Symposium on Kallikreins and Kallikrein-related Peptidases, Munich, Germany (09) <br> 36. <i>Exploring Symmetric Protein Architecture by Structural Biology to Create an Artificial Protein</i>, Japan Atomic Energy Agency, Tokai, Japan (09)<i><br> </i>35. <i>Symmetric Protein Architecture: Consequences for Protein Stability, Folding and Function,</i></span><span style='font-family:"Arial","sans-serif"; mso-bidi-font-family:"Times New Roman"'> </span><span style='font-size:10.0pt; font-family:"Arial","sans-serif";mso-bidi-font-family:"Times New Roman"; mso-bidi-font-style:italic'>Advanced Technology Institute International Forum on Protein Structure Determination and Applications, <st1:country-region w:st="on"><st1:place w:st="on">Japan</st1:place></st1:country-region> (09)<i><br> </i>34. <i>Activation Profiles and Regulatory Cascades of the Human Kallikrein-related Peptidases</i>, Department of Biophysics, <span class=SpellE>Escola</span> <span class=SpellE>Paulista</span> de <span class=SpellE>Medicina</span>, <span class=SpellE>Universidade</span> Federal de Sao Paulo, Brazil (08)<i><br> </i>33. <i>A Logical OR Redundancy within the <span class=SpellE>Asx</span>-Pro-<span class=SpellE>Asx</span>-Gly Type I beta-turn Motif</i>, Japan Atomic Energy Research Institute, Tokai <st1:country-region w:st="on"><st1:place w:st="on">Japan</st1:place></st1:country-region> (08)<i><br> </i>32. <i>Opportunities in the Design of Second-Generation Protein Therapeutics</i>, 5<sup>th</sup> Annual Conference on Regenerative Medicine, Las Vegas (08)<i><br> </i>31. <i>Activation Profiles and Regulatory Cascades of the Human Kallikrein-related Peptidases (KLKs)</i>, 2nd International Symposium on Kallikreins and Kallikrein-Related Peptidases, <span class=SpellE>Santorini</span> Island, Greece (07)<i><br> </i>30. <i>Solvent Structure in Protein Engineering of Human Fibroblast Growth Factor-1, </i>Workshop on Neutron Protein Crystallography and its Perspective, Hitachi City, Japan (07)<i><br> </i>29. <i>The Latest in Molecular Architecture: Designing New Drugs, </i>4<sup>th</sup> Annual Conference on Regenerative Medicine, <st1:City w:st="on"><st1:place w:st="on">Las Vegas</st1:place></st1:City> (07)<i><br> </i>28. <i>Protein Engineering in the Development of a Novel Angiogenic Therapy for No-Option Coronary Heart Disease Patients</i>, Grand Rounds, College of Medicine, Florida State University (06)<i><br> </i>27. <i>Stability and Function in a Symmetric Protein Architecture</i>, Department of Bioengineering, Kagoshima University, and Graduate School of Pharmaceutical Sciences, Kyushu University, Japan (06)<br> 26. <i>Confessions of a Molecular Architect</i>, Ralph Alden Bradshaw 65<sup>th</sup> Birthday Symposium, Beckman Center of the National Academy of Arts and Sciences and Engineering, University of California, Irvine (06)<br> 25. <i>Activation Cascades Involving the Human Kallikrein Family, </i>Burnett College of Biomedical Sciences, University of Central Florida (05)<br> 24. <i>DSC: Data Analysis,</i> Current Trends in <span class=SpellE>Microcalorimetry</span>, <st1:place w:st="on"><st1:City w:st="on">Boston</st1:City> <st1:State w:st="on">MA</st1:State></st1:place> (05)<i> <br> </i>23. <i>Tertiary and Primary Structure Symmetry in Protein Evolution and Design</i>, Department of Physiology and Biophysics, College of Medicine, UC Irvine (05)<i><br> </i>22.<i>The Role of Turn Regions in Protein Structure, Stability and Folding, </i>Amgen Corp, Thousand Oaks CA (05)<i><br> </i>21. <i>Structure and Function Study of Human Kallikreins, </i>Department of Biomedical Sciences, College of Medicine, <st1:place w:st="on"><st1:PlaceName w:st="on">Florida</st1:PlaceName> <st1:PlaceType w:st="on">State</st1:PlaceType> <st1:PlaceType w:st="on">University</st1:PlaceType></st1:place> (05)<br> 20. <i>Solvent Structure in the Active Site of Human Kallikrein 1: A Ghost in the Machine</i>, International Workshop on Hydrogen and Hydration in Proteins and Nucleic Acids, January 17-18, 2005 <st1:place w:st="on"><st1:City w:st="on">University of Tokyo</st1:City>, <st1:country-region w:st="on">Japan</st1:country-region></st1:place><br> 19. <i>Kallikrein 6 and Inflammatory Demyelinating Disease</i>, <span class=SpellE>Dyax</span> Corp., <st1:place w:st="on"><st1:City w:st="on">Boston</st1:City> <st1:State w:st="on">MA</st1:State></st1:place> (05)<i><br> </i>18. <i>Protein Symmetry, Stability and Function</i></span><span style='font-size:10.0pt;font-family:"Arial","sans-serif";mso-bidi-font-family: "Times New Roman"'>, CALCON 2004 - 59<sup>th</sup> Annual Calorimetry Conference, Santa Fe NM (04)<br> 17. <i>Structural Biology of Human Kallikreins 6 and 1</i>, Department of Pathology, Mount Sinai Hospital, Toronto, Ontario Canada (04)<br> 16. <i>Structural Symmetry in Protein Evolution and Design</i>, Department of Chemistry, Gettysburg College (04)<br> 15. <i>Structure and Function of <span class=SpellE>Myelencephalon</span>-specific Protease/Kallikrein 6: A Novel Serine Protease Expressed in the CNS and Implicated in Demyelinating Disease, </i><span style='mso-bidi-font-style:italic'>The Blueprint of MS, MS Society, North Florida Chapter, Tallahassee Community College, FL (04)<i> <br> </i>14.<i> Structure and function studies of <span class=SpellE>myelencephalon</span>-specific protease (MSP)/kallikrein 6, </i>Mayo Clinic, <st1:place w:st="on"><st1:City w:st="on">Jacksonville</st1:City> <st1:State w:st="on">FL</st1:State></st1:place> (04)<i><br> </i>13.<i> Structural Symmetry in a </i></span></span><i><span style='font-size:10.0pt;font-family:Symbol'>b</span></i><i><span style='font-size:10.0pt;font-family:"Arial","sans-serif";mso-bidi-font-family: "Times New Roman"'>-Trefoil - Implications for Protein Evolution and Design</span></i><span style='font-size:10.0pt;font-family:"Arial","sans-serif";mso-bidi-font-family: "Times New Roman"'>, Department of Chemistry &amp; Biochemistry, Florida State University (04); School of Natural Sciences, U.C. Merced (03); Matthews Symposium, Eugene, OR (03)<br> 12. <i>Metabolic and Protein Engineering in the Development of a New Method for the Production of Vitamin C</i>, Southeast Regional Meeting of the American Society for Microbiology, Gainesville, FL (02)<br> 11. <i>DSC, isothermal equilibrium and folding kinetics of FGF - getting it all to agree</i>, Trends in <span class=SpellE>Biocalorimetry</span>: Applications and Answers, Sealy Center for Structural Biology, UTMB Galveston, TX (02); Current Trends in <span class=SpellE>Biocalorimetry</span>, North Carolina Biotechnology Center , NC (02)<br> 10. <i>Structure and Function of <span class=SpellE>Myelencephalon</span>-specific Protease/Human Kallikrein 6: A Novel Serine Protease Expressed in the CNS and Implicated in Demyelinating Disease</i>, <span class=SpellE>Berlex</span> Biosciences (02)<br> 9. <i>Crystal Packing Effects upon Protein Structures determined by X-ray Crystallography</i><b>. </b>223<sup>rd</sup> <st1:PersonName w:st="on">American Chemical Society</st1:PersonName> Meeting (02)<br> 8. <i>Structural Assembly of the Active Site in an Aldo-<span class=SpellE>keto</span> <span class=SpellE>Reductase</span> by NADPH Cofactor</i>, Georgia State University Chemistry Seminar Series (02)<br> 7. <i>Stability and Dynamics Issues in Enzyme Engineering of an Aldo-<span class=SpellE>keto</span> <span class=SpellE>Reductase</span></i>. SERMACS 2001, Savannah GA (01)<br> 6. <i>The Role of Low Concentrations of Guanidine HCl in Reversible Denaturation of Human FGF-1</i><b>. </b>Sturtevant <span class=SpellE>Biothermodynamics</span> Symposium, Tallahassee FL (99), <st1:PersonName w:st="on">American Chemical Society</st1:PersonName> Florida Division, Orlando FL (99)<br> 5. <i>Metabolic and Protein Engineering in the Development of a New Method for the Production of Vitamin C</i><b>. </b>Florida Institute of Technology (99), <st1:State w:st="on"><st1:place w:st="on">Florida</st1:place></st1:State> State University (98)<br> 4. <i>Structure, Stability and Function of Human Acidic Fibroblast Growth Factor</i><b>. </b>Kirin Central Laboratory for Key Technology, Yokohama Japan (98), Sagami Chemical Research Center, Sagamihara Japan (98), International Institute for Advanced Research, Seika Japan (98)<br> 3. <i>Metabolic Engineering for the Production of Vitamin C: The Structure of 2,5-Diketo-D-Gluconate <span class=SpellE>Reductase</span></i><b>. </b><st1:PlaceName w:st="on"><span class=SpellE>Millsaps</span></st1:PlaceName> College (97), University of South Florida (97)<br> 2. <i>Mechanisms of Regulation of Human Acidic Fibroblast Growth Factor</i><b>. </b>20<sup>th</sup> Annual Research Seminar American Cancer Society, Florida Division (97)<br> 1. <i>Protein Structure, Stability and Function</i><b>. </b><st1:place st="on" w:st="on"><st1:PlaceName st="on" w:st="on">Clarkson</st1:PlaceName> <st1:PlaceType st="on" w:st="on">University</st1:PlaceType></st1:place> (96)<span style='mso-bidi-font-style:italic'><o:p></o:p></span></span></p> <p align=center style='text-align:center'><b><span style='font-family:"Arial","sans-serif"; mso-bidi-font-family:"Times New Roman"'>Oral Research Presentations - Contributed<o:p></o:p></span></b></p> <p><span style='font-size:10.0pt;font-family:"Arial","sans-serif";mso-bidi-font-family: "Times New Roman";mso-bidi-font-style:italic'>6. <i>A Logical OR Redundancy within the <span class=SpellE>Asx</span>-Pro-<span class=SpellE>Asx</span>-Gly Type I beta-turn Motif</i>, Northwest Crystallography Workshop (NWCW), Eugene OR (08)<i><br> </i>5. <i>1.70Å X-ray structure of human <span class=SpellE>apo</span> kallikrein 1: Structural changes upon peptide inhibitor/substrate binding</i>, 1st International Conference on Kallikreins, <st1:City w:st="on">Lausanne</st1:City> <st1:country-region w:st="on"><st1:place w:st="on">Switzerland</st1:place></st1:country-region> (05)<i><br> </i>4. <i>The Role of Symmetry in Protein Folding and Design</i></span><b><span style='font-size:10.0pt;font-family:"Arial","sans-serif";mso-bidi-font-family: "Times New Roman"'>. </span></b><st1:place w:st="on"><st1:State w:st="on"><span style='font-size:10.0pt;font-family:"Arial","sans-serif";mso-bidi-font-family: "Times New Roman";mso-bidi-font-weight:bold'>Florida</span></st1:State></st1:place><span style='font-size:10.0pt;font-family:"Arial","sans-serif";mso-bidi-font-family: "Times New Roman";mso-bidi-font-weight:bold'> Annual Meeting and Exposition of the </span><st1:PersonName w:st="on"><span style='font-size:10.0pt;font-family: "Arial","sans-serif";mso-bidi-font-family:"Times New Roman"'>American Chemical Society</span></st1:PersonName><span style='font-size:10.0pt;font-family:"Arial","sans-serif"; mso-bidi-font-family:"Times New Roman"'> (01)<br> 3. <i>Modulation of Protein Stability</i><b>. </b><st1:place w:st="on"><st1:State w:st="on"><span style='mso-bidi-font-weight:bold'>Florida</span></st1:State></st1:place><span style='mso-bidi-font-weight:bold'> Annual Meeting and Exposition of the </span><st1:PersonName w:st="on">American Chemical Society</st1:PersonName> (97)<br> 2. <i>Denaturation Studies of Human Acidic Fibroblast Growth Factor</i><b>. </b>First International Conference on the Applications of <span class=SpellE>Biocalorimetry</span> (96)<br> 1. <i>Protein Stability as a Regulatory Mechanism</i><b>. </b><st1:State w:st="on"><st1:place w:st="on"><span style='mso-bidi-font-weight:bold'>Florida</span></st1:place></st1:State><span style='mso-bidi-font-weight:bold'> Annual Meeting and Exposition of the </span><st1:PersonName w:st="on">American Chemical Society</st1:PersonName> (95)<i><o:p></o:p></i></span></p> <p align=center style='text-align:center'><a name=publications></a><b><span style='font-family:"Arial","sans-serif";mso-bidi-font-family:"Times New Roman"'>Peer-Reviewed Publications<o:p></o:p></span></b></p> <p class=MsoNormal><span style='font-size:10.0pt;font-family:"Arial","sans-serif"; mso-bidi-font-family:"Times New Roman"'>86. <i style='mso-bidi-font-style:normal'>Kallikrein 6 is a Novel Molecular Trigger of Reactive <span class=SpellE>Astrogliosis</span></i>, Scarisbrick, I., <span class=SpellE>Radulovic</span>, M., Burda, J., Larson, N., Blaber, S., <span class=SpellE>Gianinni</span>, C., Blaber, M. and <span class=SpellE>Vandell</span>, A., <i style='mso-bidi-font-style:normal'>Biol. Chem</i>. (in press)<o:p></o:p></span></p> <p class=MsoNormal><span style='font-size:10.0pt;font-family:"Arial","sans-serif"; mso-bidi-font-family:"Times New Roman"'>85. </span><i><span style='font-size: 10.0pt;font-family:"Arial","sans-serif";mso-fareast-font-family:"Times New Roman"; color:windowtext'>An empirical phase diagram approach to investigate conformational stability of &quot;second-generation&quot; functional mutants of acidic fibroblast growth factor (FGF-1),</span></i><span style='font-size:10.0pt; font-family:"Arial","sans-serif";mso-fareast-font-family:"Times New Roman"; color:windowtext'> Alsenaidy, M.A., Wang, T., Kim, J.H., Joshi, S.B., Lee, J., Blaber, M., Volkin, D.B., and Middaugh, C.R. (2011) <i>Prot. Sci.</i> (<i style='mso-bidi-font-style:normal'><span style='mso-bidi-font-weight:bold'>in press</span></i><span style='mso-bidi-font-weight:bold'>)</span></span><span style='font-size:10.0pt;font-family:"Arial","sans-serif";mso-bidi-font-family: "Times New Roman"'><br> 84. <i style='mso-bidi-font-style:normal'>Biological evaluation and docking studies of natural <span class=SpellE>isocoumarins</span> as inhibitors for human kallikrein 5 and 7</i>, Teixeira, T.S., <span class=SpellE>Freitas</span>, R,F., <span class=SpellE>Abrahão</span>, O. <span class=SpellE>Jr</span>, <span class=SpellE>Devienne</span>, K.F., de Souza, <span class=SpellE>L.R.,Blaber</span>, S.I., Blaber, M., Kondo, M.Y., Juliano, M.A., Juliano, L. and <span class=SpellE>Puzer</span>, L., <span class=SpellE><i style='mso-bidi-font-style: normal'>Bioorg</i></span><i style='mso-bidi-font-style:normal'>. Med. Chem. <span class=SpellE>Lett</span>.</i> <b style='mso-bidi-font-weight:normal'>21</b>, 6112-6115 (2011) <o:p></o:p></span></p> <p class=MsoNormal><span style='font-size:10.0pt;font-family:"Arial","sans-serif"; mso-bidi-font-family:"Times New Roman"'>83. <i style='mso-bidi-font-style:normal'>Substrate specificity of kallikrein-related peptidase 13 activated by salts or glycosaminoglycans and a search for natural substrate candidates</i>, Andrade, D., <span class=SpellE>Assis</span>, D.M., Santos, J.A.N., <span class=SpellE>Alves</span>, F.M., Hirata, I.Y., <span class=SpellE>Araujo</span>, M.S., Blaber, S.I., Blaber, M., Juliano, M.A. and Juliano, L., <span class=SpellE><i style='mso-bidi-font-style:normal'>Biochimie</i></span> <b style='mso-bidi-font-weight: normal'>93</b>, 1701-1709 (2011)<o:p></o:p></span></p> <p class=MsoNormal><span style='font-size:10.0pt;font-family:"Arial","sans-serif"; mso-bidi-font-family:"Times New Roman"'>82. <i style='mso-bidi-font-style:normal'>Expression and Function of the Kallikrein-Related Peptidase 6 in the Human Melanoma Microenvironment</i>, Krenzer, S., <span class=SpellE>Peterziel</span>, H., <span class=SpellE>Mauch</span>, C., Blaber, S.I., Blaber, M., Angel, P. and Hess, J., <i style='mso-bidi-font-style:normal'>J. Invest. Dermatol</i>.<b style='mso-bidi-font-weight:normal'>131</b>, 2281-2288 (2011)<o:p></o:p></span></p> <p class=MsoNormal><span style='font-size:10.0pt;font-family:"Arial","sans-serif"; mso-bidi-font-family:"Times New Roman"'>81. <i style='mso-bidi-font-style:normal'>Functional role of Kallikrein 6 in Regulating Immune Cell Survival</i>, Scarisbrick, I.A., Epstein, B., Cloud, B., Yoon, H., Wu, J., Blaber, S.I., Blaber, M., <span class=SpellE>Vandell</span>, A.G. and Bryson, A. <span class=SpellE><i style='mso-bidi-font-style:normal'>PLoS</i></span><i style='mso-bidi-font-style: normal'> ONE</i> <b style='mso-bidi-font-weight:normal'>6</b>(3): e18376. doi:10.1371/journal.pone.0018376 (2011)<o:p></o:p></span></p> <p class=MsoNormal><span style='font-size:10.0pt;font-family:"Arial","sans-serif"; mso-bidi-font-family:"Times New Roman"'>80. <i style='mso-bidi-font-style:normal'>A polypeptide &quot;building block&quot; for the ß-trefoil fold identified by &quot;top-down symmetric deconstruction&quot;</i>, Lee, J., Blaber, S., Dubey, V. and Blaber, M., <i style='mso-bidi-font-style:normal'>J. Mol. Biol.</i> <b style='mso-bidi-font-weight:normal'>407</b>, 744 763 (2011) (</span><b style='mso-bidi-font-weight:normal'><span style='font-size:10.0pt;font-family: "Arial","sans-serif";mso-bidi-font-family:"Times New Roman";color:blue'>selected by Faculty of 1000; Cover Article</span></b><span style='font-size:10.0pt; font-family:"Arial","sans-serif";mso-bidi-font-family:"Times New Roman"'>)<br> 79. <i style='mso-bidi-font-style:normal'>Experimental support for the evolution of symmetric protein architecture from a simple peptide motif</i>, Lee, J. and Blaber, M., <i style='mso-bidi-font-style:normal'>Proc. Natl. Acad. Sci</i>. <b style='mso-bidi-font-weight:normal'>108</b>, 126-130 (2011) (</span><b style='mso-bidi-font-weight:normal'><span style='font-size:10.0pt;font-family: "Arial","sans-serif";mso-bidi-font-family:"Times New Roman";color:blue'>selected by Faculty of 1000</span></b><span style='font-size:10.0pt;font-family:"Arial","sans-serif"; mso-bidi-font-family:"Times New Roman"'>)<o:p></o:p></span></p> <p class=MsoNormal style='mso-layout-grid-align:none;text-autospace:none'><span style='font-size:10.0pt;font-family:"Arial","sans-serif";mso-bidi-font-family: "Times New Roman"'>78. </span><i><span style='font-size:10.0pt;font-family: "Arial","sans-serif";mso-fareast-font-family:"Times New Roman"'>Increased Functional Half-life of Fibroblast Growth Factor-1 by Recovering a Vestigial Disulfide Bond</span></i><span style='font-size:10.0pt;font-family:"Arial","sans-serif"; mso-fareast-font-family:"Times New Roman"'>, Lee, J. and Blaber, M., <i>J. Proteins Proteomics</i>, <b>1</b>, 37-42 (2010)<o:p></o:p></span></p> <p class=MsoNormal><span style='font-size:10.0pt;font-family:"Arial","sans-serif"; mso-bidi-font-family:"Times New Roman"'>77. <i style='mso-bidi-font-style:normal'>Substrate specificity and inhibition of human kallikrein-related peptidase 3 (KLK3 or PSA) activated with sodium citrate and glycosaminoglycans</i>., Andrade, D., <span class=SpellE>Assis</span>, D.M., Lima, A.R., Oliveira, J.R., <span class=SpellE>Araujo</span>, M.S., Blaber, S.I., Blaber, M., Juliano, M.A. and Juliano, L., <i style='mso-bidi-font-style:normal'>Arch. <span class=SpellE>Biochem</span>. <span class=SpellE>Biophys</span></i>. <b style='mso-bidi-font-weight:normal'>498</b>, 74-82 (2010)<br> 76. <i style='mso-bidi-font-style:normal'>Functional intersection of the Kallikrein-related peptidases (KLKs) and thrombostasis axis</i>, Blaber, M., Yoon, H., Juliano, M.A., Scarisbrick, I.A., and Blaber, S.I., <i style='mso-bidi-font-style:normal'>Biological Chemistry</i> <b style='mso-bidi-font-weight:normal'>391</b>, 311-320 (2010)<o:p></o:p></span></p> <p class=MsoNormal><span style='font-size:10.0pt;font-family:"Arial","sans-serif"; mso-bidi-font-family:"Times New Roman"'>75. <i style='mso-bidi-font-style:normal'>Analysis of the Dynamics of Assembly and Structural Impact for a <span class=SpellE>Histidine</span> Tagged FGF-1  1.5 nm Au <span class=SpellE>Nanoparticle</span> <span class=SpellE>Bioconjugate</span></i>, <span class=SpellE>Kogot</span>, J.M., Parker, A.M., Lee, J., Blaber, M., <span class=SpellE>Strouse</span>, G.F. and Logan, T.M., <span class=SpellE><i style='mso-bidi-font-style:normal'>Bioconjugate</i></span><i style='mso-bidi-font-style:normal'> Chemistry</i> <b style='mso-bidi-font-weight: normal'>20</b>, 2106 2113 (2009)<br> 74. <i style='mso-bidi-font-style:normal'>X-ray Structure and Biophysical Properties of Rabbit Fibroblast Growth Factor-1</i>, Lee, J., Blaber, S.I., <span class=SpellE>Irsigler</span>, A., Aspinwall, E. and Blaber, M., <span class=SpellE><i style='mso-bidi-font-style:normal'>Acta</i></span><i style='mso-bidi-font-style:normal'> <span class=SpellE>Cryst</span>. F.</i> <b style='mso-bidi-font-weight:normal'>65</b>, 1097-1104 (2009)<o:p></o:p></span></p> <p class=MsoNormal><span style='font-size:10.0pt;font-family:"Arial","sans-serif"; mso-bidi-font-family:"Times New Roman"'>73. <i style='mso-bidi-font-style:normal'>Engineering an Improved Crystal Contact across a Solvent-Mediated Interface of Human Fibroblast Growth Factor-1</i>, Meher, A.K., Blaber, S.I., Lee, J., <span class=SpellE>Honjo</span>, E., Kuroki, R. and Blaber, M., <span class=SpellE><i style='mso-bidi-font-style:normal'>Acta</i></span><i style='mso-bidi-font-style: normal'> <span class=SpellE>Cryst</span>. F.</i> <b style='mso-bidi-font-weight: normal'>65</b>, 1136-1140 (2009)<br> 72. <i style='mso-bidi-font-style:normal'>Structural Basis of Conserved Cysteine in the Fibroblast Growth Factor Family: Evidence for a Vestigial Half-<span class=SpellE>cystine</span></i>, Lee, J. and Blaber, M., <i style='mso-bidi-font-style: normal'>J. Mol. Biol. </i><b style='mso-bidi-font-weight:normal'>393</b>, 128-139 (2009)<o:p></o:p></span></p> <p class=MsoNormal><span style='font-size:10.0pt;font-family:"Arial","sans-serif"; mso-bidi-font-family:"Times New Roman"'>71. <i style='mso-bidi-font-style:normal'>The Interaction between Thermodynamic Stability and Buried Free Cysteines in Regulating the Functional Half-life of Fibroblast Growth Factor-1</i>, Lee, J. and Blaber, M., <i style='mso-bidi-font-style:normal'>J. Mol. Biol.</i> <b style='mso-bidi-font-weight:normal'>393</b>, 113-127<i style='mso-bidi-font-style: normal'> </i>(2009)<o:p></o:p></span></p> <p class=MsoNormal><span style='font-size:10.0pt;font-family:"Arial","sans-serif"; mso-bidi-font-family:"Times New Roman"'>70. <i style='mso-bidi-font-style:normal'>A Completed KLK Activome Profile: Investigation of Activation Profiles of KLK9, 10 and 15</i>, Yoon, H., Blaber, S.I., <span class=SpellE>Debela</span>, M., <span class=SpellE>Goettig</span>, P., Scarisbrick, I.A. and Blaber, M., <i style='mso-bidi-font-style:normal'>Biological Chemistry</i> <b style='mso-bidi-font-weight:normal'>390</b>, 373-377 (2009)<o:p></o:p></span></p> <p class=MsoNormal><span style='font-size:10.0pt;font-family:"Arial","sans-serif"; mso-bidi-font-family:"Times New Roman"'>69. <i style='mso-bidi-font-style:normal'>S1 and S2 <span class=SpellE>Subsite</span> Specificities of Human Plasma <span class=SpellE>Kalikrein</span> and Tissue Kallikrein 1 on the Hydrolysis of Peptides Derived from Bradykinin Domain of Human Kininogen.</i>, Lima, A.R., <span class=SpellE>Alves</span>, F.M., Angelo, P.F., Andrade, D., Blaber, S.I., Blaber, M., <span class=SpellE>Juliano.L</span>. and Juliano, M.A., <i style='mso-bidi-font-style:normal'>Biological Chemistry </i><b style='mso-bidi-font-weight:normal'>389</b>, 1487-1494 (2008)<i style='mso-bidi-font-style:normal'><o:p></o:p></i></span></p> <p class=MsoNormal><span style='font-size:10.0pt;font-family:"Arial","sans-serif"; mso-bidi-font-family:"Times New Roman"'>68. <i style='mso-bidi-font-style:normal'>Protease Activated Receptor Dependent and Independent Signaling by Kallikreins 1 and 6 in CNS Neuron and <span class=SpellE>Astroglial</span> Cell Lines</i>, <span class=SpellE>Vandell</span>, A.G., Larson, N., Laxmikanthan, G., <span class=SpellE>Panos</span>, M., Blaber, S.I., Blaber, M. and Scarisbrick, I.A., <i style='mso-bidi-font-style:normal'>J. <span class=SpellE>Neurochem</span></i>. <b style='mso-bidi-font-weight:normal'>107</b>, 855-870 (2008)<o:p></o:p></span></p> <p class=MsoNormal><span style='font-size:10.0pt;font-family:"Arial","sans-serif"; mso-bidi-font-family:"Times New Roman"'>67. <i style='mso-bidi-font-style:normal'>Activation Profiles of Human Kallikrein-related Peptidases by Proteases of the Thrombostasis Axis</i>, Yoon, H., Blaber, S.I., Evans, D.M., Trim, J., Juliano, M.A., Scarisbrick, I.A. and Blaber, M. <i style='mso-bidi-font-style:normal'>Prot. Sci. </i><b style='mso-bidi-font-weight:normal'>17</b>, 1998-2007 (2008)<o:p></o:p></span></p> <p class=MsoNormal><span style='font-size:10.0pt;font-family:"Arial","sans-serif"; mso-bidi-font-family:"Times New Roman"'>66. <i style='mso-bidi-font-style:normal'>Kallikreins are Associated with Secondary Progressive Multiple Sclerosis and Promote <span class=SpellE>Neurodegeneration</span></i>, Scarisbrick, I.A., <span class=SpellE>Linbo</span>, R., <span class=SpellE>Vandell</span>, A.G., Keegan, M., Blaber, S.I., Blaber, M., <span class=SpellE>Sneve</span>, D., <span class=SpellE>Lucchinetti</span>, C.F., Rodriguez, M. and Diamandis, E., <i style='mso-bidi-font-style:normal'>Biol. Chem</i>. <b style='mso-bidi-font-weight: normal'>389</b>, 739-745 (2008)<o:p></o:p></span></p> <p class=MsoNormal><span style='font-size:10.0pt;font-family:"Arial","sans-serif"; mso-bidi-font-family:"Times New Roman"'>65. <i style='mso-bidi-font-style:normal'>Mutagenesis of the crystal contact of acidic fibroblast growth factor</i>, <span class=SpellE>Honjo</span>, E., <span class=SpellE>Tamada</span>, T., Adachi, M., Kuroki, R., Meher, A. and Blaber, M., <i style='mso-bidi-font-style:normal'>J. Synchrotron Radiation</i> <b style='mso-bidi-font-weight:normal'>15</b>, 285-287 (2008)<o:p></o:p></span></p> <p class=MsoNormal><span style='font-size:10.0pt;font-family:"Arial","sans-serif"; mso-bidi-font-family:"Times New Roman"'>64. <i style='mso-bidi-font-style:normal'>The Substrate Specificity of Human Kallikrein 1 and 6 Determined by Phage Display</i>, Li, H.-X., Hwang, B.-Y., Laxmikanthan, G., Blaber, S.I., Blaber, M., <span class=SpellE>Golubkov</span>, P.A., <span class=SpellE>Ren</span>, P., Iverson, B.L. and Georgiou, G. <i style='mso-bidi-font-style:normal'>Protein Science</i> <b style='mso-bidi-font-weight:normal'>17</b>, 664-672 (2008)<o:p></o:p></span></p> <p class=MsoNormal><span style='font-size:10.0pt;font-family:"Arial","sans-serif"; mso-bidi-font-family:"Times New Roman"'>63. <i style='mso-bidi-font-style:normal'>A Logical OR Redundancy within the <span class=SpellE>Asx</span>-Pro-<span class=SpellE>Asx</span>-Gly Type I </i></span><i style='mso-bidi-font-style: normal'><span style='font-size:10.0pt;font-family:Symbol'>b</span></i><i style='mso-bidi-font-style:normal'><span style='font-size:10.0pt;font-family: "Arial","sans-serif";mso-bidi-font-family:"Times New Roman"'>-turn Motif</span></i><span style='font-size:10.0pt;font-family:"Arial","sans-serif";mso-bidi-font-family: "Times New Roman"'>, Lee, J., Dubey, V.K., Longo, L.M. and Blaber, M. <i style='mso-bidi-font-style:normal'>J. Mol. Biol. </i><b style='mso-bidi-font-weight: normal'>377</b>, 1251-1264 (2008)<o:p></o:p></span></p> <p class=MsoNormal><span style='font-size:10.0pt;font-family:"Arial","sans-serif"; mso-bidi-font-family:"Times New Roman"'>62. <i style='mso-bidi-font-style:normal'>Activation Profiles and Regulatory Cascades of the Human Kallikrein-related Peptidases, </i>Yoon, H., Laxmikanthan, G., Lee, J., Blaber, S.I., Rodriguez, A., <span class=SpellE>Kogot</span>, J.M., Scarisbrick. I.A. and Blaber, M., <a name="OLE_LINK4"></a><a name="OLE_LINK3"><span style='mso-bookmark:OLE_LINK4'><i style='mso-bidi-font-style: normal'>J. Biol. Chem. </i><b style='mso-bidi-font-weight:normal'>282</b>, 31852-31864</span></a> (2007)<i style='mso-bidi-font-style:normal'><o:p></o:p></i></span></p> <p class=MsoNormal><span style='font-size:10.0pt;font-family:"Arial","sans-serif"; mso-bidi-font-family:"Times New Roman"'>61. <i style='mso-bidi-font-style:normal'>Spackling the Crack: Stabilizing Human Fibroblast Growth Factor-1 by Targeting the N- and C-terminus </i></span><i style='mso-bidi-font-style:normal'><span style='font-size:10.0pt;font-family:Symbol'>b</span></i><i style='mso-bidi-font-style: normal'><span style='font-size:10.0pt;font-family:"Arial","sans-serif"; mso-bidi-font-family:"Times New Roman"'>-strand Interactions</span></i><span style='font-size:10.0pt;font-family:"Arial","sans-serif";mso-bidi-font-family: "Times New Roman"'>, Dubey, V.K., Lee, J., <span class=SpellE>Somasundaram</span>, T., Blaber, S. and Blaber, M., <i style='mso-bidi-font-style:normal'>J. Mol. Biol.</i> </span><b style='mso-bidi-font-weight:normal'><span style='font-size: 10.0pt;font-family:"Arial","sans-serif"'>371</span></b><span style='font-size: 10.0pt;font-family:"Arial","sans-serif"'>, 256-268 (2007)</span><span style='font-size:10.0pt;font-family:"Arial","sans-serif";mso-bidi-font-family: "Times New Roman"'><o:p></o:p></span></p> <p class=MsoNormal><span style='font-size:10.0pt;font-family:"Arial","sans-serif"; mso-bidi-font-family:"Times New Roman"'>60. <i style='mso-bidi-font-style:normal'>The Autolytic Regulation of Human Kallikrein-Related Peptidase 6, </i>Blaber, S., Yoon, H., Scarisbrick, I.A., Juliano, M.A., and Blaber, M. <i style='mso-bidi-font-style: normal'>Biochemistry</i> <b style='mso-bidi-font-weight:normal'>46</b>, 5209-5217 (2007)<o:p></o:p></span></p> <p class=MsoNormal><span style='font-size:10.0pt;font-family:"Arial","sans-serif"; mso-bidi-font-family:"Times New Roman"'>59. <span class=SpellE><i style='mso-bidi-font-style:normal'>Proteinase</i></span><i style='mso-bidi-font-style: normal'>-activated Receptors (PARS): Targets for Kallikrein <span class=SpellE>Signalling</span></i>, <span class=SpellE>Oikonomopoulou</span>, K., Hansen, K.K., <span class=SpellE>Saifeddine</span>, M., Tea, I., Blaber, M., Blaber, S.I., Scarisbrick, I.A., Andrade-Gordon, P., Cottrell, G.S., <span class=SpellE>Bunnett</span>, N.W., Diamandis, E.P. and <span class=SpellE>Hollenberg</span>, M.D., <i style='mso-bidi-font-style:normal'>J. Biol. Chem.</i> <b style='mso-bidi-font-weight:normal'>281</b>, 32095-32112 (2006) <o:p></o:p></span></p> <p class=MsoNormal><span style='font-size:10.0pt;font-family:"Arial","sans-serif"; mso-bidi-font-family:"Times New Roman"'>58. <i style='mso-bidi-font-style:normal'>Dynamic Role of Kallikrein 6 in Traumatic Spinal Cord Injury</i>, Scarisbrick, I.A., <span class=SpellE>Sabharwal</span>, P., Blaber, S.I., Cruz, H., <span class=SpellE>Ameednuddin</span>, S., <span class=SpellE>Papke</span>, L.M., Larsen, N., <span class=SpellE>Fehlings</span>, M.G., Reeves, R.K., Blaber, M., <span class=SpellE>Windebank</span>, A.J. and Rodriguez, M., <i style='mso-bidi-font-style:normal'>Eur. J. <span class=SpellE>Neurosci</span>.</i> <b style='mso-bidi-font-weight:normal'>24</b>, 1457-1469 (2006) <o:p></o:p></span></p> <p class=MsoNormal><span style='font-size:10.0pt;font-family:"Arial","sans-serif"; mso-bidi-font-family:"Times New Roman"'>57. <i style='mso-bidi-font-style:normal'>Potential Scope of Action of Tissue Kallikreins in CNS Immune-Mediated Disease</i>, Scarisbrick, I.A., Blaber, S.I., Tingling, J.T., Rodriguez, M., Blaber, M, and <span class=SpellE>Christophi</span>, G.P., <i style='mso-bidi-font-style:normal'>J. <span class=SpellE>Neuroimmunol</span>.</i> <b style='mso-bidi-font-weight:normal'>178</b>, 167-176 (2006) <o:p></o:p></span></p> <p class=MsoNormal><span style='font-size:10.0pt;font-family:"Arial","sans-serif"; mso-bidi-font-family:"Times New Roman"'>56. <i style='mso-bidi-font-style:normal'>Kallikrein-Mediated Cell Signaling: Targeting <span class=SpellE>Proteinase</span>-Activated Receptors (PARs)1</i>, <span class=SpellE>Oikonomopoulou</span>, K., Hansen, K.K., <span class=SpellE>Saifeddine</span>, M., <span class=SpellE>Vergnolle</span>, N., Tea, I., Blaber, M., Blaber, S.I., Scarisbrick, <st1:place w:st="on">I.</st1:place>, Diamandis, E.P. and <span class=SpellE>Hollenberg</span>, M.D. <i style='mso-bidi-font-style:normal'>Biological Chemistry</i> <b style='mso-bidi-font-weight:normal'>387</b>, 817-824 (2006)<o:p></o:p></span></p> <p class=MsoNormal><span style='font-size:10.0pt;font-family:"Arial","sans-serif"; mso-bidi-font-family:"Times New Roman"'>55. <i style='mso-bidi-font-style:normal'>A comprehensive nomenclature for serine proteases with homology to the tissue kallikrein</i>, <span class=SpellE>Lundwall</span>, A Band, V., Blaber, M., Clements, J., <span class=SpellE>Courty</span>, Y., Diamandis, E., <span class=SpellE>Lilja</span>, H., <span class=SpellE>Maltais</span>, L.J., Olsson, Y., <span class=SpellE>Petraki</span>, C., <span class=SpellE>Sotiropoulou</span>, G., <span class=SpellE>Stenman</span>, U.-H., Stephan, C., <span class=SpellE>Talieri</span>, M. and <span class=SpellE>Yousef</span>, G. <i style='mso-bidi-font-style:normal'>Biological Chemistry</i> <b style='mso-bidi-font-weight:normal'>387</b>, 637-641(2006)<o:p></o:p></span></p> <p class=MsoNormal><span style='font-size:10.0pt;font-family:"Arial","sans-serif"; mso-bidi-font-family:"Times New Roman"'>54. <i style='mso-bidi-font-style:normal'>Substrate Specificity of Human Kallikrein 6: Salt and <span class=SpellE>Glycosaminoglycan</span> Activation Effects</i>, Angelo, P.F., <st1:place w:st="on"><st1:City w:st="on">Lima</st1:City></st1:place>, A.R., <span class=SpellE>Alves</span>, F.M., Juliano, L., Blaber, S.I., Scarisbrick, I.A., Blaber, M. and Juliano, M.A. <i style='mso-bidi-font-style: normal'>J. Biol. Chem.</i> <b style='mso-bidi-font-weight:normal'>281</b>, 3116-3126 (2006) <o:p></o:p></span></p> <p class=MsoNormal><span style='font-size:10.0pt;font-family:"Arial","sans-serif"; mso-bidi-font-family:"Times New Roman"'>53. <i style='mso-bidi-font-style:normal'>Conversion of type I 4:6 to 3:5 </i></span><i style='mso-bidi-font-style:normal'><span style='font-size:10.0pt;font-family:Symbol'>b</span></i><i style='mso-bidi-font-style: normal'><span style='font-size:10.0pt;font-family:"Arial","sans-serif"; mso-bidi-font-family:"Times New Roman"'>-turn Types in Human Acidic Fibroblast Growth Factor: Effects upon Structure, Stability, Folding and Mitogenic Function</span></i><span style='font-size:10.0pt;font-family:"Arial","sans-serif"; mso-bidi-font-family:"Times New Roman"'>, Lee, J., Dubey, V.K., <span class=SpellE>Somasundaram</span>, T. and Blaber, M. <i style='mso-bidi-font-style: normal'>Proteins</i><b style='mso-bidi-font-weight:normal'> 62, </b>686-697(2006)</span><span style='font-size:10.0pt;font-family:"Batang","serif";mso-bidi-font-family:Batang'><o:p></o:p></span></p> <p class=MsoNormal><span style='font-size:10.0pt;font-family:"Arial","sans-serif"; mso-bidi-font-family:"Times New Roman"'>52. <i style='mso-bidi-font-style:normal'>Redesigning Symmetry-Related  Mini-Core Regions of FGF-1 to Increase Primary Structure Symmetry: Thermodynamic and Functional Consequences of Structural Symmetry</i>, Dubey, V.K., Lee, J. and Blaber, M., <i style='mso-bidi-font-style:normal'>Protein Science</i> <b style='mso-bidi-font-weight:normal'>14</b>:2315-2323 (2005) <o:p></o:p></span></p> <p class=MsoNormal><span style='font-size:10.0pt;font-family:"Arial","sans-serif"; mso-bidi-font-family:"Times New Roman"'>51. <i style='mso-bidi-font-style:normal'>1.7</i></span><i style='mso-bidi-font-style:normal'><span style='font-size:10.0pt;font-family: "Arial","sans-serif"'>Å</span></i><i style='mso-bidi-font-style:normal'><span style='font-size:10.0pt;font-family:"Arial","sans-serif";mso-bidi-font-family: "Times New Roman"'> X-ray Structure of <st1:place w:st="on">Apo</st1:place> Human Kallikrein 1: Structural Changes upon Peptide Inhibitor/substrate Binding</span></i><span style='font-size:10.0pt;font-family:"Arial","sans-serif";mso-bidi-font-family: "Times New Roman"'>, Laxmikanthan, G., Blaber, S.I., <span class=SpellE>Bernett</span>, M.J., Scarisbrick, I.A., Juliano, M.A. and Blaber, M., <i style='mso-bidi-font-style: normal'>Proteins</i> <b style='mso-bidi-font-weight:normal'>58</b>, 802-814 (2005)<o:p></o:p></span></p> <p class=MsoNormal><span style='font-size:10.0pt;font-family:"Arial","sans-serif"; mso-bidi-font-family:"Times New Roman"'>50. <i style='mso-bidi-font-style:normal'>Sequence-Swapping does not Result in Conformation-Swapping for the </i></span><i style='mso-bidi-font-style:normal'><span style='font-size:10.0pt;font-family: Symbol'>b</span></i><i style='mso-bidi-font-style:normal'><span style='font-size:10.0pt;font-family:"Arial","sans-serif";mso-bidi-font-family: "Times New Roman"'>4/</span></i><i style='mso-bidi-font-style:normal'><span style='font-size:10.0pt;font-family:Symbol'>b</span></i><i style='mso-bidi-font-style: normal'><span style='font-size:10.0pt;font-family:"Arial","sans-serif"; mso-bidi-font-family:"Times New Roman"'>5 and </span></i><i style='mso-bidi-font-style: normal'><span style='font-size:10.0pt;font-family:Symbol'>b</span></i><i style='mso-bidi-font-style:normal'><span style='font-size:10.0pt;font-family: "Arial","sans-serif";mso-bidi-font-family:"Times New Roman"'>8/</span></i><i style='mso-bidi-font-style:normal'><span style='font-size:10.0pt;font-family: Symbol'>b</span></i><i style='mso-bidi-font-style:normal'><span style='font-size:10.0pt;font-family:"Arial","sans-serif";mso-bidi-font-family: "Times New Roman"'>9 </span></i><i style='mso-bidi-font-style:normal'><span style='font-size:10.0pt;font-family:Symbol'>b</span></i><i style='mso-bidi-font-style: normal'><span style='font-size:10.0pt;font-family:"Arial","sans-serif"; mso-bidi-font-family:"Times New Roman"'>-Hairpin Turns in Human Acidic Fibroblast Growth Factor</span></i><span style='font-size:10.0pt;font-family: "Arial","sans-serif";mso-bidi-font-family:"Times New Roman"'>, Kim, J., Lee, J., Brych, S.R., <st1:place w:st="on"><st1:City st="on" w:st="on">Logan</st1:City></st1:place>, T.M. and Blaber, M. <i style='mso-bidi-font-style:normal'>Protein Science</i> <b style='mso-bidi-font-weight:normal'>14</b>, 351-359 (2005) (<b style='mso-bidi-font-weight:normal'>selected by Faculty of 1000</b>)<o:p></o:p></span></p> <p class=MsoNormal><span style='font-size:10.0pt;font-family:"Arial","sans-serif"; mso-bidi-font-family:"Times New Roman"'>49. <i style='mso-bidi-font-style:normal'>Structural and Energetic Consequences of Mutations in a Solvated Hydrophobic Cavity</i>, <span class=SpellE>Adamek</span>, D.H., Guerrero, L., Blaber, M. and Caspar, D.L.D. <i style='mso-bidi-font-style:normal'>J. Mol. Biol</i>. <b style='mso-bidi-font-weight: normal'>346</b>, 307-318 (2005)<o:p></o:p></span></p> <p class=MsoNormal><span style='font-size:10.0pt;font-family:"Arial","sans-serif"; mso-bidi-font-family:"Times New Roman"'>48. <i style='mso-bidi-font-style:normal'>Distinct Promoters Regulate Tissue-specific and Differential Expression of Kallikrein 6 in CNS Demyelinating Disease</i>, <span class=SpellE>Christophi</span>, G.P., <span class=SpellE>Isackson</span>, P.J., Blaber, S., Blaber, M., Rodriguez, M. and Scarisbrick, I.A. <i style='mso-bidi-font-style:normal'>Journal of Neurochemistry </i><b style='mso-bidi-font-weight:normal'>91</b>, 1439-1449 (2004)<o:p></o:p></span></p> <p class=MsoNormal><span style='font-size:10.0pt;font-family:"Arial","sans-serif"; mso-bidi-font-family:"Times New Roman"'>47. <i style='mso-bidi-font-style:normal'>Symmetric Primary And Tertiary Structure Mutations Within A Symmetric <span class=SpellE>Superfold</span>: A Solution, Not A Constraint, To Achieve A Foldable Polypeptide</i>, Brych, S.R., Dubey, V.K., Bienkiewicz, E., Lee, J., Logan, T.M. and Blaber, M., <i style='mso-bidi-font-style:normal'>J. Mol. Biol</i>. <b style='mso-bidi-font-weight: normal'>344</b>, 769-780 (2004)<o:p></o:p></span></p> <p class=MsoNormal><span style='font-size:10.0pt;font-family:"Arial","sans-serif"; mso-bidi-font-family:"Times New Roman"'>46. <i style='mso-bidi-font-style:normal'>An Atomic Resolution Structure for Human Fibroblast Growth Factor-1</i>, <span class=SpellE>Bernett</span>, M.J., <span class=SpellE>Somasundaram</span>, T. and Blaber, M. <i style='mso-bidi-font-style:normal'>Proteins: Structure, Function and Bioinformatics </i><b style='mso-bidi-font-weight:normal'>57</b>, 626-634 (2004)<b style='mso-bidi-font-weight:normal'><span style='mso-bidi-font-style: italic'> </span></b></span><b style='mso-bidi-font-weight:normal'><span style='font-size:10.0pt;font-family:"Arial","sans-serif";mso-bidi-font-family: "Times New Roman";color:blue;mso-bidi-font-style:italic'>Cover article</span></b><i style='mso-bidi-font-style:normal'><span style='font-size:10.0pt;font-family: "Arial","sans-serif";mso-bidi-font-family:"Times New Roman"'><o:p></o:p></span></i></p> <p class=MsoNormal><span style='font-size:10.0pt;font-family:"Arial","sans-serif"; mso-bidi-font-family:"Times New Roman"'>45. <i style='mso-bidi-font-style:normal'>Targeting Kallikrein 6 Proteolysis Attenuates CNS Inflammatory Demyelinating Disease, </i>Blaber, S., <span class=SpellE>Ciric</span>, B., <span class=SpellE>Bernett</span>, M., Blaber, M., Rodriguez, M. and Scarisbrick, I.A., <i style='mso-bidi-font-style: normal'>FASEB J</i>. <b style='mso-bidi-font-weight:normal'>18</b>,<b style='mso-bidi-font-weight:normal'> </b>920-922 (2004)<o:p></o:p></span></p> <p class=MsoNormal><span style='font-size:10.0pt;font-family:"Arial","sans-serif"; mso-bidi-font-family:"Times New Roman"'>44. <i style='mso-bidi-font-style:normal'>Structural Alteration of Cofactor Specificity in <span class=SpellE>Corynebacterium</span> 2,5-diketo-D-Gluconic Acid <span class=SpellE>Reductase</span></i>, Sanli, G., Banta, S., Anderson, S. and Blaber, M. <i style='mso-bidi-font-style:normal'>Protein Science</i> <b style='mso-bidi-font-weight:normal'>13</b>, 504-512 (2004)<br> 43. <i>Accommodation of a highly symmetric core within a symmetric protein <span class=SpellE>superfold</span></i>, Brych, S.R., Kim, J., Logan, T.M. and Blaber, M., <i>Protein Science</i><span style='mso-bidi-font-style:italic'> <b style='mso-bidi-font-weight:normal'>12</b>, 2704 - 2718 (2003) </span></span><b style='mso-bidi-font-weight:normal'><span style='font-size:10.0pt;font-family: "Arial","sans-serif";mso-bidi-font-family:"Times New Roman";color:blue; mso-bidi-font-style:italic'>Cover article<br> </span></b><span style='font-size:10.0pt;font-family:"Arial","sans-serif"; mso-bidi-font-family:"Times New Roman"'>42. <i>Identification of a key structural element for protein folding within </i></span><i><span style='font-size:10.0pt;font-family:Symbol'>b</span></i><i><span style='font-size:10.0pt;font-family:"Arial","sans-serif";mso-bidi-font-family: "Times New Roman"'>-hairpin turns</span></i><span style='font-size:10.0pt; font-family:"Arial","sans-serif";mso-bidi-font-family:"Times New Roman"'>, Kim, J., Brych, S.R., Lee, J., Logan, T.M. and Blaber, M., <i>J. Mol. Biol.</i> <b>328</b>, 951 - 961 (2003)<br> 41. <i>Structural Biology of the Aldo-<span class=SpellE>keto</span> <span class=SpellE>Reductase</span> Family of Enzymes: Catalysis and Cofactor Binding</i>, Sanli, G., <st1:place w:st="on">Dudley</st1:place>, J.I. and Blaber, M., <i>Cell <span class=SpellE>Biochem</span>. <span class=SpellE>Biophys</span></i><i style='mso-bidi-font-style:normal'>.</i> <b>38</b>, 79-101 (2003) <br> 40. <i>Crystal Structure and Biochemical Characterization of Human Kallikrein 6 Reveals a Trypsin-like Kallikrein is Expressed in the Central Nervous System</i><span style='mso-bidi-font-style:italic'>, </span><span class=SpellE>Bernett</span>, M.J., Blaber, S.I., Scarisbrick, I.A., <span class=SpellE>Dhanarajan</span>, P., Thompson, S.M., and Blaber, M. <i>J. Biol. <span class=SpellE>Chem</span></i><span style='mso-bidi-font-style:italic'> </span><b>277</b>, 24562-24570 (2002)<br> 39. <i>Activity of a Newly Identified Serine Protease in <span class=SpellE>Oligodendrocyte</span> Biology and Demyelination, </i>Scarisbrick, I.A., Blaber, S.I., <span class=SpellE>Lucchinetti</span>, C.F., <span class=SpellE>Genain</span>, C.P., Blaber, M. and Rodriguez, M.. <i>Brain </i><b>125</b>, 1-14 (2002)<br> 38. <i>Alternative Type I and I' Turn Conformations in the </i></span><i><span style='font-size:10.0pt;font-family:Symbol'>b</span></i><i><span style='font-size:10.0pt;font-family:"Arial","sans-serif";mso-bidi-font-family: "Times New Roman"'>8/</span></i><i><span style='font-size:10.0pt;font-family: Symbol'>b</span></i><i><span style='font-size:10.0pt;font-family:"Arial","sans-serif"; mso-bidi-font-family:"Times New Roman"'>9 </span></i><i><span style='font-size: 10.0pt;font-family:Symbol'>b</span></i><i><span style='font-size:10.0pt; font-family:"Arial","sans-serif";mso-bidi-font-family:"Times New Roman"'>-hairpin of Human Acidic Fibroblast Growth Factor, </span></i><span style='font-size: 10.0pt;font-family:"Arial","sans-serif";mso-bidi-font-family:"Times New Roman"'>Kim, J., Blaber, S.I.,. and Blaber, M. <i>Protein Science</i> <b>11</b>, 459-466 (2002)<br> 37. <i>Characterization of Recombinant Rat <span class=SpellE>Myelencephalon</span> Specific Protease, </i>Blaber, S.I., Scarisbrick, I.A., <span class=SpellE>Bernett</span>, M.J., <span class=SpellE>Dhanarajan</span>, P., <span class=SpellE>Seavy</span>, M.A., Jin, Y., Schwartz, M.A., Rodriguez, M. and Blaber, M. <i>Biochemistry </i><b>41</b>, 1165-1173 (2002)<br> 36. <i>Structure and Stability Effects of Mutations Designed to Increase the Primary Sequence Symmetry within the Core Region of a </i></span><i><span style='font-size:10.0pt;font-family:Symbol'>b</span></i><i><span style='font-size:10.0pt;font-family:"Arial","sans-serif";mso-bidi-font-family: "Times New Roman"'>-Trefoil</span></i><span style='font-size:10.0pt;font-family: "Arial","sans-serif";mso-bidi-font-family:"Times New Roman"'> , Brych, S.R., Blaber, S.I., Logan, T.M. and Blaber, M., <i>Protein Science </i><b>10</b>, 2587-2599 (2001) <br> 35.<i> An Efficient, Flexible-Model Program for the Analysis of Differential Scanning Calorimetry Data </i>, Grek, S., <st1:place st="on" w:st="on"><st1:City st="on" w:st="on">Davis</st1:City></st1:place>, J. and Blaber, M. <i>Protein and Peptide Letters </i><b>6,</b> 429-436 (2001)<i> <br> </i>34. <i>Active Site Organization in an Aldo-<span class=SpellE>keto</span> <span class=SpellE>Reductase</span> by NADPH Cofactor</i>, Sanli, G. and Blaber, M., <i>Journal of Molecular Biology</i> <b>309</b>, 1209-1218 (2001)<br> 33.<i> Reduction of Wobble-position GC Bases in <span class=SpellE>Corynebacteria</span> Genes and Enhancement of PCR and Heterologous Expression, </i>Sanli, G., Blaber, S.I. and Blaber, M. <i>Journal of Molecular Microbiology and Biotechnology</i> <b>3</b>, 123-126 (2001)<br> 32.<i> Thermodynamic Characterization of Mutants of Human FGF-1 with an Increased Physiological Half-life, </i><span class=SpellE>Culajay</span>, J.F., Blaber, S.I., <span class=SpellE>Khurana</span>, A. and Blaber, M. <i>Biochemistry</i> <b>39</b>, 7153-7158 (2000)<br> 31. <i>Preferential Expression of <span class=SpellE>Myelencephalon</span> Specific Protease by Oligodendrocytes of the Adult Rat Spinal Cord White Matter, </i>Scarisbrick, I.A., <span class=SpellE>Asakura</span>, K., Blaber, S., Blaber, M., <span class=SpellE>Isackson</span>, P.J., <span class=SpellE>Bieto</span>, T., Rodriguez, M. and <span class=SpellE>Windebank</span>, A.J. <span class=SpellE><i>Glia</i></span> <b>30</b>, 219-230 (2000)<br> 30.<i> Molecular Modeling of Substrate Binding in Wild Type and Mutant <span class=SpellE>Corynebacteria</span> 2,5-Diketo-D-Gluconate <span class=SpellE>Reductase</span>, </i><span class=SpellE>Khurana</span>, S., Sanli, G., Powers, D.B., Anderson, S.A. and Blaber, M. <i>Proteins: Structure, Function and Genetics</i> <b>39</b>, 68-75 (2000)<i> <br> </i>29.<i> The Role of Low Concentrations of Guanidine HCl in Reversible Thermal Denaturation of Human FGF-1, </i>Blaber, S.I., <span class=SpellE>Culajay</span>, J.F., <span class=SpellE>Khurana</span>, A. and Blaber, M. <i>Biophysical Journal </i><b>77</b>, 470-477 (1999)<br> 28.<i> Disordered water within a hydrophobic protein cavity visualized by x-ray crystallography, </i>Yu, B., Blaber, M., <span class=SpellE>Gronenborn</span>, A.M., <span class=SpellE>Clore</span>, G.M. and Caspar, D.L.D. <i>Proceedings of the National Academy of Sciences </i><b>96</b>, 103-108 (1999)<br> 27.<i> <st1:place w:st="on"><st1:City w:st="on">Crystal</st1:City></st1:place> Structure of 2,5-diketo-D-gluconate <span class=SpellE>Reductase</span> A <span class=SpellE>Complexed</span> with NADPH at 2.1Resolution, </i><span class=SpellE>Khurana</span>, S., Powers, D.B., Anderson, S.A. and Blaber, M. <i>Proceedings of the National Academy of Sciences </i><b>95</b>, 6768-6773 (1998)<br> 26.<i> Preliminary x-ray crystallographic analysis and molecular replacement studies with 2,5-diketo-gluconate <span class=SpellE>reductase</span>, </i><span class=SpellE>Khurana</span>, S., Powers, D.B., Anderson, S. and Blaber, M. <i>Protein and Peptide Letters </i><b>4</b>, 287-290 (1997)<br> 25.<i> Crystallization and Preliminary X-ray Analysis of Mouse Pro-<span class=SpellE>Renin</span> Converting Enzyme, </i>Blaber, M. <i>Protein and Peptide Letters </i><b>4</b>, 207-210 (1997)<br> 24.<i> X-ray Crystal Structure of Human Acidic Fibroblast Growth Factor, </i>Blaber, M., DiSalvo, J. and Thomas, K.A. <i>Biochemistry</i> <b>35</b>, 2086-2094 (1996)<br> 23.<i> Alanine Scanning Mutagenesis in the Helix 115-123 of Phage T4 <span class=SpellE>Lysozyme</span>: Effects upon Structure, Stability and Solvent Accessibility, </i>Blaber, M., <span class=SpellE>Baase</span>, W.A., <span class=SpellE>Gassner</span>, N. and Matthews, B.W. <i>J. Mol. Biol. </i><b>246, </b>317-330 (1995)<br> 22.<i> Determination of a-helix Propensity within the Context of a Folded Protein: Sites 44 and 131 in <span class=SpellE>Bacteriophage</span> T4 <span class=SpellE>Lysozyme</span>, </i>Blaber, M., Zhang, X.-J., Lindstrom, J.D., <span class=SpellE>Pepiot</span>, S.D., <span class=SpellE>Baase</span>, W.A. and Matthews, B.W. <i>J. Mol. Biol.</i> <b>235</b>, 600-624 (1994)<br> 21.<i> <span class=SpellE>Accomodation</span> of Amino Acid Insertions in an a-Helix of T4 <span class=SpellE>Lysozyme</span>: Structural and Thermodynamic Analysis, </i>Heinz, D.W., <span class=SpellE>Baase</span>, W.A., Zhang, X.-J., Blaber, M., <span class=SpellE>Dahlquist</span>, F.W. and Matthews, B.W. <i>J. Mol. Biol.</i> <b>236</b>, 869-886 (1994)<br> 20.<i> Energetic Cost and Structural Consequences of Burying a Hydroxyl Group within the Core of a Protein Determined from Ala-&gt;Ser and Val-&gt;Thr Substitutions in T4 <span class=SpellE>Lysozyme</span>, </i>Blaber, M., Lindstrom, J.D., <span class=SpellE>Gassner</span>, N., Xu, J., Heinz, D.W. and Matthews, B.W. <i>Biochemistry</i> <b>32</b>, 11363-11373 (1993)<br> 19.<i> Structural Basis of Amino Acid a Helix Propensity, </i>Blaber, M., Zhang, X.-J. and Matthews, B.W. <i>Science</i> <b>260</b>, 1637-1640 (1993)<br> 18.<i> Response of a Protein Structure to Cavity-Creating Mutations and Its Relation to the Hydrophobic Effect, </i>Eriksson, A.E., <span class=SpellE>Baase</span>, W.A., Zhang, X.-J., Heinz, D.W., Blaber, M., Baldwin, E.P. and Matthews, B.W. <i>Science</i> <b>255</b>, 178-183 (1992)<br> 17.<i> Dissection of Protein Structure and Folding by Directed Mutagenesis, </i><span class=SpellE>Baase</span>, W.A., Eriksson, A.E., Zhang, X.-J., Heinz, D.W., Sauer, U., Blaber, M., Baldwin, E.P., Wozniak, J.A. and Matthews, B.W. <i>Faraday Discuss.</i> <b>93</b>, 173-181 (1992)<br> 16.<i> Synthetic Chimeras of Mouse Growth Factor-associated Glandular Kallikreins. I. Kinetic Properties, </i>Blaber, M., <span class=SpellE>Isackson</span>, P.J., <span class=SpellE>Burnier</span>, J.P., <span class=SpellE>Marsters</span>, <span class=SpellE>J.C.Jr</span>. and Bradshaw, R.A. <i>Prot. Sci.</i> <b>2</b>, 1210-1219 (1993)<br> 15.<i> Synthetic Chimeras of Mouse Growth Factor-associated Glandular Kallikreins. II. Growth Factor Binding Properties, </i>Blaber, M., <span class=SpellE>Isackson</span>, P.J., Holden, H.M. and Bradshaw, R.A. <i>Prot. Sci.</i> <b>2</b>, 1220-1228 (1993)<br> 14.<i> Prediction of the Three-dimensional Structures of the Nerve Growth Factor and Epidermal Growth Factor Binding Proteins (Kallikreins) and an Hypothetical Structure of the High Molecular Weight Complex of Epidermal Growth Factor with its Binding Protein, </i><span class=SpellE>Bax</span>, B., Blaber, M., Ferguson, G., Sternberg, M.J.E. and Walls, P.H. <i>Prot. Sci.</i> <b>2</b>, 1229-1241 (1993)<br> 13.<i> Structure and Function Analyses of Growth Factor Associating <span class=SpellE>Murine</span> Glandular Kallikreins, </i>Blaber, M. <i>Ph.D. Thesis, University of California, Irvine CA </i>(1990)<br> 12.<i> The Characterization of Recombinant Mouse Glandular Kallikreins from E. coli, </i>Blaber, M., <span class=SpellE>Isackson</span>, P.J. and Bradshaw, R.A. <i>Proteins: <span class=SpellE>Struct</span>. <span class=SpellE>Funct</span>. Genet.</i> <b>7</b>, 280-290 (1990)<br> 11.<i> The Protease <span class=SpellE>Inhibitory</span> Properties of the Alzheimer's Beta-Amyloid Precursor Protein, </i><span class=SpellE>Sinha</span>, S., <span class=SpellE>Dovey</span>, H.F., <span class=SpellE>Seubert</span>, P., Ward, P.J., <span class=SpellE>Blacher</span>, R.W., Blaber, M., Bradshaw, R.A., <span class=SpellE>Arici</span>, M., Mobley, W.C. and <span class=SpellE>Lieberburg</span>, I. <i>J. Biol. Chem.</i> <b>265</b>, 8983-8985 (1990)<br> 10.<i> Substrate Specificities of Growth Factor Associated Kallikreins of the Mouse <span class=SpellE>Submandibular</span> Gland, </i>Blaber, M., <span class=SpellE>Isackson</span>, P.J., <span class=SpellE>Marsters</span>, J.C. Jr., <span class=SpellE>Burnier</span>, J.P. and Bradshaw, R.A. <i>Biochemistry</i> <b>28</b>, 7813-7819 (1989)<br> 9.<i> A Complete cDNA for the Major Epidermal Growth Factor Binding Protein in the Male Mouse <span class=SpellE>Submandibular</span> Gland, </i>Blaber, M., <span class=SpellE>Isackson</span>, P.J. and Bradshaw, R.A. <i>Biochemistry</i> <b>26</b>, 6742-6749 (1987)<br> 8.<i> Epidermal Growth Factor Binding Protein: A Model Serine Protease for Enzyme Engineering, </i>Blaber, M., Blevins, R.A., Thomas, K.A., <span class=SpellE>Isackson</span>, P.J. and Bradshaw, R.A. <i>Protein Structure, Folding and Design 2.</i>, D. <span class=SpellE>Oxender</span>, ed., Alan R. <span class=SpellE>Liss</span>, Inc., (1987)<br> 7.<i> Epidermal Growth Factor Binding Protein: Identification of a Different Protein, </i><span class=SpellE>Isackson</span>, P.J., Silverman, R.E., Blaber, M., Server, A.C., Nichols, R.A., Shooter, E.M. and Bradshaw, R.A. <i>Biochemistry</i> <b>26</b>, 2082-2085 (1987)<br> 6.<i> Complete Nucleotide Sequence of the Escherichia coli Gene Encoding <span class=SpellE>Malate</span> <span class=SpellE>Dehydrogenase</span>, </i>McAlister-<span class=SpellE>Henn</span>, L., Blaber, M., Bradshaw, R.A. and <span class=SpellE>Nisco</span>, S.J. <span class=SpellE><i>Nucl</i></span><i>. Acids Res.</i> <b>15</b>, 4993 (1987)<br> 5.<i> Purification and Characterization of Single-Chain Urokinase from E. coli, </i>Winkler, M.E. and Blaber, M. <i>Biochemistry</i> <b>25</b>, 4041-4045 (1986)<br> 4.<i> Activation of Plasminogen by Pro-Urokinase. I. Mechanism, </i><span class=SpellE>Lijnen</span>, H.R., <span class=SpellE>Zamarron</span>, C., Blaber, M., Winkler, M.E. and <span class=SpellE>Collen</span>, D. <i>J. Biol. Chem. </i><b>261</b>, 1253-1258 (1986)<br> 3.<i> Purification and Characterization of Recombinant Urokinase from E. coli, </i>Winkler, M.E., Blaber, M., <span class=SpellE>Bennet</span>, G.L., Holmes, W.E. and Vehar, G.A. <i>Nature Biotechnology </i><b>3</b>, 990-1000 (1985)<br> 2.<i> Cloning and Expression of the Gene for Pro-Urokinase in Escherichia Coli, </i>Holmes, W.E., <span class=SpellE>Pennica</span>, D., Blaber, M., Rey, M.W., <span class=SpellE>Gunzler</span>, W.A., Steffens, G.J. and <span class=SpellE>Heyneker</span>, H.L. <i>Nature Biotechnology </i><b>3</b>, 923-929 (1985)<br> 1.<i> Biological and Thrombolytic Properties of <span class=SpellE>Proenzyme</span> and Active Forms of Urokinase III: Thrombolytic Properties of Natural and Recombinant Urokinase in Rabbits with Experimental Jugular Vein Thrombosis, </i><span class=SpellE>Collen</span>, D., Stassen, J.M., Blaber, M., Winkler, M.E. and <span class=SpellE>Verstraete</span>, M. <span class=SpellE><i>Thromb</i></span><i>. <span class=SpellE>Haemostasis</span></i> <b>52</b>, 27-30 (1984)<o:p></o:p></span></p> <p align=center style='text-align:center'><b><span style='font-family:"Arial","sans-serif"; mso-bidi-font-family:"Times New Roman"'>Book Chapters and Other Publications<o:p></o:p></span></b></p> <p class=MsoNormal><span style='font-size:10.0pt;font-family:"Arial","sans-serif"; mso-bidi-font-family:"Times New Roman"'>15. <i style='mso-bidi-font-style:normal'>Kallikrein-related Peptidase 6</i>, Scarisbrick, I.A. and Blaber, M., <i style='mso-bidi-font-style: normal'>Handbook of Proteolytic Enzymes</i> (2012, in press<span class=GramE>)</span><br> 14. <span class=GramE><i style='mso-bidi-font-style:normal'>As the Worm Turns: One Man s Descent into Periodic Error</i>, Blaber, M., <i style='mso-bidi-font-style: normal'>Amateur Astronomy</i> <b style='mso-bidi-font-weight:normal'>71</b>, 41-44 (2011) <br> 13.</span> <i style='mso-bidi-font-style:normal'>The Essential Need for Protein Chemists</i>, Blaber, M., <i style='mso-bidi-font-style:normal'>Journal of Proteins and Proteomics</i>, <b style='mso-bidi-font-weight:normal'>1</b>, 1-2 (2010)<o:p></o:p></span></p> <p class=MsoNormal><span style='font-size:10.0pt;font-family:"Arial","sans-serif"; mso-bidi-font-family:"Times New Roman"'>12. <i style='mso-bidi-font-style:normal'>Solvent Structure in the Active Site of Human Kallikrein 1,</i> Laxmikanthan, G., Blaber, S.I., Scarisbrick, I.A. and Blaber, M., <i style='mso-bidi-font-style: normal'>Hydrogen- and Hydration-Sensitive Structural Biology</i>, <span class=SpellE>Niimura</span>, N., Mizuno, H., <span class=SpellE>Helliwell</span>, J. and <span class=SpellE>Westhof</span>, E., Eds., <span class=SpellE>Kubapro</span>, Co. Ltd Publishers, Tokyo Japan (2005) Ch. 3-6, 175-183<o:p></o:p></span></p> <p class=MsoNormal><span style='font-size:10.0pt;font-family:"Arial","sans-serif"; mso-bidi-font-family:"Times New Roman"'>11. <i style='mso-bidi-font-style:normal'>Engineering <span class=SpellE>Allostery</span> via Tandem Duplication and Turn <span class=SpellE>Energetics</span></i>, Blaber, M. <i style='mso-bidi-font-style: normal'>Trends in Biotechnology</i> <b style='mso-bidi-font-weight:normal'>22</b>, 1-2 (2004)<o:p></o:p></span></p> <p class=MsoNormal><span style='font-size:10.0pt;font-family:"Arial","sans-serif"; mso-bidi-font-family:"Times New Roman"'>10. <i style='mso-bidi-font-style:normal'>The Role of the Turn Symmetry in the Folding and Stability of FGF-1</i>, Lee, J., Kim, J., Blaber, M. and <st1:place w:st="on"><st1:City w:st="on">Logan</st1:City></st1:place>, T. <i style='mso-bidi-font-style:normal'>National High Magnetic Field Laboratory Reports</i> <b style='mso-bidi-font-weight:normal'>10</b>, 11-13 (2003)<br> 9. <span class=SpellE><i>Myelencephalon</i></span><i>-specific Protease</i>, Scarisbrick, I.A., Blaber, S. and Blaber, M., Handbook of Proteolytic Enzymes, 2<sup>nd</sup> Ed., <span class=SpellE>Vol</span> 1-2, pp1587-1590, Barrett, A.J., Rawlings, N.D., and <span class=SpellE>Woessner</span>, J.F., Eds., Elsevier Ltd., London (<span style='mso-bidi-font-style:italic'>2003</span>)<br> 8. <i>Protein Thermal Characterization and Parameter Analysis: A Rapid, Flexible Analysis on the Windows Platform</i>, Grek, S., <st1:City w:st="on"><st1:place w:st="on">Davis</st1:place></st1:City>, J.K., and Blaber, M. <i>Thirty-Second Southeastern Symposium on System Theory Proceedings</i>, Roberts, R.G. and Simons, F.O., Jr., Eds. (<span style='mso-bidi-font-style:italic'>2000</span>) pp. 41-45<br> 7.<i> Denaturation Studies of Human Acidic Fibroblast Growth Factor, </i><span class=SpellE>Adamek</span>, D., Popovic, A., Blaber, S. and Blaber, M. <span class=SpellE><i>Biocalorimetry</i></span><i>: Applications of Calorimetry in the Biological Sciences</i>, John Wiley &amp; Sons, <span class=SpellE>Ladbury</span>, J.E. and <span class=SpellE>Haq</span>, I., Eds. (<span style='mso-bidi-font-style: italic'>1998</span>) Chapter 16, pp 235-241<br> 6.<i> Contribution of Free Cysteine Residues to the Stability of Human Acidic Fibroblast Growth Factor, </i>Popovic, A., <span class=SpellE>Adamek</span>, D., Blaber, S. and Blaber, M. <span class=SpellE><i>Biocalorimetry</i></span><i>: Applications of Calorimetry in the Biological Sciences</i>, John Wiley &amp; Sons, <span class=SpellE>Ladbury</span>, J.E. and <span class=SpellE>Haq</span>, I., Eds. (<span style='mso-bidi-font-style:italic'>1998</span>) Chapter 20, pp 277-282<br> 5.<i> Biophysical and Structural Analysis of Human Acidic Fibroblast Growth Factor, </i>Blaber, M., <span class=SpellE>Adamek</span>, D.H., Popovic, A. and Blaber, S.I. <i>Techniques in Protein Chemistry VIII,</i> Academic Press,<i> </i><span class=SpellE><span style='mso-bidi-font-style:italic'>Marshak</span></span><span style='mso-bidi-font-style:italic'>, D.R., Ed.</span> 745-753 (1997)<br> 4.<i> Glandular Kallikreins as Growth Factor Processing Enzymes, </i>Blaber, M., <span class=SpellE>Isackson</span>, P.J. and Bradshaw, R.A. <i>Growth Regulation and Carcinogenesis, <span class=SpellE>Vol</span> II, </i><span class=SpellE>Paukovits</span>, W.R., Ed., CRC Press, Inc. (1991)<br> 3.<i> Neurotrophic Factors in the CNS: Biosynthetic Processing and Functional Responses, </i>Bradshaw, R.A., <span class=SpellE>Altin</span>, J.G., Blaber, M., Cavanaugh, K.P., Eveleth, D.D., <span class=SpellE>Kornblum</span>, H.I., Leslie, F.M. and <span class=SpellE>Raffioni</span>, S., <i>Progress in Brain Research, Vol. 86,</i> P. Coleman, G. Higgins and C. Phelps, eds. Elsevier Science Publishers B.V. (1990)<br> 2.<i> Purification of the Nerve Growth Factor Receptor, </i>Blaber, M., Eveleth, D.D. and Bradshaw, R.A. <i>Nerve Growth Factors, <span class=SpellE>Vol</span> 12, </i>R.A. Rush ed., IBRO Handbook Series: Methods in the Neurosciences 279-298 (1989)<br> 1.<i> Neurotrophic Factors of the Central Nervous System: Synthesis and Activities, </i>Bradshaw, R.A., Blaber, M., Cavanaugh, K., Eveleth, D.D., <span class=SpellE>Isackson</span>, P.J., <span class=SpellE>Kornblum</span>, H.I. Leslie, F., Morrison R.S, Schwarz, M. and Sharma, A. <i>Symposia In Neuroscience, Volume 7: Neuronal Plasticity and <span class=SpellE>Trophic</span> Factors.</i> G. <span class=SpellE>Biggio</span>, P.F. <span class=SpellE>Spano</span>, G. <span class=SpellE>Toffano</span>, S.H. <span class=SpellE>Appel</span> and G.L. <span class=SpellE>Gessa</span>, eds. Springer <span class=SpellE>Verlag</span>/<span class=SpellE>Liviana</span> Press (1988)<o:p></o:p></span></p> <p align=center style='text-align:center'><b><span style='font-family:"Arial","sans-serif"'>Abstracts<o:p></o:p></span></b></p> <p class=MsoNormal><span style='font-size:10.0pt;font-family:"Arial","sans-serif"'>125.</span> <i style='mso-bidi-font-style:normal'><span style='font-size:10.0pt;font-family: "Arial","sans-serif"'>Novel <span class=SpellE>Saloplastic</span> Wound Dressing Technology for Accelerated Healing</span></i><span style='font-size: 10.0pt;font-family:"Arial","sans-serif"'>, Xia, X., Blaber, M. and Schlenoff, J., <i style='mso-bidi-font-style:normal'>2<sup>nd</sup> Annual Life Sciences Symposium Florida State University</i> (2012)<o:p></o:p></span></p> <p class=MsoNormal><span style='font-size:10.0pt;font-family:"Arial","sans-serif"'>124. <i style='mso-bidi-font-style:normal'>Folding Pathway Redundancy and the Evolution of Symmetric Protein Architecture</i>, Longo, L., Lee, J. and Blaber, M., <i style='mso-bidi-font-style:normal'>2<sup>nd</sup> Annual Life Sciences Symposium Florida State University</i> (2012)<o:p></o:p></span></p> <p class=MsoNormal><span style='font-size:10.0pt;font-family:"Arial","sans-serif"'>Authors:<span style='mso-spacerun:yes'>  </span>Liam Longo, Jihun Lee, Michael Blaber<o:p></o:p></span></p> <p class=MsoNormal><span style='font-size:10.0pt;font-family:"Arial","sans-serif"'>123. <i style='mso-bidi-font-style:normal'>The rise and fall of kallikrein 6 in traumatic brain injury</i>, Phipps, H. W., Jackson, S., <span class=SpellE>Suber</span>, J., Levenson, C.W., Blaber, S.I., Blaber, M. and Vanlandingham, J., <i style='mso-bidi-font-style:normal'>J. Head Trauma Rehab</i>. <b style='mso-bidi-font-weight:normal'>26</b>, 426 (2011)<o:p></o:p></span></p> <p class=MsoNormal><span style='font-size:10.0pt;font-family:"Arial","sans-serif"'>122. <span class=SpellE><i style='mso-bidi-font-style:normal'>Immunopathophysiological</i></span><i style='mso-bidi-font-style:normal'> roles of kallikreins in CNS inflammatory disease</i>, Scarisbrick, I.A., Renner, D.N., Blaber, S., Blaber, M., Yoon, H., <span class=SpellE>Vandell</span>, A.G. and Paulsen, A.R., <i style='mso-bidi-font-style: normal'>4<sup>th</sup> International Symposium on Kallikreins and Kallikrein-related Peptidases</i>, 31 (2011)<br> 121. <span class=GramE><i style='mso-bidi-font-style:normal'>Functional intersection of matrix <span class=SpellE>metalloproteases</span> with kallikrein-related peptidases</i>, Blaber, M., Blaber, S., Yoon, H. and Scarisbrick, I.A., <i style='mso-bidi-font-style:normal'>4<sup>th</sup> International Symposium on Kallikreins and Kallikrein-related Peptidases</i>, 27 (2011)<br> 120.</span> <span class=GramE><i style='mso-bidi-font-style:normal'>Role of kallikrein-related peptidase 6 in <span class=SpellE>atrogliosis</span></i>, <span class=SpellE>Radulovic</span>, M., Burda, J. <span class=SpellE>Drucker</span>, K., Blaber, S., Blaber, M., Yoon, H., <span class=SpellE>Vandell</span>, A.G., Paulsen, A.R. and Scarisbrick, I.A.,<i style='mso-bidi-font-style:normal'> 4<sup>th</sup> International Symposium on Kallikreins and Kallikrein-related Peptidases</i>, 69 (2011)<br> 119.</span> <i style='mso-bidi-font-style:normal'>Human pro-KLK4 activation, revisited</i>, Blaber, S., Li, W., Yoon, H., Scarisbrick, I.A., and Blaber, M., <i style='mso-bidi-font-style:normal'>4<sup>th</sup> International Symposium on Kallikreins and Kallikrein-related Peptidases</i>, 83 (2011)<br> 118. <i style='mso-bidi-font-style:normal'>An Empirical Phase Diagram Approach to Investigate Conformational Stability of  Second-generation Functional Mutants of Acidic Fibroblast Growth Factor</i>, Alsenaidy, M.A., Wang, T., Lee, J. Blaber, M., Kim, J.H., Joshi, S., Volkin, D.B. and Middaugh, C.R., <i style='mso-bidi-font-style:normal'>Colorado Protein Stability Conference</i> (2011)<o:p></o:p></span></p> <p class=MsoNormal><span style='font-size:10.0pt;font-family:"Arial","sans-serif"'>117. <i style='mso-bidi-font-style:normal'>Turn Structure in the Transition State of Fibroblast Growth Factor-1</i>, Longo, L., Lee, J., Lee, W. and Blaber, M.,<i style='mso-bidi-font-style:normal'> 1<sup>st</sup> Annual Life Sciences Symposium Florida State University</i> (2011)<o:p></o:p></span></p> <p class=MsoNormal><span style='font-size:10.0pt;font-family:"Arial","sans-serif"'>116. <i style='mso-bidi-font-style:normal'>Identification of rK6 Inhibitor in Rat Brain</i>, Jackson, S. and Blaber, M., <i style='mso-bidi-font-style:normal'>1<sup>st</sup> Annual Life Sciences Symposium Florida State University</i> (2011) <o:p></o:p></span></p> <p class=MsoNormal><span style='font-size:10.0pt;font-family:"Arial","sans-serif"'>115. <i style='mso-bidi-font-style:normal'>The interaction between thermodynamic stability and buried free cysteines in regulating the functional half-life of fibroblast growth factor-1</i>, Lee, J. and Blaber, M., <i style='mso-bidi-font-style: normal'>Zing Structural Biology and Drug Discovery Conference</i> (2010)<br> 114. <i style='mso-bidi-font-style:normal'>Salt and <span class=SpellE>glycosaminoglycan</span> effects on substrate specificity of human kallikrein 3 (hKLK3) and 13 (hKLK13)</i>, Andrade, d., Lima, A.R., <span class=SpellE>Assis</span>, D.M., Angelo, P.F., <span class=SpellE>Alves</span>, F.M., Blaber, S.I., Blaber, M., Juliano, M.A. and Juliano, L., </span><i style='mso-bidi-font-style:normal'><span style='font-size:10.0pt;font-family:"Arial","sans-serif";mso-bidi-font-family: "Times New Roman"'>3<sup>rd</sup> International Symposium on Kallikreins &amp; Kallikrein-related Peptidases, </span></i><span style='font-size:10.0pt; font-family:"Arial","sans-serif";mso-bidi-font-family:"Times New Roman"'>47 (2009)</span><span style='font-size:10.0pt;font-family:"Arial","sans-serif"'><o:p></o:p></span></p> <p class=MsoNormal><span style='font-size:10.0pt;font-family:"Arial","sans-serif"'>113. <i style='mso-bidi-font-style:normal'>Regulation and function of kallikrein related peptidase 6 in malignant melanomas</i>, Krenzer S., <span class=SpellE>Klucky</span> B., <span class=SpellE>Mauch</span> C., Blaber M., Angel P., and Hess J., </span><i style='mso-bidi-font-style:normal'><span style='font-size:10.0pt;font-family: "Arial","sans-serif";mso-bidi-font-family:"Times New Roman"'>3<sup>rd</sup> International Symposium on Kallikreins &amp; Kallikrein-related Peptidases, </span></i><span style='font-size:10.0pt;font-family:"Arial","sans-serif";mso-bidi-font-family: "Times New Roman"'>37 (2009)</span><span style='font-size:10.0pt;font-family: "Arial","sans-serif"'><o:p></o:p></span></p> <p class=MsoNormal><span style='font-size:10.0pt;font-family:"Arial","sans-serif"'>112. <i style='mso-bidi-font-style:normal'>Structural biology and enzymology of the human kallikrein-related peptidases</i>, Blaber, M., Yoon, H., Lee, J., Scarisbrick, I.A., <span class=SpellE>Debela</span>, M., <span class=SpellE>Goettig</span>, P. and Blaber, S., </span><i style='mso-bidi-font-style:normal'><span style='font-size:10.0pt;font-family:"Arial","sans-serif";mso-bidi-font-family: "Times New Roman"'>3<sup>rd</sup> International Symposium on Kallikreins &amp; Kallikrein-related Peptidases,</span></i><span style='font-size:10.0pt; font-family:"Arial","sans-serif";mso-bidi-font-family:"Times New Roman"'> 25 (2009)</span><span style='font-size:10.0pt;font-family:"Arial","sans-serif"'><o:p></o:p></span></p> <p class=MsoNormal><span style='font-size:10.0pt;font-family:"Arial","sans-serif"'>111.</span><span style='font-size:10.0pt;font-family:"Arial","sans-serif";mso-bidi-font-family: "Times New Roman"'> </span><i style='mso-bidi-font-style:normal'><span style='font-size:10.0pt;font-family:"Arial","sans-serif"'>Kallikrein mediated signaling in CNS neurons and astrocytes</span></i><span style='font-size:10.0pt; font-family:"Arial","sans-serif"'>, A. G. <span class=SpellE>Vandell</span>, J. E. Burda, N. Larson, J. Wu, P. Angelo, S. I. Blaber, M. Blaber, Scarisbrick, I. A. <i style='mso-bidi-font-style:normal'>Society for Neuroscience</i> (2009)<o:p></o:p></span></p> <p class=MsoNormal><span style='font-size:10.0pt;font-family:"Arial","sans-serif"; mso-bidi-font-family:"Times New Roman"'>110. <i style='mso-bidi-font-style: normal'>Association of Kallikreins with Neuron Loss and Progressive Multiple Sclerosis, </i><span class=SpellE>Linbo</span>, R.A., <span class=SpellE>Vandell</span>, A.G., Larson, N.S., Keegan, M.B., Blaber, S.I., Blaber, M., <span class=SpellE>Sneve</span>, D.M., <span class=SpellE>Lucchinetti</span>, C.F., Rodriguez, M., Diamandis, E.P. Scarisbrick, I.A., <i style='mso-bidi-font-style:normal'>133rd American Neurological Association Meeting, Utah</i> (2008)<br> 109. <i style='mso-bidi-font-style:normal'>A logical OR redundancy within the <span class=SpellE>Asx</span>-Pro-<span class=SpellE>Asx</span>-Gly type I </i></span><i style='mso-bidi-font-style:normal'><span style='font-size:10.0pt;font-family: Symbol'>b</span></i><i style='mso-bidi-font-style:normal'><span style='font-size:10.0pt;font-family:"Arial","sans-serif";mso-bidi-font-family: "Times New Roman"'>-turn motif</span></i><span style='font-size:10.0pt; font-family:"Arial","sans-serif";mso-bidi-font-family:"Times New Roman"'>, Lee, J., Dubey, V., Longo, L., and Blaber, M., <i style='mso-bidi-font-style:normal'>Protein Science</i>, <b style='mso-bidi-font-weight:normal'>17 (suppl. 1)</b>, 232 (2008)<br> 108. <i style='mso-bidi-font-style:normal'>The autolytic regulation of human kallikrein-related peptidase 6 is negative feedback inhibition</i>, Blaber, S., Yoon, H., Scarisbrick, <st1:place w:st="on">I.</st1:place>, Juliano, M., and Blaber, M., <i style='mso-bidi-font-style:normal'>Protein Science</i>, <b style='mso-bidi-font-weight:normal'>17 (suppl. 1)</b>, 97 (2008)<br> 107. <i style='mso-bidi-font-style:normal'>Activation profiles and regulatory cascades of the human kallikrein-related peptidases</i>, Yoon, H., Laxmikanthan, G., Lee, J., Blaber, S., Rodriguez, A., <span class=SpellE>Kogot</span>, J. and Blaber, M., <i style='mso-bidi-font-style:normal'>Protein Science</i>, <b style='mso-bidi-font-weight:normal'>17(suppl. 1)</b>, 96 (2008)<br> 106. <i style='mso-bidi-font-style:normal'>De novo protein design technique in cardiovascular heart disease: expanding to a systematic approach</i>, Smith, A., Russo, C., <span class=SpellE>Nymeyer</span>, H., Blaber, M., <span class=SpellE>Fenley</span>, M.O., <i style='mso-bidi-font-style:normal'>FLACS </i><b style='mso-bidi-font-weight:normal'>LXI</b>, 84 (2008)<br> 105. <i style='mso-bidi-font-style:normal'>The autolytic regulation of human kallikrein-related peptidase 6 is negative feedback inhibition</i>, Blaber, S.I., Yoon, H., Scarisbrick, I.A., Juliano, M.A., and Blaber, M. <i style='mso-bidi-font-style:normal'>2<sup>nd</sup> International Symposium on Kallikreins &amp; Kallikrein-related Peptidases</i>, 57 (2007)<br> 104. <i style='mso-bidi-font-style:normal'>The first screening method to identify potential activation for the human kallikrein family</i>, Yoon, H., Laxmikanthan, G., Lee, J., Blaber, S.I., Rodriguez, A., <span class=SpellE>Kogot</span>, J.M., Scarisbrick, I.A., and Blaber, M., <i style='mso-bidi-font-style:normal'>2<sup>nd</sup> International Symposium on Kallikreins &amp; Kallikrein-related Peptidases</i>, 54 (2007)<br> 103. <i style='mso-bidi-font-style:normal'>Multiple human tissue Kallikreins are regulated by <span class=SpellE>lympho</span>-epithelial <span class=SpellE>Kazal</span>-type inhibitor and digest <span class=SpellE>desmoglein</span> 1</i>, <span class=SpellE>Borgono</span>, C. A., Michael, I. P., Komatsu, N., <span class=SpellE>Sotiropoulou</span>, G., <span class=SpellE>Jayakumar</span>, A., Wu, H., <span class=SpellE>Clayman</span>, G. L., Blaber, S. I., Blaber, M., <span class=SpellE>Mikolajczyk</span>, S. D., Diamandis, E. P., <i style='mso-bidi-font-style: normal'>Journal Of Investigative Dermatology</i> <b style='mso-bidi-font-weight: normal'>126</b>: 60-60 359 Suppl. 1 (2006)<br> 102. <i style='mso-bidi-font-style:normal'>1.70Å X-ray structure of human <span class=SpellE>apo</span> kallikrein 1: structural changes upon peptide inhibitor/substrate binding</i>, Laxmikanthan, G., Blaber, S.I., <span class=SpellE>Bernett</span>, M.J., Scarisbrick, I.A., Juliano, M.A. and Blaber, M., <i style='mso-bidi-font-style:normal'>1<sup>st</sup> International Symposium on Kallikreins</i>, 45 (2005)<br> 101. <i style='mso-bidi-font-style:normal'>Kallikreins and cell signaling: differential regulation of <span class=SpellE>proteinase</span>-activated receptors (PARS)</i>, <span class=SpellE>Oikonomopoulou</span>, K., Hansen, K.K., <span class=SpellE>Saifeddine</span>, M., <span class=SpellE>Vergnolle</span>, N., Tea, I., Blaber, M., Blaber, S.I., Scarisbrick, I., Diamandis, E.P., and <span class=SpellE>Hollenberg</span>, M.D., <i style='mso-bidi-font-style:normal'>1<sup>st</sup> International Symposium on Kallikreins</i>, 53 (2005)<br> 100. <i style='mso-bidi-font-style:normal'>Hydrogen and Hydration <span class=SpellE>DataBase</span> for Bio-Macromolecules (HHDB)</i>, Kuroki, R., <span class=SpellE>Chatake</span>, T., <span class=SpellE>Kurihara</span>, K., <span class=SpellE>Ohhara</span>, T., <span class=SpellE>Umino</span>, H., <span class=SpellE>Cachau</span>, R.E., Blaber, M. and <span class=SpellE>Niimura</span>, N. <span class=SpellE><i style='mso-bidi-font-style:normal'>Acta</i></span><i style='mso-bidi-font-style:normal'> <span class=SpellE>cryst</span></i>. <b style='mso-bidi-font-weight:normal'>A61</b>, C481 (2005)<br> 99. <i style='mso-bidi-font-style:normal'>Redesigning the &quot;mini-core&quot; regions of FGF-1 to increase primary structure symmetry</i>, Dubey, V.K. and Blaber, M. <i style='mso-bidi-font-style:normal'>Prot. Sci</i>. <b style='mso-bidi-font-weight:normal'>14 </b>(suppl. 1):175 (2005)<br> 98. <i style='mso-bidi-font-style:normal'>A novel method to characterize the activation of serine proteases using hybrid bait protein</i>, Laxmikanthan, G., <span class=SpellE>Kogot</span>, J., Blaber, S.I. and Blaber, M. <i style='mso-bidi-font-style:normal'>Prot. Sci</i>. <b style='mso-bidi-font-weight: normal'>14</b>(suppl. 1):167 (2005)<br> 97. <i style='mso-bidi-font-style:normal'>Effect of beta-hairpin conformations on protein stability and folding kinetics</i>, Lee, J. and Blaber, M. <i style='mso-bidi-font-style:normal'>Prot. Sci</i>. <b style='mso-bidi-font-weight: normal'>14</b>(suppl. 1):106 (2005)<br> 96. <i style='mso-bidi-font-style:normal'>Tissue-specific expression and differential regulation of multiple kallikrein 6 transcripts in CNS demyelinating <span class=SpellE>disease,.<span style='font-style:normal'>Christophi</span></span></i>, G.P., <span class=SpellE>Isackson</span>, P.J., Blaber, S.I., Blaber, M., Rodriguez, M. and Scarisbrick, I.A. <i style='mso-bidi-font-style:normal'>36th Annual Soc. <span class=SpellE>Neurosci</span></i>. 936.12 (2004)<br> 95. <i style='mso-bidi-font-style:normal'>1.7Å X-ray structure of <span class=SpellE>apo</span> human kallikrein 1: Evidence for an induced-fit basis of dual substrate specificity</i>, Laxmikanthan, G., Blaber, S.I., <span class=SpellE>Bernett</span>, M.J., Scarisbrick, I.A., Juliano, M.A. and Blaber, M. Gordon Research Conference, <i>Proteolytic Enzymes and Their Inhibitors</i> (2004 )<br> 94. <i style='mso-bidi-font-style:normal'>Protein symmetry, stability and function</i>, Dubey, V.K., Brych, S.R., Lee, J. and Blaber, M, CALCON 2004 - the <i style='mso-bidi-font-style:normal'>59<sup>th</sup> Annual Calorimetry Conference</i>, 27 (2004)<br> 93. <i style='mso-bidi-font-style:normal'>Structure, stability and functional studies of 2,5-diketo-D-gluconate <span class=SpellE>reductases</span></i>, Blaber, M., Dudley, J. and Sanli, G., <i style='mso-bidi-font-style:normal'>American Heart Association Research Symposium</i>, 5 (2003)<br> 92. <i>Structural symmetry in a </i></span><i><span style='font-size:10.0pt; font-family:Symbol'>b</span></i><i><span style='font-size:10.0pt;font-family: "Arial","sans-serif";mso-bidi-font-family:"Times New Roman"'>-trefoil <span class=SpellE>superfold</span> </span></i><span style='font-size:10.0pt; font-family:"Arial","sans-serif";mso-bidi-font-family:"Times New Roman"'>, Brych, S.R., Kim, J., Logan, T.M. and Blaber, M., <i>New Horizons in Molecular Sciences and Systems: An Integrated Approach, Okinawa Institute of Science and Technology Project, Cabinet Office, The Government of Japan, 55</i> (2003)<br> 91. <i>Increased primary sequence symmetry within the hydrophobic core of hFGF-1: Evidence of genetic drift</i>, Brych, S.R., Kim, J., Logan, T.M. and Blaber, M., <i>FLACS LVI, </i>20 (2003)<br> 90. <i>Cloning of the human kallikreins</i>, Frost, N.A., Blaber, S.I., and Blaber, M., <i>FLACS LVI, </i>19 (2003)<br> 89. <i>Expanded substrate specificity of human kallikrein 6 (hK6)</i>, <span class=SpellE>Bernett</span>, M.J., Blaber, S.I., <span class=SpellE>Somasundaram</span>, T. and Blaber, M., <i>FLACS LVI, </i>18 (2003)<br> 88. <i>Thermal stability of various disulfide bond mutants of 2,5-DKGR-A</i>, Dudley, J.I. and Blaber, M., <i>FLACS LVI, </i>18 (2003)<br> 87. <i>Effect of turn conformational change on protein folding kinetics in human acidic fibroblast growth factor 1(hFGF-1)</i>, Lee, J., Kim, J. and Blaber, M., <i>FLACS LVI, </i>18 (2003)<br> 86. <i>Identification of a key structural element for protein folding within </i></span><i><span style='font-size:10.0pt;font-family:Symbol'>b</span></i><i><span style='font-size:10.0pt;font-family:"Arial","sans-serif";mso-bidi-font-family: "Times New Roman"'>-hairpin turns</span></i><span style='font-size:10.0pt; font-family:"Arial","sans-serif";mso-bidi-font-family:"Times New Roman"'>, Kim, J., Brych, S.R., Lee, J., Logan, T.M. and Blaber, M., <i>FLACS LVI, </i>18 (2003)<br> 85. <i>Molecular insights on substrate specificity of human kallikrein 1</i>, Laxmikanthan, G., Blaber, S., <span class=SpellE>Bernett</span>, M. and Blaber, M., <i>FLACS LVI, </i>17 (2003)<br> 84. <i>Cofactor specificity of <span class=SpellE>Corynebacterium</span> 2,5-diketo-D-gluconic acid <span class=SpellE>reductase</span> for NADP(H)</i>, Sanli, G. and Blaber, M., <i>FLACS LVI, </i>16 (2003)<br> 83. <i>Metabolic and protein engineering in the development of a new method for the production of vitamin C</i>, Sanli, G., Dudley, J.I. and Blaber, M., <i>Program of the Southeastern Branch of the American Society for Microbiology</i> A47 (2002)<br> 82. <i>Structure and stability effects of mutations designed to increase the primary sequence symmetry within the core region of a </i></span><i><span style='font-size:10.0pt;font-family:Symbol'>b</span></i><i><span style='font-size:10.0pt;font-family:"Arial","sans-serif";mso-bidi-font-family: "Times New Roman"'>-trefoil</span></i><span style='font-size:10.0pt;font-family: "Arial","sans-serif";mso-bidi-font-family:"Times New Roman"'>, Brych, S., Blaber, S., <st1:City w:st="on"><st1:place w:st="on">Logan</st1:place></st1:City>, M. and Blaber, M., <i>Protein Science</i> <b>11 (suppl. 1)</b>, 218 (2002)<br> 81. <i>Crystal structure and biochemical characterization of human kallikrein 6 reveals a trypsin-like kallikrein is expressed in the central nervous system</i>, <span class=SpellE>Bernett</span>, M.J., Blaber, S.I., Scarisbrick, I.A., <span class=SpellE>Dhanarajan</span>, P., Thompson, S.M. and Blaber, M., <i>Protein Science</i> <b>11 (suppl. 1)</b>, 137 (2002)<br> 80. <i>Alternative type I and I' turn conformations in the </i></span><i><span style='font-size:10.0pt;font-family:Symbol'>b</span></i><i><span style='font-size:10.0pt;font-family:"Arial","sans-serif";mso-bidi-font-family: "Times New Roman"'>8/</span></i><i><span style='font-size:10.0pt;font-family: Symbol'>b</span></i><i><span style='font-size:10.0pt;font-family:"Arial","sans-serif"; mso-bidi-font-family:"Times New Roman"'>9 </span></i><i><span style='font-size: 10.0pt;font-family:Symbol'>b</span></i><i><span style='font-size:10.0pt; font-family:"Arial","sans-serif";mso-bidi-font-family:"Times New Roman"'>-hairpin of human acidic fibroblast growth factor</span></i><span style='font-size:10.0pt; font-family:"Arial","sans-serif";mso-bidi-font-family:"Times New Roman"'>, Kim, J., Blaber, S.I. and Blaber, M., <i>Protein Science</i> <b>11 (suppl. 1)</b>, 80 (2002)<br> 79. <i>Enzymatic properties of rat <span class=SpellE>myelencephalon</span>-specific protease</i>, Blaber, S., Scarisbrick, I., <span class=SpellE>Dhanarajan</span>, P., <span class=SpellE>Bernett</span>, M., Schwartz, M., <span class=SpellE>Seavy</span>, M., Rodriguez, M., Jin, Y. and Blaber, M., <i>Protein Science</i> <b>11 (suppl. 1)</b>, 59 (2002)<br> 78. <i>Crystal structure and biochemical characterization of human kallikrein 6 reveals a trypsin-like kallikrein is expressed in the central nervous system,</i> <span class=SpellE>Bernett</span>, M.J., Blaber, S.I., Scarisbrick, I.A., <span class=SpellE>Dhanarajan</span>, P., Thompson, S.M. and Blaber , M. Gordon Research Conference, <i>Proteolytic Enzymes and Their Inhibitors</i> (2002 )<br> 77. <i>Crystal packing effects upon protein structure determined by x-ray crystallography, </i>Blaber, M., Kim, J. and Blaber, S.., <i>Abstracts of Papers of the <st1:PersonName w:st="on">American Chemical Society</st1:PersonName> </i><b>223,</b><i> </i>166-IEC Part 1<i> </i>(2002) <br> 76. <i>Role of a newly identified serine protease in immune-mediated demyelination, </i>Scarisbrick I.A., Blaber S.I., Blaber M., Rodriguez M., <i>FASEB Journal </i><b>16,</b><i> </i>A591-A591 Part 1<i> </i>(2002) <br> 75. <i>Stability and Dynamics Issues in Enzyme Engineering of an Aldo-<span class=SpellE>keto</span> <span class=SpellE>Reductase</span></i>, <span class=SpellE>Sanili</span>, G. and Blaber, M. <i>SERMACS 2001</i>, 121 (2001)<br> 74. <i>Alterations in Structure, Stability and Folding Kinetics Associated with an Increase in Internal Symmetry in Human Fibroblast Growth Factor 1</i>, Brych, S., Blaber, S.I., and Blaber, M. <i>Protein Science</i> <b>10 (suppl. 2)</b>, 182 (2001)<br> 73. <i>Expression, Purification and in vitro Characterization of <span class=SpellE>Myelencephalon</span> Specific Protease (MSP), a Novel Serine Protease Expressed in Mammalian Central Nerve System</i>, Blaber, S.I., <span class=SpellE>Dhanarajan</span>, P., Scarisbrick, I.A., <span class=SpellE>Seavy</span>, M., Jin, Y. and Blaber, M. <i>Protein Science</i> <b>10 (suppl. 2)</b>, 161 (2001)<br> 72. <i>Alternate Conformations in the beta 8/beta 9 Loop of Human Fibroblast Growth Factor 1</i>, Kim, J., Blaber, S.I., Brych, S. and Blaber, M. <i>Protein Science</i> <b>10 (suppl. 2)</b>, 74 (2001)<br> 71. <i>The Role of Symmetry in Protein Folding and Design</i>, Blaber, M., Brych, S. and Kim, J. <i>FLACS</i> <b>54</b>, 19 (2001)<br> 70. <i>Expression, Purification and in vitro Characterization of <span class=SpellE>Myelencephalon</span> Specific Protease (MSP), A Novel Serine Protease Expressed in Mammalian Central Nerve System, </i>Blaber, S., <span class=SpellE>Bernett</span>, M.J., <span class=SpellE>Dhanarajan</span>, P., Scarisbrick, I.A., <span class=SpellE>Seavy</span>, M., Jin, Y. and Blaber, M. <i>Southeast Nerve Net, 17th Annual Meeting</i> (2001)<br> 69. <i>X-ray Structure of Apo-2,5-Diketo-D-Gluconic Acid <span class=SpellE>Reductase</span> A</i>, Sanli, G., <span class=SpellE>Somasundaram</span>, T. and Blaber, M., <i>Biophysical Journal</i> <b>80</b>, 257 Part 2 (2001)<br> 68. <span class=SpellE><i>Energetics</i></span><i> of the myosin IISH1 helix during contractility</i>, Sale, K., Kelly, D.F., Fajer, P. and Blaber, M. <i>Biophysical Journal</i> <b>78</b>, 1448Pos Part 2 (2000)<br> 67. <i>Structural Studies of Synthetic 2,5-Diketo-D-gluconic Acid <span class=SpellE>Reductase</span> <span class=SpellE>Complexed</span> with its Substrate and Oxidized Cofactor</i>, Sanli, G. and Blaber, M. <i>Proc. 8<sup>th</sup> Intl. Conf. Crystal. Biol. <span class=SpellE>Macromol</span>.</i>, 202 (2000)<br> 66. <i>Structural Biology of the Mouse Glandular Kallikrein Family of Proteases</i>, Kim, J., Blaber, S.I. and Blaber, M. <i>Proc. 8<sup>th</sup> Intl. Conf. Crystal. Biol. <span class=SpellE>Macromol</span>.</i>, 165 (2000)<br> 65. <i>A His-tagged form of Human Acidic Fibroblast Growth Factor with Enhanced Crystallographic Properties</i>, Blaber, S.I. and Blaber, M. <i>Proc. 8<sup>th</sup> Intl. Conf. Crystal. Biol. <span class=SpellE>Macromol</span>.</i>, 121 (2000)<br> 64. <i>Structural Changes Associated with Mutations Designed to Probe the Role of a Symmetric Core-packing Arrangement in Human Acidic FGF</i>, Brych, S.R., Blaber, S., <span class=SpellE>Khurana</span>, A., Blaber, M. <i>Proc. 8<sup>th</sup> Intl. Conf. Crystal. Biol. <span class=SpellE>Macromol</span>.</i>, 102 (2000)<br> 63. <i>A Rapid Accurate and Automated Windows-based Program for the Analysis of Differential Scanning Calorimetry Data</i>, Grek, S., <st1:place w:st="on"><st1:City st="on" w:st="on">Davis</st1:City></st1:place>, J. and Blaber, M. <i>Protein Science</i> <b>9</b> (Suppl.1) 167 (2000)<br> 62. <i>The Role of Post-translational Modification on the Enzyme Activity of Mouse Glandular Kallikreins</i>, Kim, J., Blaber, S.I., and Blaber, M. <i>Protein Science</i> <b>9</b> (Suppl.1) 110 (2000)<br> 61. <i>Structure and Stability Effects of Cavity Reducing and Core Packing Mutants in Human Fibroblast Growth Factor I</i>, Brych, S.R., Blaber, S.I., <span class=SpellE>Khurana</span>, S. and Blaber, M. <i>Protein Science</i> <b>9</b> (Suppl.1) 108 (2000)<br> 60. <i>The Effects of Cysteine Mutations on the Stability of Human Acidic FGF</i>, <span class=SpellE>Culajay</span>, J.F., Blaber, S.I., <span class=SpellE>Khurana</span>, A. and Blaber, M. <i>Protein Science</i> <b>9</b> (Suppl.1) 100 (2000)<br> 59. <i>Increased Stability of Human FGF-1 Against Thermal Denaturation by Sulfate and Phosphate Binding</i>, Whitten, S.T., Blaber, S.I., and Blaber, M. <i>Protein Science</i> <b>9</b> (Suppl.1) 94 (2000)<br> 58. A Flexible, 2-State, Statistical Mechanics Based Model For DSC Analysis Implemented Under Windows, Grek, S., <st1:place w:st="on"><st1:City st="on" w:st="on">Davis</st1:City></st1:place>, J. and Blaber, M.<i> Proceedings of the Gibbs Symposium </i>(2000)<br> 57. <i>Reversible Thermal Denaturation of Human FGF-1 Induced by Low Concentrations of Guanidine HCl</i>, Blaber, S. I., <span class=SpellE>Culajay</span>, J.F., <span class=SpellE>Khurana</span>, A. and Blaber, M., <i>Proceedings of the Gibbs Symposium </i>(2000)<br> 56.<i> <span class=SpellE>Deconvolution</span> of Calorimetric Data for the Characterization of Protein Thermodynamic Parameters, </i>Grek, S., Davis, J., Noble, N. and Blaber, M. <i>Proceedings of the54th Calorimetry Conference</i>, 154 (1999)<br> 55.<i> Structure and Stability Effects of Mutations Designed to Probe the Role of a Symmetric Core-packing Arrangement in Human Acidic FGF, </i>Brych, S.R., Blaber, S., <span class=SpellE>Khurana</span>, S., <span class=SpellE>Khurana</span>, A. and Blaber, M. <i>Proceedings of the54th Calorimetry Conference</i>, 147 (1999)<br> 54.<i> Thermodynamic Characterization of Mutants of Human FGF-1 that have an Increased Physiological Half-life, </i><span class=SpellE>Culajay</span>, J.F., Blaber, S.I., <span class=SpellE>Khurana</span>, S., <span class=SpellE>Khurana</span>, A., Kennedy, D., Williams, K. and Blaber, M. <i>Proceedings of the54th Calorimetry Conference</i>, 150 (1999)<br> 53.<i> Construction and Characterization of a Synthetic 2,5-Diketo-D-Gluconate <span class=SpellE>Reductase</span> Gene, </i>Sanli, G., Blaber, S., <span class=SpellE>Khurana</span>, S. and Blaber, M. <i>Proceedings of the54th Calorimetry Conference</i>, 164 (1999)<i>)<br> </i>52.<i> <span class=SpellE>Energetics</span> of the Myosin II SH1 Helix during Contractility, </i>Kelly, D., Sale, K. and Blaber, M. <i>Proceedings of the54th Calorimetry Conference</i>, 158 (1999)<br> 51. <i>Structural Characterization of a Highly Thermostable Mutant of Human Acidic Fibroblast Growth Factor (FGF-1)</i>, <span class=SpellE>Khurana</span>, S., <span class=SpellE>Culajay</span>, J.F., Grek, S., <span class=SpellE>Khurana</span>, A. and Blaber, M., <i>Protein Science</i> <b>8</b>, 125 (1999)<br> 50.<i> Thermodynamic Characterization of Mutants of Human FGF-1 that have an Increased Physiological Half-life, </i><span class=SpellE>Culajay</span>, J.F., Blaber, S.I., <span class=SpellE>Khurana</span>, S., <span class=SpellE>Khurana</span>, A., Kennedy, D. and Blaber, M. <i>Protein Science</i> <b>8</b>, 95 (1999)<br> 49.<i> The Role of Low Concentrations of Guanidine HCl in Reversible Thermal Denaturation of Human FGF-1, </i>Blaber, S.I., <span class=SpellE>Culajay</span>, J.F., <span class=SpellE>Khurana</span>, A. and Blaber, M. <i>Protein Science </i><b>8</b>, 96 (1999)<br> 48.<i> Construction and Characterization of a Synthetic Gene for 2,5-Diketo-D-Gluconate <span class=SpellE>Reductase</span>, </i>Sanli, G., Blaber, S., <span class=SpellE>Khurana</span>, S. and Blaber, M. <i>Protein Science </i><b>8</b>, 65 (1999)<br> 47.<i> The Role of Low Concentrations of Guanidine HCl in Reversible Thermal Denaturation of Human Fibroblast Growth Factor-1, </i>Blaber, M., Blaber, S.I., <span class=SpellE>Culajay</span>, J.F., and <span class=SpellE>Khurana</span>, A. <i>FLACS</i> <b>52</b>, 10 (1999)<br> 46.<i> Proton Donor Promiscuity in an Aldo-<span class=SpellE>keto</span> <span class=SpellE>Reductase</span>, </i><span class=SpellE>Khurana</span>, S., Sanli, G., Powers, D.B., Anderson, S. and Blaber, M. <i>FLACS</i> <b>52</b>, 49 (1999)<br> 45.<i> Construction and Characterization of a Synthetic Gene for 2,5-Diketo-D-Gluconate <span class=SpellE>Reductase</span>, </i>Sanli, G., Blaber, S., <span class=SpellE>Khurana</span>, S. and Blaber, M. <i>FLACS</i> <b>52</b>, 49 (1999)<br> 44.<i> The Role of Low Concentrations of Guanidine HCl in Reversible Denaturation of Human Acidic Fibroblast Growth Factor-1, </i>Blaber, S.I., <span class=SpellE>Culajay</span>, J.F., <span class=SpellE>Khurana</span>, A. and Blaber, M. <i>Biophysical Journal</i>, <b>76</b>, A107 (1999)<br> 43.<i> <span class=SpellE>Deconvolution</span> of Calorimetric Data for Protein Stability Studies, </i>Grek, S., Davis, J. and Blaber, M. <i>Proceedings of the 1<sup>st</sup> Annual NASA Partners in Education and Research Conference </i>(1998)<br> 42.<i> Crystal Structure of 2,5-diketo-D-Gluconic Acid <span class=SpellE>Reductase</span> A <span class=SpellE>Complexed</span> with NADPH at 2.1Resolution, </i><span class=SpellE>Khurana</span>, S., Powers, D.B., <st1:place st="on" w:st="on"><st1:City st="on" w:st="on">Anderson</st1:City></st1:place>, S. and Blaber, M. <i>Protein Science </i><b>7<i> </i>(suppl. 1)</b>. 122 (1998)<br> 41.<i> Cysteine Residue Mutations in Human Acidic FGF and Effects upon Thermal Stability, </i><span class=SpellE>Culajay</span>, J.F., Blaber, S.I. and Blaber, M. <i>FLACS</i> <b>51</b>, 44 (1998)<br> 40.<i> Structural Influence on Specificity and Catalytic Behavior in Serine Proteases, </i><span class=SpellE>Badisa</span>, R.B., Blaber, S.I. and Blaber, M. <i>FLACS</i> <b>51</b>, 44 (1998)<br> 39.<i> Evaluation and Characterization of Mutations of Human Acidic Fibroblast Growth Factor to Enhance Thermal Stability and Biological Activity, </i>Grek, S., <span class=SpellE>Culajay</span>, J.F. and Blaber, M. <i>21<sup>st</sup> Annual Research Seminar, American Cancer Society</i> (1998)<br> 38.<i> Effects of Low Concentrations of Guanidine Hydrochloride on the Stability and Reversible Denaturation of Human Acidic Fibroblast Growth Factor, </i>Blaber, S. and Blaber, M. <i>Proceedings of the 3<sup>rd</sup> Annual Johns Hopkins Protein Folding Meeting (1998)<br> </i>37.<i> Structure Solved for Key Enzyme in Vitamin C Production, </i>Blaber, M. <i>Industrial <span class=SpellE>Bioprocessing</span></i> <b>19</b>, 5 (1997)<br> 36.<i> Modulation of protein stability, </i>Blaber, M. <i>FLACS</i> <b>50</b>, 33 (1997)<br> 35.<i> The preliminary x-ray characterization and molecular replacement studies with 2,5-diketo-D-gluconate <span class=SpellE>reductase</span> crystals, </i><span class=SpellE>Khurana</span>, S., Powers, D. and Blaber, M. <i>FLACS</i> <b>50</b>, 39 (1997)<br> 34.<i> An approach to accurate DSC analyses of irreversibly unfolding proteins, </i><span class=SpellE>Adamek</span>, D., Blaber, S., <span class=SpellE>Culajay</span>, J.F. and Blaber, M. <i>FLACS</i> <b>50</b>, 59 (1997)<br> 33.<i> Contribution of the cysteine residues to the thermal and physiological stability of the human acidic fibroblast growth factor, </i><span class=SpellE>Culajay</span>, J.F., Blaber, S., <span class=SpellE>Adamek</span>, D., <span class=SpellE>Khurana</span>, S. and Blaber, M. <i>FLACS</i> <b>50</b>, 59 (1997)<br> 32.<i> Mechanisms of Regulation of Human Acidic Fibroblast Growth Factor, </i>Blaber, M., <span class=SpellE>Adamek</span>, D., Blaber, S., <span class=SpellE>Culjay</span>, J. and <span class=SpellE>Khurana</span>, S. <i>20<sup>th</sup> Annual Research Seminar American Cancer Society, <st1:State w:st="on"><st1:place w:st="on">Florida</st1:place></st1:State> Division (1997)<br> </i>31.<i> Avoiding the Aggravation of Aggregation: Denaturation Studies of Acidic Fibroblast Growth Factor, </i><span class=SpellE>Adamek</span>, D., Grek, S., Blaber, S. and Blaber, M. <i>Proceedings of the 5<sup>th</sup> Annual <span class=SpellE>Suddath</span> Symposium (1997) <br> </i>30.<i> The Use of Low Concentration Guanidine Hydrochloride to Achieve Reversible Thermal Denaturation of Acidic Fibroblast Growth Factor, </i><span class=SpellE>Adamek</span>, D., Blaber, S. and Blaber, M. <i>Proceedings of the 2<sup>nd</sup> Annual Johns Hopkins Protein Folding Meeting (1997)<br> </i>29.<i> Denaturation Studies of Human Acidic Fibroblast Growth Factor, </i><span class=SpellE>Adamek</span>, D., Popovic, A., Blaber, S. and Blaber, M. <i>First International Conference on the Applications of <span class=SpellE>Biocalorimetry</span></i>, R-01 (1996)<br> 28.<i> Contribution of Free Cysteine Residues to the Stability of Human Acidic Fibroblast Growth Factor, </i>Popovic, A., <span class=SpellE>Adamek</span>, D., Blaber, S. and Blaber, M. <i>First International Conference on the Applications of <span class=SpellE>Biocalorimetry</span></i>, P-19 (1996)<br> 27.<i> X-ray Crystal Structure of Human Acidic Fibroblast Growth Factor, </i>Blaber, M. <i>Protein Science</i> <b>5 (suppl. 1),</b> 101 (1996)<br> 26.<i> Crystallographic Analysis of the Central Cavity of Interleukin-1b, </i>Blaber, M., Yu, B., Bhyravbhatla, B. and Caspar, D.L.D. <i>International Conference on Protein Folding and Design, National Institutes of Health</i> (1996)<br> 25.<i> Structure and Function Studies of Mouse Glandular Kallikreins, </i>Lang, E. and Blaber, M. <i>Proceedings of the 4<sup>th</sup> Annual <span class=SpellE>Suddath</span> Symposium (1996)<br> </i>24.<i> Stability Studies of Human Acidic Fibroblast Growth Factor. I. Effect of pH on the Enthalpy of Unfolding, </i>Popovic, A., <span class=SpellE>Adamek</span>, D. and Blaber, M. <i>Proceedings of the 4<sup>th</sup> Annual <span class=SpellE>Suddath</span> Symposium</i> (1996)<br> 23.<i> Stability Studies of Human Acidic Fibroblast Growth Factor. II. Effect of Denaturants on the Reversibility of Unfolding, </i><span class=SpellE>Adamek</span>, D., Popovic, A. and Blaber, M. <i>Proceedings of the 4<sup>th</sup> Annual <span class=SpellE>Suddath</span> Symposium</i> (1996)<br> 22.<i> X-ray Crystal Structure of Human Acidic Fibroblast Growth Factor, </i>Blaber, M. <i>Proceedings of the 4<sup>th</sup> Annual <span class=SpellE>Suddath</span> Symposium</i> (1996)<br> 21.<i> Structure of Human Acidic Fibroblast Growth Factor, </i>Blaber, M. <i>19<sup>th</sup> Annual Research Seminar, American Cancer Society</i> (1996)<br> 20.<i> pH Studies of Human Acidic Fibroblast Growth Factor, </i><span class=SpellE>Adamek</span>, D., Popovic, A. and Blaber, M. <i>19<sup>th</sup> Annual Research Seminar, American Cancer Society</i> (1996)<br> 19.<i> Protein Stability as a Regulatory Mechanism, </i>Blaber, M. <i>FLACS</i> <b>48</b>, 65 (1995)<br> 18.<i> Structure and Specificity Relationships in Serine Proteases, </i>Lang, E. and Blaber, M. <i>FLACS</i> <b>48</b>, 45 (1995)<br> 17.<i> Buried Cysteine Residues and Irreversible Protein Denaturation, </i>Popovic, A. and Blaber, M. <i>FLACS</i> <b>48</b>, 42 (1995)<br> 16.<i> Crystallographic Analysis of Mouse Pro-<span class=SpellE>renin</span> Converting Enzyme, </i>Blaber, M. <i>J. Cell. <span class=SpellE>Biochem</span>.</i>, <b>Suppl. 18D</b>, 151 (1994)<br> 15.<i> Data Collection from Crystals of Escherichia coli b-<span class=SpellE>Galactosidase</span>, </i>Jacobson, R.H., Blaber, M., Dubose, R.F. and Matthews, B.W. <i>Photon Factory Activity Report</i> <b>11</b>, 79 (1993)<br> 14.<i> Alpha Helix Propensity of Amino Acids - Technical Note </i>Blaber, M., Zhang, X.-J. and Matthews, B.W. <i>Science </i><b>262, </b>917-918 (1993)<br> 13.<i> Mutations Affecting Solvent Accessibility in a-Helices, </i>Blaber, M., <span class=SpellE>Baase</span>, W.A. and Matthews, B.W. <i>Protein Society, 6th Symposium Proceedings</i>, 45 (1992)<br> 12.<i> Structural and Thermodynamic Consequences of Mutations which Introduce a Hydroxyl Group in T4 <span class=SpellE>Lysozyme</span>, </i><span class=SpellE>Gassner</span>, N., Blaber, M., Lindstrom, J.D. and Matthews, B.W. <i>Protein Society, 6th Symposium Proceedings</i>, 45 (1992)<br> 11.<i> Structural And Genetic Analysis Of The Interactions That Stabilize Proteins, </i>Dao-pin, S., Nicholson, H., Zhang, X.-J., <span class=SpellE>Baase</span>, W.A., Blaber, M., Heinz, D. and Matthews, B.W. <i>J. Cell. <span class=SpellE>Biochem</span>.</i> <b>15G</b>, 46 (1991)<br> 10.<i> Alanine-Serine Substitutions Within a-Helical Secondary Structure: Effects Upon Protein Stability, </i>Blaber, M. and Matthews, B.W. <i>J. Cell. <span class=SpellE>Biochem</span>.</i> <b>15G</b>, 205 (1991)<br> 9.<i> Processing of Growth Factor Precursors, </i>Bradshaw, R.A., Blaber, M. and <span class=SpellE>Isackson</span>, P.J. <i>J. Cell. <span class=SpellE>Biochem</span>.</i> <b>15G</b>, 106 (1991)<br> 8.<i> The <span class=SpellE>Kunitz</span> Protease <span class=SpellE>Inhibitory</span> Domain of the Beta-amyloid Precursor Protein is Sufficient for its Protease <span class=SpellE>Inhibitory</span> Properties, </i><span class=SpellE>Sinha</span>, S., <span class=SpellE>Dovey</span>, H.F., <span class=SpellE>Seubert</span>, P., Ward, P.J., <span class=SpellE>Blacher</span>, R.W., Blaber, M., Bradshaw, R.A., <span class=SpellE>Arici</span>, M., Mobley, W.C. and <span class=SpellE>Lieberburg</span>, I. <i>Neurobiology of Aging</i> <b>11</b>, 311 (1990)<br> 7.<i> Processing of Recombinant Nerve Growth Factor, </i><span class=SpellE>Isackson</span>, P.J., Blaber, M., Cavanaugh, K. and Bradshaw, R.A. <span class=SpellE><i>Trophic</i></span><i> Agents V, Society for Neuroscience Abstracts</i> <b>15</b>, 866 (1989)<br> 6. <i>Epidermal growth-factor binding-protein - A model serine protease for enzyme engineering</i>, Blaber, M., <span class=SpellE>Isackson</span>, P.J. and Bradshaw, R.A., <i>Journal of Cellular Biochemistry</i> <b>Suppl. 11C</b>, 223 (1987)<br> 5.<i> Growth Factor Processing: Molecular <span class=SpellE>Modelling</span> of EGF and NGF Associated Kallikreins, </i>Blaber, M., Blevins, R., Thomas, K.A., <span class=SpellE>Isackson</span>, P.J. and Bradshaw, R.A. <span class=SpellE><i>Abst</i></span><i>. 1st <span class=SpellE>Symp</span>. Protein Soc. (San Diego, CA) </i>42<i> </i>(1987)<br> 4.<i> Natural and Recombinant High Molecular Weight <span class=SpellE>Urokinase</span> Contain a <span class=SpellE>Kringle</span> Specific <span class=SpellE>Benzamidine</span> Binding Site, </i>Blaber, M. and Winkler, M.E. <span class=SpellE><i>Thromb</i></span><i>. <span class=SpellE>Haemostasis</span></i> <b>54</b>, 103 (1985)<br> 3.<i> Molecular Characterization of Human Urokinase Produced in Bacteria as Compared to Urokinase Obtained from Human Urine, </i>Steffens, G.J., <span class=SpellE>Gunzler</span>, W.A., <span class=SpellE>Henninger</span>, W., <span class=SpellE>Hennies</span>, H.H., Kim, S.M.A., <span class=SpellE>Otting</span>, F., <span class=SpellE>Frankus</span>, E., <span class=SpellE>Flohe</span>, L., Blaber, M. and Winkler, M.E. <span class=SpellE><i>Haemostasis</i></span> <b>14</b>, 60 (1984)<br> 2.<i> Functional Characterization of Human Urokinase Produced in Bacteria as Compared to Urokinase Obtained from Human Urine, </i><span class=SpellE>Gunzler</span>, W.A., <span class=SpellE>Henninger</span>, W., <span class=SpellE>Hennies</span>, H.H., <span class=SpellE>Otting</span>, G., Schneider, J., <span class=SpellE>Frederichs</span>, E., <span class=SpellE>Giertz</span>, H., <span class=SpellE>Flohe</span>, L., Blaber, M. and Winkler, M.E. <span class=SpellE><i>Haemostasis</i></span> <b>14</b>, 60 (1984)<br> 1.<i> The Comparison of E. coli Recombinant Urokinase with Natural Urokinase, </i>Winkler, M.E., Blaber, M. and <span class=SpellE>Vehar</span>, G.A. <span class=SpellE><i>Thromb</i></span><i>. <span class=SpellE>Haemostasis</span></i> <b>50</b>, 386 (1983)<o:p></o:p></span></p> <div class=MsoNormal align=center style='text-align:center'><span style='font-family:"Arial","sans-serif";mso-bidi-font-family:"Times New Roman"'> <hr size=1 width="100%" align=center> </span></div> <p><i><span lang=DE style='font-size:7.5pt;font-family:"Arial","sans-serif"; mso-bidi-font-family:"Times New Roman";color:red;mso-ansi-language:DE'>(c) 2011 Michael Blaber, Ph.D.<o:p></o:p></span></i></p> </div> </body> </html>